Ensembl_ID	Gene_symbol	logFC	FDR	Comparison	LncBook ID	Type	Conservation	miRNA	GWAS	nearest PC	Top correlated gene
ENSG00000103472	RRN3P2	-2.49440270905817	0.00344208874048779	LPS_vs_PBS	HSALNG0110562	integenic	Not conserved	NA	NA	LAT	PPARGC1A
ENSG00000163081	CCDC140	4.31625160408828	0.00191794771494615	LPS_vs_PBS	NA	NA	NA	NA	NA	SGPP2	SPATA13-AS1
ENSG00000175147	TMEM51-AS1	-1.77905996018645	0.00158405027845066	LPS_vs_PBS	HSALNG0001056	anti_sense	Q50	hsa-miR-25-5p,hsa-miR-1203,hsa-miR-4492,hsa-miR-2467-3p	-	CASP9	SNED1
ENSG00000176124	DLEU1	-2.74644220934423	1.71922053037664e-11	LPS_vs_PBS	HSALNG0097105	anti_sense	Q50	hsa-miR-30b-3p,hsa-miR-619-5p,hsa-miR-4286,hsa-miR-4710,hsa-miR-7152-5p,hsa-miR-8485	Bmi-adjusted waist-hip ratio,Appendicular lean mass; Monocyte count,Sex hormone-binding globulin measurement,Body height,Serum alanine aminotransferase measurement; Forced expiratory volume; Lean body mass; Body height; Vital capacity; Triglyceride measurement,Intelligence,Serum alanine aminotransferase measurement; Sex hormone-binding globulin measurement; Glomerular filtration rate; Creatinine measurement; Bmi-adjusted waist-hip ratio,Bmi-adjusted hip circumference,Monocyte percentage of leukocytes; Monocyte count,Diabetic maculopathy,Body height; Bmi-adjusted hip circumference,Basophil count,Lymphocyte percentage of leukocytes; Lymphocyte count,Leukocyte count,Electrocardiography,Psoriasis,Psoriasis; Bmi-adjusted hip circumference; Primary biliary cirrhosis; Bmi-adjusted waist-hip ratio; Autoimmune disease,Appendicular lean mass,Hematocrit; Hemoglobin measurement; Erythrocyte count,Hypothyroidism,Snoring measurement; Aortic root size,Eczema; Allergic rhinitis,High density lipoprotein cholesterol measurement,Celiac disease,Leukocyte count; Lymphocyte count,Tnf-related apoptosis-inducing ligand measurement,Fatty acid measurement,Diffuse large b-cell lymphoma; Bmi-adjusted hip circumference; Chronic lymphocytic leukemia; Triglyceride measurement,Hematocrit; Hemoglobin measurement,Thyroid peroxidase antibody measurement,Lipoprotein a measurement,Creatinine measurement; Glomerular filtration rate,Eosinophil count; Eosinophil percentage of granulocytes; Eosinophil percentage of leukocytes,Adiponectin measurement,Bmi-adjusted adiponectin measurement,Body mass index,Low density lipoprotein cholesterol measurement,Bmi-adjusted hip circumference; Bmi-adjusted waist-hip ratio,Triglyceride measurement,Left ventricular structural measurement,Fear of severe pain measurement,Hemoglobin measurement,Gamma-aminoisobutyric acid measurement,Eosinophil count,Heel bone mineral density,Prostate carcinoma,Grip strength measurement,Prostate specific antigen measurement,Blood urea nitrogen measurement; Forced expiratory volume,Grip strength measurement; Appendicular lean mass,Magnesium measurement,Caudal anterior cingulate cortex volume measurement,Blood urea nitrogen measurement,Breast carcinoma,Puberty; Heel bone mineral density; Bmi-adjusted hip circumference; Body height; Height growth measurement,Body height; Diastolic blood pressure; Systolic blood pressure,Hip circumference,Body height; Cardiovascular disease; Bmi-adjusted hip circumference; Systolic blood pressure,Transforming growth factor beta measurement,Primary biliary cirrhosis,Appendicular lean mass; Bmi-adjusted hip circumference,Body weight,Waist-hip ratio; Bmi-adjusted waist-hip ratio,Bmi-adjusted waist circumference; Bmi-adjusted waist-hip ratio,Protein measurement,Tumor necrosis factor-alpha measurement,Urinary albumin to creatinine ratio,Body height; Attention deficit hyperactivity disorder,Hematocrit,Bmi-adjusted waist circumference,Osteosarcoma; Bmi-adjusted hip circumference; Bmi-adjusted waist-hip ratio; Inguinal hernia,Bmi-adjusted waist circumference; Bmi-adjusted hip circumference; Waist-hip ratio; Bmi-adjusted waist-hip ratio,Interleukin 9 measurement,Waist-hip ratio; Bmi-adjusted waist-hip ratio; Triglyceride measurement,Snoring measurement,Sphingomyelin 22:0 measurement,Platelet component distribution width,Lymphocyte count,Total blood protein measurement,Hematocrit; Odontogenesis,Blood phosphate measurement,Platelet count,Reticulocyte count; Reticulocyte measurement,Reticulocyte measurement,Hemorrhoid,Anthropometric measurement; Brachial circumference,Bipolar disorder; Unipolar depression,Benign prostatic hyperplasia; Lower urinary tract symptom,Platelet-to-lymphocyte ratio,Eosinophil count; Eosinophil percentage of leukocytes,Total cholesterol measurement,Adolescent idiopathic scoliosis,-	RNASEH2B	ZNF345
ENSG00000176349	NA	-3.372894616752	0.00182647882904261	LPS_vs_PBS	NA	NA	NA	NA	NA	ELFN1	ENSG00000224207
ENSG00000177133	PRDM16-DT	2.98179696482245	0.0183696427521116	LPS_vs_PBS	HSALNG0000303	anti_sense	Q50	hsa-miR-612,hsa-miR-1180-5p,hsa-miR-663b,hsa-miR-1207-3p,hsa-miR-4472,hsa-miR-3960,hsa-miR-4638-5p,hsa-miR-4710,hsa-miR-6787-5p,hsa-miR-6894-3p,hsa-miR-8072	Waist-hip ratio; Bmi-adjusted waist-hip ratio; Monocyte count,Bmi-adjusted waist circumference,Platelet crit; Monocyte count,Platelet crit,Monocyte count,Myocardial infarction,-	TTC34	PPARD
ENSG00000177340	FLJ13224	2.93517454865886	6.55839917794157e-4	LPS_vs_PBS	NA	NA	NA	NA	NA	DDX11	KLHL29
ENSG00000177369	FLJ40194	-3.61094567316099	1.3296156022542e-6	LPS_vs_PBS	HSALNG0117173	integenic	Not conserved	hsa-miR-6089	Testosterone measurement	ABI3	ARHGEF40
ENSG00000177406	NINJ2-AS1	-1.99836526660543	3.45666886866115e-6	LPS_vs_PBS	HSALNG0088498	anti_sense	Q50	hsa-miR-6809-3p	Platelet component distribution width,Mean platelet volume; Lymphocyte count; Platelet crit; Neutrophil percentage of leukocytes; Platelet count; Monocyte count,Soluble triggering receptor expressed on myeloid cells 2 measurement,Monocyte percentage of leukocytes,Monocyte count,Granulocyte percentage of myeloid white cells; Monocyte percentage of leukocytes,-	B4GALNT3	LYL1
ENSG00000177788	RAB4A-AS1	-3.88177821944626	2.88027411644096e-8	LPS_vs_PBS	HSALNG0011302	anti_sense	Not conserved	hsa-miR-188-3p,hsa-miR-4281,hsa-miR-3620-5p,hsa-miR-1587,hsa-miR-4733-3p,hsa-miR-2467-3p,hsa-miR-8485	Response to antidepressant,Mean arterial pressure; Alcohol drinking,Parental genotype effect measurement; Food allergy measurement,-	CCSAP	ENSG00000267533
ENSG00000178803	ADORA2A-AS1	4.57322357242812	3.69404369514874e-16	LPS_vs_PBS	HSALNG0134495	anti_sense	Q50	hsa-miR-370-3p,hsa-miR-6807-3p	Alcohol consumption measurement,Acne,Sodium measurement,Glucagon measurement,Coffee consumption measurement,Supramarginal gyrus volume measurement,Tea consumption measurement,Cups of coffee per day measurement,Serum gamma-glutamyl transferase measurement,Coffee consumption measurement; Tea consumption measurement,Alcohol use disorder measurement; Alcohol consumption measurement,-	GUCD1	TSLP
ENSG00000178977	LINC00324	-2.72587377745547	2.76000226366767e-7	LPS_vs_PBS	HSALNG0114404	overlap_sense,sense	Q75	hsa-miR-23a-5p,hsa-miR-1260b,hsa-miR-4526	Apolipoprotein a 1 measurement,Mitochondrial dna measurement,Panic disorder; Anxiety disorder,Diastolic blood pressure,-,Neuroticism measurement,Monocyte count	CTC1	CCSAP
ENSG00000179406	LINC00174	-1.39349549742393	0.00126899398257611	LPS_vs_PBS	HSALNG0058597	integenic	Not conserved	NA	NA	GUSB	KIZ
ENSG00000180539	LINC02908	-3.99417020836419	1.64480618870789e-16	LPS_vs_PBS	HSALNG0075339	anti_sense	Q50	hsa-miR-210-5p,hsa-miR-619-5p,hsa-miR-4308,hsa-miR-4270,hsa-miR-6752-3p	Leukocyte count,Lymphocyte count,-	PAXX	MAEA
ENSG00000181577	LINC03040	3.6610421341514	2.69247068634486e-8	LPS_vs_PBS	NA	NA	NA	NA	NA	TMEM63B	MAP1LC3A
ENSG00000181800	CELF2-AS1	-2.73713378074415	4.959365524379e-6	LPS_vs_PBS	HSALNG0142713	anti_sense	Not conserved	NA	NA	USP6NL	CIITA
ENSG00000183154	NA	-4.75221515276289	4.62955575128521e-8	LPS_vs_PBS	HSALNG0150383	anti_sense	Q75	NA	-	BRF2	TRIM45
ENSG00000183242	WT1-AS	4.41977163976346	0.00131076649277244	LPS_vs_PBS	HSALNG0083478	integenic	Q90	NA	-	EIF3M	CNIH3-AS1
ENSG00000183250	LINC01547	-1.47268897787265	0.0210732561048393	LPS_vs_PBS	HSALNG0133586	integenic	Not conserved	hsa-miR-1268b,hsa-miR-1273h-5p	Heel bone mineral density	ITGB2	ENSG00000267801
ENSG00000184441	NA	-1.39771944287206	0.0326161542877022	LPS_vs_PBS	HSALNG0133526	anti_sense	Not conserved	hsa-miR-4447,hsa-miR-4472,hsa-miR-4781-5p,hsa-miR-6748-3p	-	PFKL	GIGYF1
ENSG00000185433	LINC00158	5.59303550026611	1.9540322683430702e-14	LPS_vs_PBS	HSALNG0132374	integenic	Not conserved	NA	NA	MRPL39	LINC03025
ENSG00000186235	LINC02610	-2.76303508693942	7.84032246792912e-4	LPS_vs_PBS	HSALNG0023418	integenic	Not conserved	hsa-miR-3620-5p,hsa-miR-4492,hsa-miR-4505,hsa-miR-1587,hsa-miR-4685-3p,hsa-miR-6753-5p,hsa-miR-6784-5p,hsa-miR-1273h-5p,hsa-miR-7846-3p,hsa-miR-8072	Chronotype measurement	HES6	CDCA3
ENSG00000188185	LINC00265	-1.66398692133155	0.00251972516594558	LPS_vs_PBS	HSALNG0057380	sense	Not conserved	hsa-miR-3925-3p,hsa-miR-6089	-	RALA	SIRT5
ENSG00000196668	LINC00173	3.54357420350999	0.0341649766860807	LPS_vs_PBS	HSALNG0094327	integenic	Q75	hsa-miR-4297,hsa-miR-7109-5p	-	MAP1LC3B2	TBX5
ENSG00000196810	CTBP1-DT	-1.52493449020012	0.00173646077197548	LPS_vs_PBS	HSALNG0032263	anti_sense	Not conserved	hsa-miR-505-5p	Pulse pressure measurement,-	MAEA	ENSG00000273387
ENSG00000197536	IRF1-AS1	3.5090275640972	1.2108671468202002e-16	LPS_vs_PBS	HSALNG0044848	anti_sense,sense	Q50	hsa-miR-33b-5p,hsa-miR-4257,hsa-miR-4463,hsa-miR-6748-3p,hsa-miR-6803-5p	Fibrinogen measurement,Chronic obstructive pulmonary disease,Metabolite measurement,Apolipoprotein b measurement,Glycine measurement,Red blood cell distribution width,Neutrophil percentage of leukocytes,Ulcerative colitis; Diastolic blood pressure; Inflammatory bowel disease; Crohn's disease,Psoriasis; Inflammatory bowel disease; Ulcerative colitis; Ankylosing spondylitis; Crohn's disease; Adult onset asthma; Sclerosing cholangitis,Fibrinogen measurement; Sex hormone-binding globulin measurement,Urinary albumin to creatinine ratio,Diastolic blood pressure; Crohn's disease,Atopic asthma,Eosinophil count; Eosinophil percentage of leukocytes,Mean corpuscular hemoglobin,Nasal cavity polyp; Perceived unattractiveness to mosquitos measurement; Adult onset asthma,Serum metabolite measurement; Low density lipoprotein cholesterol measurement; Crohn's disease; Eczema; Systemic juvenile idiopathic arthritis, polyarticular juvenile idiopathic arthritis, rheumatoid factor negative, oligoarticular juvenile idiopathic arthritis; Rheumatoid arthritis; Aspartate aminotransferase measurement,Respiratory system disease; Adult onset asthma,Carotid plaque build,Low density lipoprotein cholesterol measurement,Chronic obstructive pulmonary disease; Smoking status measurement,Neutrophil count,Fibrinogen measurement; Lymphocyte count,Polycystic ovary syndrome,Fibrinogen measurement; Sex hormone-binding globulin measurement; Balding measurement,Neutrophil percentage of granulocytes; Eosinophil percentage of granulocytes; Mosquito bite reaction itch intensity measurement; Basophil count; Mosquito bite reaction size measurement; Eosinophil percentage of leukocytes; Eosinophil count,Mitochondrial dna measurement,Estrogen-receptor positive breast cancer; Breast carcinoma,Inhalant adrenergic use measurement,Cardiovascular disease,Eosinophil count,Diastolic blood pressure,Lymphocyte percentage of leukocytes,Total cholesterol measurement; Low density lipoprotein cholesterol measurement,Platelet count,Platelet crit,Psoriasis; Ulcerative colitis; Ankylosing spondylitis; Crohn's disease; Sclerosing cholangitis,Eczema; Allergic rhinitis,Fev/fec ratio,Autoimmune thyroid disease; Psoriasis; Common variable immunodeficiency; Mosquito bite reaction itch intensity measurement; Ulcerative colitis; Ankylosing spondylitis; Basophil count; Systemic lupus erythematosus; Crohn's disease; Mosquito bite reaction size measurement; Celiac disease; Autoimmune disease; Juvenile idiopathic arthritis,Psoriasis; Ulcerative colitis; Ankylosing spondylitis; Leukocyte count; Crohn's disease; Eosinophil percentage of leukocytes; Eosinophil count; Sclerosing cholangitis; Aspartate aminotransferase measurement,Hemoglobin a1 measurement,Reticulocyte count; Reticulocyte measurement,-	NA	ENSG00000225886
ENSG00000197670	NA	-1.56971382242656	0.021315844827128	LPS_vs_PBS	HSALNG0130935	anti_sense	Not conserved	NA	Mean reticulocyte volume; Sex hormone-binding globulin measurement; Mean corpuscular volume; Erythrocyte count,Lymphocyte count	TSHZ2	AHRR
ENSG00000197989	SNHG12	-2.27584794137342	4.4960166030093995e-12	LPS_vs_PBS	HSALNG0002075	anti_sense	Q50	hsa-miR-363-5p,hsa-miR-324-5p,hsa-miR-3178,hsa-miR-4466,hsa-miR-6089,hsa-miR-6890-3p	-	TAF12	FAM168B
ENSG00000198711	SSBP3-AS1	-2.90425305880898	1.84120638489221e-5	LPS_vs_PBS	HSALNG0141766	anti_sense	Q50	NA	-	MRPL37	GRK3
ENSG00000203327	NA	-3.46914335945795	0.00215305825968823	LPS_vs_PBS	HSALNG0014994	sense	Not conserved	hsa-miR-6089	NA	CLHC1	ADCY10P1
ENSG00000203364	NA	3.79113233171705	0.0176110233470048	LPS_vs_PBS	HSALNG0072823	anti_sense	Not conserved	hsa-miR-4488,hsa-miR-6089,hsa-miR-6763-5p	Serum alanine aminotransferase measurement; Aspartate aminotransferase measurement,Aspartate aminotransferase measurement,Dna methylation,Response to tenofovir	CARD19	LINC02995
ENSG00000203395	NA	3.14911334293791	0.0240137669216969	LPS_vs_PBS	HSALNG0015689	anti_sense	Q50	hsa-miR-1268b	NA	CNRIP1	RHOF
ENSG00000203446	SUGCT-AS1	2.13000221506051	7.43666360381332e-4	LPS_vs_PBS	HSALNG0057426	anti_sense	Q90	hsa-miR-6089,hsa-miR-6824-3p	-	MPLKIP	RPS6KA3
ENSG00000203644	NA	-1.19251140095532	0.0161259101640565	LPS_vs_PBS	HSALNG0147928	sense	Not conserved	NA	NA	TMCC1	ENSG00000279088
ENSG00000203804	ADAMTSL4-AS1	3.18554036041697	2.55953481642295e-4	LPS_vs_PBS	HSALNG0007053	anti_sense,sense	Q50	hsa-miR-30b-3p,hsa-miR-3196,hsa-miR-4508,hsa-miR-7160-3p	Aspartate aminotransferase measurement,Pulse pressure measurement,Eosinophil count; Eosinophil percentage of leukocytes,Basophil count,Total blood protein measurement; Neutrophil percentage of leukocytes; Blood protein measurement,Oral ulcer,Coronary artery disease,-	MCL1	RASSF5
ENSG00000203865	ATP1A1-AS1	-1.49074879838501	0.00842173563098585	LPS_vs_PBS	HSALNG0006325	anti_sense	Q50	hsa-miR-1207-5p,hsa-miR-6891-5p	Leukocyte count; Myeloid white cell count,-,Leukocyte count	CD58	EGR2
ENSG00000204054	LINC00963	-2.28859486347607	5.00517972449716e-13	LPS_vs_PBS	HSALNG0074742	integenic	Q75	hsa-miR-30b-3p,hsa-miR-619-5p,hsa-miR-1268b,hsa-miR-378g,hsa-miR-4686,hsa-miR-2467-5p,hsa-miR-5088-5p,hsa-miR-6089,hsa-miR-6742-5p,hsa-miR-6803-5p	Body height,-	NTMT1	RMND5A
ENSG00000204261	PSMB8-AS1	1.86137691494807	2.12412534854042e-6	LPS_vs_PBS	HSALNG0049455	anti_sense,sense	Q75	NA	Systemic lupus erythematosus,Iga glomerulonephritis,Kidney disease,-,Platelet-to-lymphocyte ratio,Autoimmune disease	PSMB9	GOLPH3
ENSG00000204685	STARD7-AS1	-1.24390765974506	0.00856435026602329	LPS_vs_PBS	HSALNG0017031	integenic	Not conserved	hsa-miR-676-3p	NA	CIAO1	PGBD2
ENSG00000205300	NA	2.65315572872851	0.0222229742924112	LPS_vs_PBS	HSALNG0128297	integenic	Q50	hsa-miR-6769b-5p	Vital capacity,Platelet-derived growth factor bb measurement,-	RNF24	HIVEP3
ENSG00000205444	KU-MEL-3	5.36088355721085	9.82387107015119e-5	LPS_vs_PBS	HSALNG0047755	integenic	Not conserved	hsa-miR-3619-5p	Balding measurement,-	CDYL	SMARCA1
ENSG00000205562	FLRT2-AS1	-3.55779028228425	0.0191840797941682	LPS_vs_PBS	HSALNG0102926	integenic	Q50	NA	-	GALC	SH3BP5-AS1
ENSG00000206344	HCG27	2.15693525394396	0.00103418438980007	LPS_vs_PBS	HSALNG0049246	integenic	Not conserved	hsa-miR-4640-3p,hsa-miR-6769b-5p	Sneeze,Multiple myeloma,Platelet-to-lymphocyte ratio,Bmi-adjusted waist-hip ratio,Squamous cell lung carcinoma; Peptic ulcer and gastro-oesophageal reflux disease (gord) drug use measurement; Upper aerodigestive tract neoplasm; Susceptibility to pneumonia measurement,Blood protein measurement,Intelligence; Diastolic blood pressure; Susceptibility to mycobacterium tuberculosis infection measurement,Cytokine measurement,Bmi-adjusted hip circumference; Bmi-adjusted waist-hip ratio,Susceptibility to shingles measurement,Lymphocyte count,Bmi-adjusted waist circumference,Bmi-adjusted hip circumference,Serum igg glycosylation measurement,Coronary artery disease,Platelet count,Autism spectrum disorder; Parental longevity,Von willebrand factor measurement,Bmi-adjusted waist circumference; Bmi-adjusted waist-hip ratio,Autism spectrum disorder,High density lipoprotein cholesterol measurement,Lung carcinoma,Response to thioamide; Drug-induced agranulocytosis,Handedness,Lupus nephritis; Blood protein measurement,-	TCF19	ENSG00000287543
ENSG00000206567	NA	-1.63931095492437	0.0222383183261104	LPS_vs_PBS	HSALNG0024081	sense	Not conserved	hsa-miR-3620-5p,hsa-miR-3650,hsa-miR-4472,hsa-miR-4486,hsa-miR-4505,hsa-miR-1587,hsa-miR-4747-3p,hsa-miR-6089	NA	EMC3	FAM83D
ENSG00000212694	LINC01089	-1.70323826067127	3.28339497993849e-6	LPS_vs_PBS	HSALNG0094605	anti_sense,sense	Q90	hsa-miR-525-3p,hsa-miR-524-3p,hsa-miR-762,hsa-miR-3692-5p,hsa-miR-4433a-3p,hsa-miR-4472,hsa-miR-3155b,hsa-miR-4787-5p,hsa-miR-5581-5p,hsa-miR-5787,hsa-miR-6763-5p,hsa-miR-6803-5p,hsa-miR-4433b-3p	Leukocyte count; Neutrophil count; Myeloid white cell count; Platelet crit,Mean platelet volume,Eosinophil count,-	RHOF	DNASE1
ENSG00000212719	LINC02693	-1.00273490805508	0.0130908269291322	LPS_vs_PBS	HSALNG0115274	integenic	Not conserved	hsa-miR-612,hsa-miR-4268,hsa-miR-3670,hsa-miR-4486,hsa-miR-4492,hsa-miR-4514,hsa-miR-6870-5p,hsa-miR-6879-5p	Protein measurement,-	NATD1	ENSG00000276096
ENSG00000213468	FIRRE	2.25281537157813	0.00226726880107425	LPS_vs_PBS	HSALNG0140173	integenic	Not conserved	hsa-miR-6089	NA	IGSF1	MYH11
ENSG00000213600	NA	-1.99591516201616	0.0158425403919626	LPS_vs_PBS	HSALNG0026005	intronic_sense	Not conserved	hsa-miR-4508	NA	GNAI2	ZNF850
ENSG00000213963	NA	-1.6484838019787	4.79980229925573e-5	LPS_vs_PBS	HSALNG0020668	sense	Not conserved	NA	NA	NFE2L2	GSE1
ENSG00000213994	NA	2.23650808883981	0.0426824818435103	LPS_vs_PBS	HSALNG0075928	anti_sense	Not conserved	hsa-miR-4279,hsa-miR-6860	Interleukin 2 receptor antagonist measurement,Cumulative dose response to bevacizumab,-	IL2RA	ENSG00000251922
ENSG00000214783	POLR2J4	-1.83919432244185	0.0113501674095665	LPS_vs_PBS	HSALNG0057608	anti_sense	Not conserved	NA	NA	URGCP	ENSG00000272777
ENSG00000214870	LINC02981	-1.74562927434487	0.0183440081959981	LPS_vs_PBS	HSALNG0056819	integenic	Not conserved	NA	NA	SNX10	BICD1
ENSG00000214894	LINC00243	3.4711983326659	0.0122363535026613	LPS_vs_PBS	HSALNG0049199	integenic	Not conserved	hsa-miR-619-5p,hsa-miR-6744-3p	Breast carcinoma,Mean platelet volume,Sleep duration,Cutaneous lupus erythematosus,Intelligence,Angina pectoris,Bmi-adjusted waist-hip ratio,Response to vaccine,Bmi-adjusted hip circumference,Reticulocyte count,Autoimmune thyroid disease; Bipolar disorder,Age-related macular degeneration,Reaction time measurement,Decreased fine motor function,17-hydroxyprogesterone measurement,Cytokine measurement,Protein measurement; Bmi-adjusted hip circumference,Bmi-adjusted hip circumference; Arterial stiffness measurement,Susceptibility to cold sores measurement,Susceptibility to plantar warts measurement,Susceptibility to chickenpox measurement,Susceptibility to shingles measurement,Autism spectrum disorder,Serum igg glycosylation measurement,Response to candesartan,Rosacea severity measurement,Cervical carcinoma,Eosinophil count,Glomerular filtration rate,Susceptibility to urinary tract infection measurement,Tonsillectomy risk measurement,Qrs amplitude; Qrs complex,Mosquito bite reaction size measurement; Mosquito bite reaction itch intensity measurement,-	IER3	NCOA4P2
ENSG00000214900	LINC01588	2.15933097586527	0.0014010910128519	LPS_vs_PBS	HSALNG0101158	integenic	Q50	NA	NA	VCPKMT	IQGAP1
ENSG00000215244	LINC02649	1.5413666181141	0.00852602908054518	LPS_vs_PBS	HSALNG0142500	integenic	Not conserved	NA	Rheumatoid arthritis,Thyroid preparation use measurement	PFKFB3	PALS1
ENSG00000215256	DHRS4-AS1	-1.19184458995662	0.0017613762591402	LPS_vs_PBS	HSALNG0100084	integenic	Q50	hsa-miR-8089	-	NRL	MORF4L2
ENSG00000215765	NA	4.61438743665973	0.00267611269726245	LPS_vs_PBS	HSALNG0127569	sense	Not conserved	NA	Blood protein measurement,Monocyte percentage of leukocytes,-	KIR2DL1	PTCHD3P2
ENSG00000215769	ARHGAP27P1-BPTFP1-KPNA2P3	-1.44198694437836	0.012512341057556	LPS_vs_PBS	HSALNG0118135	integenic	Not conserved	hsa-miR-5088-3p,hsa-miR-7108-3p,hsa-miR-10392-3p	-	LRRC37A3	RTL5
ENSG00000216863	LY86-AS1	-1.96672366502295	0.00306523479696063	LPS_vs_PBS	HSALNG0047825	integenic	Not conserved	NA	NA	F13A1	ALMS1
ENSG00000216895	RBM33-DT	-1.69695405763996	0.00111181658930647	LPS_vs_PBS	HSALNG0062595	anti_sense	Q75	hsa-miR-486-3p,hsa-miR-619-5p,hsa-miR-4723-3p	Self reported educational attainment,-	NA	ZNF573
ENSG00000218510	LINC00339	-2.21292179557879	7.33313610234017e-5	LPS_vs_PBS	HSALNG0001554	sense	Q90	hsa-miR-25-5p,hsa-miR-765,hsa-miR-4448,hsa-miR-4733-3p,hsa-miR-6088	Leukocyte count; Neutrophil count; Myeloid white cell count,Neutrophil count,Neutrophil percentage of leukocytes,Alkaline phosphatase measurement,Body height; Bmi-adjusted hip circumference,Age at first birth measurement,Bmi-adjusted hip circumference,Systolic blood pressure; Body mass index,-	NA	ZNF850
ENSG00000219665	ZNF433-AS1	-1.2928213509025	0.00947644811698597	LPS_vs_PBS	HSALNG0124080	anti_sense,sense	Q75	hsa-miR-619-5p,hsa-miR-4290,hsa-miR-4488,hsa-miR-6735-5p	Corneal endothelial cell measurement,Heel bone mineral density,-	NA	SRA1
ENSG00000221883	ARIH2OS	1.96184499352459	3.56583582749785e-4	LPS_vs_PBS	HSALNG0025886	anti_sense,sense	Q50	hsa-miR-619-5p,hsa-miR-6089	Platelet crit,-	SLC25A20	RORB
ENSG00000221949	LINC01465	3.85956951426319	3.2363694346571395e-11	LPS_vs_PBS	HSALNG0143651	integenic	Q75	hsa-miR-4447	-	PPM1H	ENSG00000289589
ENSG00000222004	LINC02860	-3.56955267241019	0.0136736857714801	LPS_vs_PBS	HSALNG0149622	integenic	Q90	hsa-miR-8485	NA	SNX10	RPSAP22
ENSG00000222041	CYTOR	1.73412320563812	3.56372237776838e-7	LPS_vs_PBS	HSALNG0016642	integenic	Not conserved	hsa-miR-519d-5p,hsa-miR-1343-3p,hsa-miR-5787,hsa-miR-6779-5p,hsa-miR-6800-3p,hsa-miR-6813-5p	Mitochondrial heteroplasmy measurement,-	PLGLB2	SAT1
ENSG00000222042	NA	4.61850757158703	0.00198473442262698	LPS_vs_PBS	HSALNG0132366	integenic	Not conserved	NA	NA	MRPL39	ZDHHC4P1
ENSG00000222043	NA	2.56379681022958	2.12492700986155e-5	LPS_vs_PBS	HSALNG0020654	anti_sense	Q75	hsa-miR-326,hsa-miR-1237-5p,hsa-miR-6889-5p	-	HNRNPA3	FOXC1
ENSG00000223387	LINC02068	6.14104961432013	6.9548696264230405e-9	LPS_vs_PBS	HSALNG0030744	integenic	Q75	hsa-miR-619-5p,hsa-miR-7150	Breast carcinoma,Serum alanine aminotransferase measurement; Sex hormone-binding globulin measurement; Hemoglobin measurement; Platelet crit; Monocyte percentage of leukocytes; Protein measurement; Tnf-related apoptosis-inducing ligand measurement; Serum gamma-glutamyl transferase measurement; Aspartate aminotransferase to alanine aminotransferase ratio; Platelet count; Triglyceride measurement; Hematocrit; Mean corpuscular volume; Aspartate aminotransferase measurement,Serum gamma-glutamyl transferase measurement,Sex hormone-binding globulin measurement; Serum albumin measurement,Sex hormone-binding globulin measurement; Renal cell carcinoma	NCEH1	HHIP-AS1
ENSG00000223446	NA	3.68030287575429	0.00753328201989982	LPS_vs_PBS	HSALNG0072817	integenic	Q50	hsa-miR-326,hsa-miR-619-5p,hsa-miR-4507,hsa-miR-5585-3p,hsa-miR-6132,hsa-miR-6764-5p,hsa-miR-6799-5p,hsa-miR-7112-5p	Body height,Adolescent idiopathic scoliosis	NINJ1	DSP-AS1
ENSG00000223511	LINC02968	2.54052029851415	0.0152253370067945	LPS_vs_PBS	HSALNG0151032	integenic	Not conserved	hsa-miR-512-5p	NA	ASMT	LINC02202
ENSG00000223534	HLA-DQB1-AS1	-1.97636461503217	0.0146992540727599	LPS_vs_PBS	HSALNG0049432	anti_sense	Q50	NA	Ulcerative colitis,Total cholesterol measurement; Adult onset asthma,Physical activity measurement,Epstein-barr virus infection; Antibody measurement; Unipolar depression,Nephrotic syndrome,Varicella zoster virus seropositivity,Cancer,Neutrophil count,Bmi-adjusted hip circumference,Susceptibility to scarlet fever measurement	HLA-DQA1	ENSG00000270001
ENSG00000223662	SAMSN1-AS1	4.14853633448109	0.00547460775731287	LPS_vs_PBS	HSALNG0131951	anti_sense	Q75	NA	-	RBM11	RNU2-6P
ENSG00000223692	DIP2A-IT1	-3.92030429584664	0.00779533179664748	LPS_vs_PBS	HSALNG0133742	sense	Q50	NA	S100 calcium-binding protein b measurement	DIP2A	ENSG00000226987
ENSG00000223711	NA	2.37410875748581	0.00620391191345477	LPS_vs_PBS	HSALNG0031810	anti_sense	Q50	hsa-miR-619-5p,hsa-miR-939-5p,hsa-miR-1237-5p,hsa-miR-4535,hsa-miR-6816-5p	-	MUC20	MIR5696
ENSG00000223745	CCDC18-AS1	-1.2164749238891	0.0020822990709265	LPS_vs_PBS	HSALNG0005250	anti_sense	Q75	hsa-miR-619-5p,hsa-miR-4768-3p	Triglyceride measurement,Neutrophil percentage of granulocytes; Eosinophil count; Eosinophil percentage of granulocytes,Self reported educational attainment,Testosterone measurement,Mathematical ability,-	TMED5	SEC31B
ENSG00000223768	LINC00205	-2.35812386094656	2.6767813413420898e-11	LPS_vs_PBS	HSALNG0133618	integenic	Q50	hsa-miR-92b-5p,hsa-miR-619-5p,hsa-miR-1205,hsa-miR-3692-5p,hsa-miR-3934-5p,hsa-miR-4472,hsa-miR-4505,hsa-miR-6751-3p,hsa-miR-6803-5p	Systemic lupus erythematosus,Bmi-adjusted waist-hip ratio,Bmi-adjusted waist circumference; Bmi-adjusted waist-hip ratio,Bmi-adjusted waist circumference,-	ADARB1	TRIM65
ENSG00000223834	NA	-4.94022938442436	8.53665650195044e-5	LPS_vs_PBS	HSALNG0077094	integenic	Q50	NA	-	ZEB1	ENSG00000260316
ENSG00000223842	NA	-3.46437513403393	0.0395929420410404	LPS_vs_PBS	HSALNG0010639	integenic	Not conserved	hsa-miR-7843-5p	NA	ZC3H11B	TIGD4
ENSG00000223855	PDGFA-DT	2.52866972887515	0.00353633026268041	LPS_vs_PBS	HSALNG0055544	anti_sense	Q90	hsa-miR-4508,hsa-miR-6789-3p	Balding measurement,Alopecia,-	DNAAF5	KRTCAP3
ENSG00000223882	ABCC5-AS1	-3.69054011898064	0.0327631814565185	LPS_vs_PBS	HSALNG0031195	anti_sense	Q50	NA	Leukocyte count; Myeloid white cell count; Monocyte percentage of leukocytes	HTR3D	CKAP2-DT
ENSG00000223901	NA	2.60319994955719	8.99719306394586e-4	LPS_vs_PBS	HSALNG0133720	anti_sense	Q50	NA	-	YBEY	ZDHHC4P1
ENSG00000223923	TNS1-AS1	3.99967279275381	0.012787287768242	LPS_vs_PBS	HSALNG0022218	anti_sense	Q50	hsa-miR-30b-3p,hsa-miR-4265,hsa-miR-6873-3p	Cognitive decline measurement,-	RUFY4	ENSG00000291158
ENSG00000223960	CHROMR	1.12388103366106	5.45888563474133e-5	LPS_vs_PBS	HSALNG0020702	anti_sense	Q50	hsa-miR-6089	Blood protein measurement,Psoriasis; Atopic eczema,-,Oligoclonal band measurement	OSBPL6	FAM111A
ENSG00000224078	SNHG14	-1.57834977988503	4.98434713008384e-7	LPS_vs_PBS	HSALNG0104546	anti_sense,sense	Q75	hsa-miR-30b-3p,hsa-miR-188-3p,hsa-miR-370-3p,hsa-miR-574-5p,hsa-miR-619-5p,hsa-miR-3176,hsa-miR-4268,hsa-miR-4430,hsa-miR-4478,hsa-miR-4492,hsa-miR-3064-3p,hsa-miR-4755-3p,hsa-miR-5193,hsa-miR-5693,hsa-miR-6845-5p,hsa-miR-6858-5p,hsa-miR-7109-5p	Panic disorder,Blood osmolality measurement,Neuroticism measurement,Myopia,Bone density,Inflammatory biomarker measurement; Ykl40 measurement,-	SNRPN	SOCS6
ENSG00000224116	INHBA-AS1	3.91973809343604	0.0034043493200254	LPS_vs_PBS	HSALNG0057482	integenic	Not conserved	hsa-miR-6124	NA	SUGCT	MTCO1P4
ENSG00000224186	PITX1-AS1	-2.50918219118277	2.0826328848216e-4	LPS_vs_PBS	HSALNG0045024	integenic	Not conserved	NA	NA	CATSPER3	PPIAP55
ENSG00000224307	LINC02975	-3.75583509213155	3.9599926697948e-11	LPS_vs_PBS	HSALNG0074715	integenic	Not conserved	hsa-miR-520a-5p,hsa-miR-4492,hsa-miR-4684-3p,hsa-miR-4748,hsa-miR-5693	NA	NA	MGME1
ENSG00000224376	NA	-2.65255427731557	0.00134354515825856	LPS_vs_PBS	HSALNG0022936	integenic	Not conserved	hsa-miR-4481,hsa-miR-4726-5p	Electrocardiography; Monocyte percentage of leukocytes,Monocyte count	B3GNT7	ENSG00000227698
ENSG00000224418	STK24-AS1	4.8524867858765	2.36772918436277e-11	LPS_vs_PBS	HSALNG0098863	anti_sense	Q50	hsa-miR-4447,hsa-miR-6826-3p,hsa-miR-10392-3p	Body height; Body mass index,Body mass index,-	FARP1	TSPAN33
ENSG00000224478	NA	3.29765368578785	0.026971988633895	LPS_vs_PBS	HSALNG0054727	integenic	Not conserved	hsa-miR-6089	Psoriasis vulgaris,Nicotine dependence symptom count; Depressive symptom measurement	FNDC1	ENSG00000236770
ENSG00000224616	RTCA-AS1	-1.61044207976856	0.0198416883601916	LPS_vs_PBS	HSALNG0005524	integenic	Not conserved	hsa-miR-4514	Lung carcinoma,-	DBT	POU5F1
ENSG00000224660	SH3BP5-AS1	-1.25422762621228	7.1976967951067e-5	LPS_vs_PBS	HSALNG0024394	anti_sense	Q90	NA	-	CAPN7	HECTD1
ENSG00000224666	ETV7-AS1	3.92309137463976	0.00377601302568388	LPS_vs_PBS	HSALNG0049748	anti_sense	Q50	hsa-miR-619-5p,hsa-miR-3652,hsa-miR-4674,hsa-miR-6089	Rheumatoid arthritis,Leukocyte count,Mean platelet volume,Eczema; Allergic rhinitis,-	KCTD20	BMP6
ENSG00000224699	LAMTOR5-AS1	-2.0005352230477502	0.00759032835993879	LPS_vs_PBS	HSALNG0005977	anti_sense	Q75	NA	-	RBM15	CABP4
ENSG00000224738	NA	-1.94430265572635	0.0360709873170714	LPS_vs_PBS	HSALNG0117749	intronic_antisense	Q75	NA	NA	PRR11	FUT7
ENSG00000224875	EML4-AS1	3.09403943724244	0.00293005967658793	LPS_vs_PBS	HSALNG0014464	anti_sense	Q75	NA	C-reactive protein measurement,-	COX7A2L	ENSG00000287382
ENSG00000224934	GOT1-DT	-2.62023012247727	8.53753640572182e-7	LPS_vs_PBS	HSALNG0080041	integenic	Q50	hsa-miR-659-5p,hsa-miR-4268,hsa-miR-4695-5p	-	CNNM1	DLEU7
ENSG00000224945	NA	-6.22106198196649	2.2819386219349e-8	LPS_vs_PBS	HSALNG0072581	sense	Not conserved	NA	NA	SHC3	DEPDC7
ENSG00000225062	CATIP-AS1	-3.85031432266383	0.0238946746078571	LPS_vs_PBS	HSALNG0022253	anti_sense	Q50	hsa-miR-4772-3p	-	TMBIM1	ENSG00000289151
ENSG00000225138	SLC9A3-AS1	-2.68188575477464	5.39377268745452e-7	LPS_vs_PBS	HSALNG0039449	anti_sense	Q75	hsa-miR-762,hsa-miR-541-3p,hsa-miR-4279,hsa-miR-3619-5p,hsa-miR-4505,hsa-miR-4508,hsa-miR-4632-3p,hsa-miR-1343-5p,hsa-miR-4722-5p,hsa-miR-4749-3p,hsa-miR-5787,hsa-miR-6132,hsa-miR-6720-3p,hsa-miR-6747-5p,hsa-miR-6873-3p	-,Hemoglobin measurement	EXOC3	TMEM150C
ENSG00000225177	NHSL1-AS1	-2.40501238109107	2.14080973112089e-6	LPS_vs_PBS	HSALNG0053831	anti_sense	Q75	hsa-miR-345-5p,hsa-miR-1228-5p,hsa-miR-4534,hsa-miR-6816-5p	-	CCDC28A	KLHL8
ENSG00000225313	NA	-1.3369183572547	0.0012282933853574	LPS_vs_PBS	HSALNG0002394	anti_sense	Q75	hsa-miR-3665,hsa-miR-6089	White matter volume measurement,Body mass index,Eosinophil percentage of leukocytes,Lean body mass; Body height; Risk-taking behaviour,Platelet count,Risk-taking behaviour,Susceptibility to plantar warts measurement,Attention deficit hyperactivity disorder; Smoking behavior; Smoking status measurement; Substance abuse; Body weight; Risk-taking behaviour; Antisocial behaviour measurement,-	ZNF362	ENSG00000272356
ENSG00000225329	LHFPL3-AS2	3.51420259742388	0.0130886998206122	LPS_vs_PBS	HSALNG0060286	anti_sense	Q90	NA	NA	SRPK2	HMGB1P3
ENSG00000225377	NRSN2-AS1	1.31409825475449	0.00827716926708459	LPS_vs_PBS	HSALNG0128021	integenic	Not conserved	NA	NA	C20orf96	ZFYVE26
ENSG00000225434	LINC01504	-1.51376830293212	0.00220012541196261	LPS_vs_PBS	HSALNG0071849	anti_sense	Q90	hsa-miR-619-5p,hsa-miR-4436a,hsa-miR-8485	Serum albumin measurement,Cognitive function measurement,-	GDA	DOCK11
ENSG00000225465	RFPL1S	-2.75602982892889	2.43494485542184e-5	LPS_vs_PBS	HSALNG0134830	anti_sense	Q90	hsa-miR-30b-3p,hsa-miR-361-3p,hsa-miR-363-5p,hsa-miR-619-5p,hsa-miR-1247-5p,hsa-miR-1268b,hsa-miR-4525,hsa-miR-6089,hsa-miR-6803-5p	Breast carcinoma,Upper aerodigestive tract neoplasm,-	THOC5	SYK
ENSG00000225519	NA	5.37205387557663	2.59855489860868e-7	LPS_vs_PBS	HSALNG0079635	integenic	Q50	hsa-miR-30c-2-3p	Abnormality of refraction,Fibroblast growth factor basic measurement,-	RPP30	FCHSD2
ENSG00000225733	FGD5-AS1	-1.13809150026044	1.04849853066764e-5	LPS_vs_PBS	HSALNG0024363	anti_sense	Q75	hsa-miR-6748-3p	NA	MRPS25	BIRC6
ENSG00000225792	SNX10-AS1	2.43282269343185	1.19651358965965e-6	LPS_vs_PBS	HSALNG0056814	anti_sense	Q90	hsa-miR-4505,hsa-miR-1587,hsa-miR-3960	Bmi-adjusted waist-hip ratio,Blood urea nitrogen measurement; Bmi-adjusted waist circumference,Body weight; Body mass index,Bmi-adjusted waist circumference; Bmi-adjusted waist-hip ratio,Vaginal microbiome measurement,-	HNRNPA2B1	SNX10
ENSG00000225886	NA	5.55458718390098	1.09174734089568e-28	LPS_vs_PBS	HSALNG0002013	integenic	Not conserved	NA	NA	FAM76A	CALM1
ENSG00000225938	S1PR1-DT	3.8686970958884	1.35495404672289e-8	LPS_vs_PBS	HSALNG0005575	integenic	Q50	hsa-miR-3194-3p,hsa-miR-4279,hsa-miR-6752-5p,hsa-miR-6845-3p	-	DPH5	DNAJB6P1
ENSG00000225963	NA	3.98757817040013	1.26870223909798e-10	LPS_vs_PBS	HSALNG0022854	anti_sense	Q50	hsa-miR-6089,hsa-miR-6763-5p	Subcutaneous adipose tissue measurement,Metabolic rate measurement,Serum non-albumin protein measurement,Obsessive-compulsive disorder; Obsessive-compulsive symptom measurement,-	SP140	SLC30A4
ENSG00000225964	NRIR	4.38898086543363	4.92510865701608e-10	LPS_vs_PBS	HSALNG0012717	integenic	Q75	NA	Depressive symptom measurement,-	CMPK2	HSH2D
ENSG00000225975	ZNF567-DT	-1.94218891196418	6.11856106330262e-4	LPS_vs_PBS	HSALNG0125780	anti_sense	Not conserved	hsa-miR-4463,hsa-miR-6869-3p,hsa-miR-1273h-5p	NA	ZNF461	PCMTD2
ENSG00000226004	LINC02528	4.91215391300396	3.78805536656951e-13	LPS_vs_PBS	HSALNG0053802	integenic	Q50	NA	Eosinophil count; Ejection fraction measurement; Eosinophil percentage of leukocytes,Cardiac troponin t measurement,Rheumatoid arthritis,-	PERP	DNAAF1
ENSG00000226012	NA	3.58428169769156	0.0347754906119112	LPS_vs_PBS	HSALNG0133051	anti_sense	Not conserved	hsa-miR-30b-3p,hsa-miR-6089,hsa-miR-7703	Bmi-adjusted hip circumference,-	KCNJ6	SULT6B1
ENSG00000226091	LINC00937	2.2709764038902	0.0173426824709834	LPS_vs_PBS	HSALNG0089057	integenic	Not conserved	hsa-miR-619-5p,hsa-miR-6089,hsa-miR-6735-5p	Viral load,-	FAM90A1	TNFRSF4
ENSG00000226125	LINC01907	-5.02957207300935	5.63696233070175e-5	LPS_vs_PBS	HSALNG0022889	integenic	Not conserved	hsa-miR-6089	-	GPR55	ENSG00000280060
ENSG00000226137	BAIAP2-DT	-3.56508148833429	2.2122962839033898e-11	LPS_vs_PBS	HSALNG0119226	integenic	Not conserved	hsa-miR-3943	-	AATK	RASAL1
ENSG00000226149	NA	-2.31076968695651	0.00111580343121095	LPS_vs_PBS	HSALNG0053423	anti_sense	Q50	hsa-miR-6763-5p,hsa-miR-8485	Sporadic amyotrophic lateral sclerosis,Hypermetropia; Self reported educational attainment; Refractive error; Retinal break; Retinal detachment; Age at onset; Myopia; Axial length measurement,Abnormality of refraction,Refractive error,Cortical surface area measurement,Body height,Cortical thickness,Sleep duration,Body mass index,Periodontitis,Cytokine measurement,Response to alcohol,-	ARHGAP18	CEP295NL
ENSG00000226167	AP4B1-AS1	-2.74863788195582	1.80840820363774e-4	LPS_vs_PBS	HSALNG0006197	anti_sense	Q90	hsa-miR-619-5p,hsa-miR-1227-5p,hsa-miR-1247-5p,hsa-miR-3178,hsa-miR-4755-3p	Autoimmune thyroid disease; Ulcerative colitis; Ankylosing spondylitis; Basophil count; Systemic scleroderma; Systemic lupus erythematosus; Thyroid preparation use measurement; Granulocyte count; Hashimoto's thyroiditis; Drugs used in diabetes use measurement; Serum igm measurement; Alkaline phosphatase measurement; Graves disease; Sclerosing cholangitis; Addison disease; Alopecia areata; Latent autoimmune diabetes in adults; Monocyte count; Hypothyroidism; Eosinophil count; Vitiligo; Hodgkins lymphoma; Psoriasis; Lymphocyte count; Basal cell carcinoma; Polymyositis; Hyperthyroidism; Neutrophil count; Myeloid white cell count; Myositis; Leukocyte count; Crohn's disease; Autoimmune disease; Rheumatoid arthritis; Immune system disease; Late-onset myasthenia gravis,Aspartate aminotransferase to alanine aminotransferase ratio,Self reported educational attainment,Autoimmune disease; Rheumatoid arthritis,Autoimmune thyroid disease,Rheumatoid arthritis; Systemic lupus erythematosus; Myositis; Systemic scleroderma,Mean corpuscular volume; Mean corpuscular hemoglobin,-,Mean corpuscular volume	DCLRE1B	PTPN4
ENSG00000226239	NA	4.81917508641196	4.14372393335859e-10	LPS_vs_PBS	HSALNG0129532	anti_sense	Q50	NA	Cystatin c measurement,Cognitive decline measurement,-	PDRG1	STAP1
ENSG00000226281	NA	-3.59326600088208	1.05288397987339e-10	LPS_vs_PBS	HSALNG0047836	integenic	Not conserved	hsa-miR-762,hsa-miR-5787	NA	F13A1	CCDC88A
ENSG00000226312	CFLAR-AS1	2.52763327700897	1.41554053075098e-5	LPS_vs_PBS	HSALNG0021529	anti_sense	Q50	hsa-miR-30b-3p	Total blood protein measurement,-	HYCC2	DDX3X
ENSG00000226419	SLC16A1-AS1	-1.47932423073788	0.00178864577861837	LPS_vs_PBS	HSALNG0006160	integenic	Not conserved	NA	NA	LRIG2	ADCY1
ENSG00000226445	THBS2-AS1	-2.71850006929235	2.0933907414355e-4	LPS_vs_PBS	HSALNG0055336	anti_sense	Not conserved	NA	NA	C6orf120	ZNF573
ENSG00000226688	ENTPD1-AS1	-1.28350940926893	0.0495794195805633	LPS_vs_PBS	HSALNG0079858	overlap_antisense,anti_sense	Not conserved	NA	Diverticular disease,White matter hyperintensity measurement,Bmi-adjusted waist circumference,Total blood protein measurement,Age at menopause,Mean corpuscular volume,-	TCTN3	ENSG00000261167
ENSG00000226696	LENG8-AS1	-1.47110564661658	0.0158853222224979	LPS_vs_PBS	HSALNG0127531	anti_sense	Not conserved	hsa-miR-5007-5p	-	LENG9	SRPK1
ENSG00000226816	NA	-2.71174091640397	0.00709295730670144	LPS_vs_PBS	HSALNG0056646	integenic	Not conserved	NA	NA	NUP42	NDUFA4P1
ENSG00000226950	DANCR	-1.34266388722438	0.00114716398706536	LPS_vs_PBS	HSALNG0148096	anti_sense	Q50	hsa-miR-619-5p,hsa-miR-7108-3p	Response to citalopram; Mood disorder; Response to escitalopram; Unipolar depression,-	RASL11B	ENSG00000232628
ENSG00000227082	LINC02798	1.99161210362187	0.0198662731857986	LPS_vs_PBS	HSALNG0006555	integenic	Not conserved	hsa-miR-548c-5p,hsa-miR-548d-5p,hsa-miR-548w,hsa-miR-548o-5p,hsa-miR-548ad-5p,hsa-miR-548ae-5p,hsa-miR-548ak,hsa-miR-548am-5p,hsa-miR-548ar-5p,hsa-miR-548au-5p,hsa-miR-548ay-5p	NA	SRGAP2C	MUC22
ENSG00000227189	NA	-4.04114633037828	0.0137051328488114	LPS_vs_PBS	NA	NA	NA	NA	NA	FGFRL1	ENSG00000284697
ENSG00000227199	ST7-AS1	2.45044112969094	7.05723688567021e-4	LPS_vs_PBS	HSALNG0060774	anti_sense	Q75	hsa-miR-1249-3p,hsa-miR-4313,hsa-miR-4488,hsa-miR-4508,hsa-miR-4787-5p	Blood protein measurement,-	WNT2	AMPD3
ENSG00000227354	RBM26-AS1	-1.66475137689357	0.0411834488789242	LPS_vs_PBS	HSALNG0098147	anti_sense	Q50	hsa-miR-619-5p,hsa-miR-4463	-	NDFIP2	KIF20A
ENSG00000227392	HPN-AS1	3.64928880344509	3.89196204520726e-4	LPS_vs_PBS	HSALNG0125567	anti_sense	Not conserved	NA	NA	LGI4	RAB1AP1
ENSG00000227398	KIF9-AS1	-1.73188176038988	0.0171824081212681	LPS_vs_PBS	HSALNG0025756	integenic	Not conserved	hsa-miR-4259,hsa-miR-6089,hsa-miR-8485	NA	KLHL18	COX7BP6
ENSG00000227502	MROCKI	1.51902408183657	0.00422576503750581	LPS_vs_PBS	HSALNG0052921	integenic	Q50	hsa-miR-619-5p,hsa-miR-4505	NA	HDAC2	AXL
ENSG00000227512	NA	-2.04873153611933	0.00600162508137189	LPS_vs_PBS	HSALNG0075265	anti_sense	Q90	NA	-	PMPCA	EPM2A
ENSG00000227531	NA	4.11856764779035	0.0259252549080966	LPS_vs_PBS	HSALNG0073676	integenic	Q50	hsa-miR-23a-5p,hsa-miR-619-5p,hsa-miR-6089,hsa-miR-7107-5p	Bmi-adjusted waist-hip ratio,Monocyte count,Bmi-adjusted hip circumference,Electrocardiography,Leukocyte count,Body height at birth; Birth weight,Waist-hip ratio; Bmi-adjusted waist-hip ratio; Monocyte count,Granulocyte percentage of myeloid white cells; Waist-hip ratio; Bmi-adjusted hip circumference; Myeloid white cell count; Bmi-adjusted waist-hip ratio; Monocyte count; Monocyte percentage of leukocytes,Late-onset alzheimers disease,Myeloid white cell count,Leukocyte count; Lymphocyte percentage of leukocytes,Monocyte percentage of leukocytes,Granulocyte percentage of myeloid white cells; Monocyte percentage of leukocytes,Body height,Neutrophil percentage of leukocytes; Bmi-adjusted waist-hip ratio; Monocyte count,Granulocyte percentage of myeloid white cells; Monocyte percentage of leukocytes; Monocyte count,Neutrophil percentage of leukocytes; Birth weight; Basophil count,Eosinophil count,Parental genotype effect measurement; Birth weight,Response to antineoplastic agent; Venous thromboembolism,-	OR2K2	SEMA6D
ENSG00000227896	WAPL-DT	-1.9149348555797	0.0165697151168095	LPS_vs_PBS	HSALNG0079399	anti_sense	Q90	hsa-miR-4660,hsa-miR-4687-3p,hsa-miR-6089,hsa-miR-6779-5p	Parental longevity,-	OPN4	ENSG00000279611
ENSG00000227917	NA	3.83645251856097	0.0122363535026613	LPS_vs_PBS	HSALNG0069521	integenic	Not conserved	hsa-miR-4722-5p	-	FOXD4	INSL6
ENSG00000228013	IL6R-AS1	2.11884914054707	0.0354572381562208	LPS_vs_PBS	HSALNG0007394	anti_sense	Q75	hsa-miR-4710,hsa-miR-6736-5p	C-reactive protein measurement,C-reactive protein measurement; Serum non-albumin protein measurement,Albumin:globulin ratio measurement,Total blood protein measurement,Serum non-albumin protein measurement,Systemic juvenile idiopathic arthritis, polyarticular juvenile idiopathic arthritis, rheumatoid factor negative, oligoarticular juvenile idiopathic arthritis,-	SHE	ENSG00000253227
ENSG00000228109	MELTF-AS1	-3.0489768579185	0.00216880369305144	LPS_vs_PBS	HSALNG0031988	anti_sense	Q50	hsa-miR-331-3p,hsa-miR-1228-5p,hsa-miR-4472,hsa-miR-4492,hsa-miR-4701-3p,hsa-miR-4734,hsa-miR-7108-3p	-	NCBP2AS2	SLC26A6
ENSG00000228192	ZNF691-DT	-1.41211495339255	0.0153249885898646	LPS_vs_PBS	HSALNG0003039	anti_sense	Q50	hsa-miR-619-5p,hsa-miR-4492,hsa-miR-5693	Red blood cell distribution width,-	SVBP	GCFC2
ENSG00000228203	GRASLND	4.0463921877376	6.76839942788304e-5	LPS_vs_PBS	HSALNG0012734	anti_sense	Q50	hsa-miR-4710	NA	CMPK2	USP11
ENSG00000228223	HCG11	-1.53618552268209	1.11022256673401e-4	LPS_vs_PBS	HSALNG0048782	integenic	Not conserved	NA	-	HMGN4	GIGYF1
ENSG00000228315	GUSBP11	-1.55556463984222	5.44276244865321e-5	LPS_vs_PBS	HSALNG0134423	integenic	Not conserved	NA	Adolescent idiopathic scoliosis	DRICH1	ENSG00000286681
ENSG00000228317	FKTN-AS1	4.71203371087791	0.0240407154422138	LPS_vs_PBS	HSALNG0073451	anti_sense	Q50	hsa-miR-5589-5p	Lysophosphatidylethanolamine 18:1 measurement,-	ABCA1	RNU6-444P
ENSG00000228318	NA	4.65317221319497	6.60700819710155e-7	LPS_vs_PBS	HSALNG0133209	anti_sense,sense	Not conserved	hsa-miR-1268b,hsa-miR-6089	Serum alanine aminotransferase measurement,3-hydroxypropylmercapturic acid measurement,Atrial fibrillation; Diastolic blood pressure; Ventricular rate measurement; Diabetes mellitus; Heart failure; Cancer; Body mass index; Stroke; Total cholesterol measurement; Systolic blood pressure; Mortality; High density lipoprotein cholesterol measurement; Triglyceride measurement; Hematocrit; Glucose measurement; Coronary artery disease,-	TMPRSS2	ENSG00000251922
ENSG00000228427	NA	-2.1899186178709	9.04074608417825e-4	LPS_vs_PBS	HSALNG0138463	integenic	Q75	hsa-miR-30b-3p,hsa-miR-6089	Prostate carcinoma	ZMYM3	HHEX
ENSG00000228436	RRAGC-DT	2.74540148778185	6.2440280395745805e-9	LPS_vs_PBS	HSALNG0002723	overlap_antisense,anti_sense	Q90	hsa-miR-363-5p,hsa-miR-619-5p	Protein measurement,Blood protein measurement,Kunitz-type protease inhibitor 1 measurement,Triglyceride measurement,Age at menopause,Unipolar depression,Sweet beverage consumption measurement,-	AKIRIN1	MAP1LC3A
ENSG00000228526	MIR34AHG	-2.40777479403202	4.84081668858944e-13	LPS_vs_PBS	HSALNG0000682	integenic	Q50	hsa-miR-4279,hsa-miR-500b-3p,hsa-miR-4723-3p,hsa-miR-6724-5p,hsa-miR-6744-3p,hsa-miR-7150,hsa-miR-7152-5p	Granulocyte percentage of myeloid white cells; Monocyte percentage of leukocytes; Monocyte count; Aspartate aminotransferase measurement,Body height,Lean body mass,Linguistic error measurement; Specific language impairment,-	GPR157	LDLRAD4
ENSG00000228536	LYPLAL1-AS1	4.20654401853862	1.84137870099422e-8	LPS_vs_PBS	HSALNG0010664	integenic	Q50	hsa-miR-4492,hsa-miR-8485	Bmi-adjusted waist-hip ratio,Bmi-adjusted waist circumference,Bmi-adjusted hip circumference,Heel bone mineral density,Triglyceride measurement; Bmi-adjusted waist circumference,Protein measurement,Bmi-adjusted waist circumference; Bmi-adjusted hip circumference; Bmi-adjusted waist-hip ratio,Lean body mass,Appendicular lean mass,Bmi-adjusted hip circumference; Bmi-adjusted waist-hip ratio,Serum alanine aminotransferase measurement; Sex hormone-binding globulin measurement; Low density lipoprotein triglyceride measurement; Body fat percentage; High density lipoprotein cholesterol measurement; Triglyceride measurement; Aspartate aminotransferase measurement,Body mass index,Visceral:subcutaneous adipose tissue ratio; Body mass index,Body height,Body weight,Reticulocyte measurement; Bmi-adjusted hip circumference,Insulin measurement,Pulse pressure measurement; Obesity; Osteoarthritis, hip, osteoarthritis, knee, total joint arthroplasty,Visceral:subcutaneous adipose tissue ratio,Osteoarthritis, hip; Body mass index; Physical activity measurement; Bmi-adjusted waist-hip ratio; Fasting blood insulin measurement; Osteoarthritis, hip, osteoarthritis, knee,Waist-hip ratio,Hip circumference; Bmi-adjusted hip circumference; Bmi-adjusted waist-hip ratio,Triglyceride measurement; Reticulocyte measurement; Bmi-adjusted hip circumference; Reticulocyte count,Red blood cell density measurement; Hemorrhoid; Erythrocyte count,Sex interaction measurement; Age at assessment; Bmi-adjusted waist-hip ratio,Nose morphology measurement,Bmi-adjusted waist-hip ratio; Physical activity measurement,Waist-hip ratio; Bmi-adjusted waist-hip ratio,Serum alanine aminotransferase measurement,High density lipoprotein cholesterol measurement,Open-angle glaucoma,Smoking behavior; Bmi-adjusted waist-hip ratio,Triglyceride measurement; High density lipoprotein cholesterol measurement,Adiponectin measurement,Apolipoprotein a 1 measurement,Body fat percentage; Bmi-adjusted hip circumference,Total blood protein measurement; High density lipoprotein cholesterol measurement,Astigmatism,Bmi-adjusted waist circumference; Drugs used in diabetes use measurement; Bmi-adjusted hip circumference,Bmi-adjusted waist circumference; Bmi-adjusted waist-hip ratio,Waist-hip ratio; Bmi-adjusted waist-hip ratio; Physical activity measurement,Bmi-adjusted waist circumference; Appendicular lean mass,Varicose veins; Inguinal hernia,Acne; Bmi-adjusted hip circumference,Serum gamma-glutamyl transferase measurement,Bmi-adjusted waist circumference; Total cholesterol measurement; Low density lipoprotein cholesterol measurement; High density lipoprotein cholesterol measurement; Bmi-adjusted waist-hip ratio; Triglyceride measurement,Body mass index; Adiponectin measurement; Fasting blood insulin measurement,Systolic blood pressure,Sex hormone-binding globulin measurement; Adiponectin measurement,-	ZC3H11B	LINC02605
ENSG00000228544	CCDC183-AS1	-1.70929487474209	0.00803333517507867	LPS_vs_PBS	HSALNG0075303	anti_sense	Q90	hsa-miR-3620-5p,hsa-miR-1587	-	LCN15	CFAP157
ENSG00000228649	SNHG26	-1.24818725519491	0.0440054711477124	LPS_vs_PBS	HSALNG0056623	integenic	Q75	hsa-miR-483-3p,hsa-miR-4320	Alkaline phosphatase measurement,-	IL6	FABP5
ENSG00000228741	SPATA13	3.32870089761259	0.0372040296150253	LPS_vs_PBS	HSALNG0095761	sense	Not conserved	hsa-miR-874-3p	NA	SPATA13	CFAP161
ENSG00000228784	LINC00954	-2.01596521950331	0.00668285461284294	LPS_vs_PBS	HSALNG0013382	integenic	Not conserved	hsa-miR-4433a-3p	Creatinine measurement,-	RHOB	CLDN11
ENSG00000228863	NA	3.10489600739494	1.62036838772096e-5	LPS_vs_PBS	HSALNG0007856	anti_sense	Not conserved	hsa-miR-4776-3p	Moderate albuminuria,-	SLAMF7	ZHX2
ENSG00000229153	EPHA1-AS1	3.4874169512134	8.76237151611562e-7	LPS_vs_PBS	HSALNG0061963	anti_sense,sense	Q50	hsa-miR-762,hsa-miR-3657,hsa-miR-1268b,hsa-miR-6089	Family history of alzheimer’s disease,Protein measurement,-	TAS2R41	PTPN1
ENSG00000229331	GK-IT1	2.33007319652006	0.0288424103292858	LPS_vs_PBS	HSALNG0137205	intronic_sense	Not conserved	hsa-miR-619-5p	NA	GK	PSMD14-DT
ENSG00000229484	LINC02766	-4.94517550477502	3.51221781963602e-5	LPS_vs_PBS	HSALNG0000944	integenic	Not conserved	NA	-	VPS13D	RNF135
ENSG00000229660	NA	2.35121912153817	0.0393713403599012	LPS_vs_PBS	HSALNG0062729	integenic	Not conserved	hsa-miR-485-5p,hsa-miR-940,hsa-miR-4492,hsa-miR-4512	Mean corpuscular hemoglobin; Mean corpuscular hemoglobin concentration	PTPRN2	LINC01140
ENSG00000229664	NA	5.64556858967844	5.18633507153196e-13	LPS_vs_PBS	HSALNG0075911	anti_sense	Not conserved	hsa-miR-4722-5p,hsa-miR-6089,hsa-miR-6873-3p	Liver fibrosis measurement; Epstein barr virus nuclear antigen 1 igg measurement,Response to diisocyanate,Interleukin 2 receptor antagonist measurement,Crohn's disease; Inflammatory bowel disease,Hypothyroidism; Thyroid preparation use measurement,Eosinophil count; Respiratory system disease; Eosinophil percentage of leukocytes,Tonsillectomy risk measurement,Ovarian serous carcinoma; Response to carboplatin; Response to paclitaxel; Progression free survival,-	RBM17	MED28-DT
ENSG00000229867	STEAP3-AS1	1.97462167791514	0.00281100280280733	LPS_vs_PBS	HSALNG0018314	anti_sense	Q75	NA	-,Cocaine dependence; Late-onset alzheimers disease	C2orf76	PLEKHF2
ENSG00000229873	OGFR-AS1	2.96542949174413	2.2381601008898103e-9	LPS_vs_PBS	HSALNG0131564	anti_sense	Q90	hsa-miR-1271-5p,hsa-miR-6800-3p	-	TCFL5	MVP-DT
ENSG00000229915	NA	-3.84785816337638	0.0214070307746588	LPS_vs_PBS	HSALNG0023432	anti_sense	Not conserved	NA	NA	PER2	DIP2A-IT1
ENSG00000229922	LINC02865	5.34913784407862	2.18176496999273e-6	LPS_vs_PBS	HSALNG0053801	integenic	Q50	hsa-miR-6873-3p	Eosinophil count; Ejection fraction measurement; Eosinophil percentage of leukocytes,Cardiac troponin t measurement,Rheumatoid arthritis,Phosphatidylcholine ether measurement,-	TNFAIP3	TRIM31
ENSG00000229962	NA	3.22827557363012	0.0229658374327084	LPS_vs_PBS	HSALNG0132380	integenic	Q75	hsa-miR-6507-5p,hsa-miR-6732-5p	Hair color,Hair colour measurement,-	MRPL39	KRT7
ENSG00000230061	TRPM2-AS	-2.36277404365014	0.0222457466378802	LPS_vs_PBS	HSALNG0133533	anti_sense	Q50	hsa-miR-4486,hsa-miR-6888-5p,hsa-miR-7110-5p	-	TSPEAR	GLI1
ENSG00000230113	NA	-1.98590748897126	0.00208435236642525	LPS_vs_PBS	HSALNG0115671	anti_sense	Q90	hsa-miR-520a-5p	-	TEFM	ENSG00000206914
ENSG00000230149	NA	4.10849455542597	7.531124932813529e-13	LPS_vs_PBS	HSALNG0135439	anti_sense,sense	Q90	hsa-miR-1227-5p,hsa-miR-500b-3p	White matter microstructure measurement,-	GTPBP1	IRF1-AS1
ENSG00000230387	NA	-4.90753461769854	9.93795471456034e-4	LPS_vs_PBS	HSALNG0129227	integenic	Q50	hsa-miR-151b,hsa-miR-3620-5p,hsa-miR-4492,hsa-miR-4505,hsa-miR-1587,hsa-miR-5006-5p,hsa-miR-8485	Serum alanine aminotransferase measurement,Susceptibility to mycobacterium tuberculosis infection measurement,Venous thromboembolism	SSTR4	PPP1R3B-DT
ENSG00000230426	LINC01036	2.95784764277589	4.08538438543867e-4	LPS_vs_PBS	HSALNG0009116	integenic	Q50	hsa-miR-619-5p,hsa-miR-3940-5p,hsa-miR-6802-5p	Asthma exacerbation measurement,Diet measurement,Unipolar depression,Fatty acid measurement; Fasting blood insulin measurement,Mouth morphology measurement,Non-alcoholic steatohepatitis,Protein measurement,5-hiaa measurement,Adolescent idiopathic scoliosis,Response to tenofovir,Corneal endothelial cell measurement,Interleukin 13 measurement,-	PLA2G4A	RCAN2
ENSG00000230438	SERPINB9P1	4.09281118112956	5.6367629486799296e-11	LPS_vs_PBS	HSALNG0047525	integenic	Not conserved	NA	NA	SERPINB9	PKIG
ENSG00000230479	NA	-1.41554087770095	0.00722125419574133	LPS_vs_PBS	HSALNG0132951	integenic	Not conserved	NA	NA	CHAF1B	FAM50B
ENSG00000230533	LINC03004	4.56951358654189	0.00794882855195962	LPS_vs_PBS	HSALNG0053783	integenic	Q75	hsa-miR-619-5p	NA	TNFAIP3	RPLP0P2
ENSG00000230631	NA	4.05482261357204	1.99142234457598e-4	LPS_vs_PBS	HSALNG0048221	integenic	Not conserved	hsa-miR-920	Cytokine measurement,-	MCUR1	MMP10
ENSG00000230647	NA	5.23115577238389	3.98738157454236e-13	LPS_vs_PBS	HSALNG0145008	integenic	Q75	hsa-miR-619-5p	Heel bone mineral density,-	HS3ST3B1	SAMD9
ENSG00000230686	NA	4.7139853831922	1.90498421851971e-4	LPS_vs_PBS	HSALNG0021144	anti_sense	Q50	NA	NA	GLS	FKTN-AS1
ENSG00000230918	DPP4-DT	3.37255973412113	9.67916021674457e-4	LPS_vs_PBS	HSALNG0020015	anti_sense	Q75	hsa-miR-6124	-	SLC4A10	LINC00513
ENSG00000230943	LINC02541	3.31087052972502	1.54505306412297e-10	LPS_vs_PBS	HSALNG0052910	integenic	Not conserved	NA	NA	HDAC2	LINC00158
ENSG00000231074	HCG18	-1.05439839667009	5.73705885060805e-4	LPS_vs_PBS	HSALNG0049135	integenic	Not conserved	NA	Psoriatic arthritis,Systemic lupus erythematosus	TRIM26	ZNF891
ENSG00000231113	LINC02976	-1.79964889428631	4.36862898404177e-4	LPS_vs_PBS	HSALNG0050136	integenic	Not conserved	hsa-miR-619-5p,hsa-miR-4505,hsa-miR-6089	Diabetic nephropathy; Mean corpuscular hemoglobin,Apolipoprotein a 1 measurement,-	CNPY3	LNMICC
ENSG00000231128	NA	-4.17830030454977	0.00611083663225199	LPS_vs_PBS	HSALNG0006198	anti_sense	Not conserved	hsa-miR-619-5p	NA	DCLRE1B	ENSG00000256029
ENSG00000231131	LNCAROD	1.45026992504924	2.74121499331809e-4	LPS_vs_PBS	HSALNG0078017	integenic	Not conserved	hsa-miR-6895-5p	Heel bone mineral density,Bone density; Dickkopf‐related protein 1 measurement; Heel bone mineral density,Bone density,Bone density; Heel bone mineral density,Dickkopf‐related protein 1 measurement,Femoral neck bone mineral density; Spine bone mineral density,Bone fracture,Velocity of sound measurement; Bone quantitative ultrasound measurement; Heel bone mineral density,Bone quantitative ultrasound measurement	MBL2	MAX
ENSG00000231177	LINC00852	-2.6842231884937	4.50976701657988e-6	LPS_vs_PBS	HSALNG0024099	anti_sense,sense	Q90	hsa-miR-4650-5p	Self reported educational attainment,Ghrelin measurement,-	NA	ENSG00000238246
ENSG00000231233	CFAP58-DT	2.10773020825924	1.70171266429435e-4	LPS_vs_PBS	HSALNG0080427	integenic	Q50	NA	NA	ITPRIP	RNF19A
ENSG00000231249	ITPR1-DT	-3.09085459083179	6.71666299852124e-6	LPS_vs_PBS	HSALNG0023876	integenic	Q75	hsa-miR-6090,hsa-miR-6763-3p	NA	SUMF1	ZNF10
ENSG00000231346	LINC01160	-2.40704585705261	1.40122079471751e-4	LPS_vs_PBS	HSALNG0006063	anti_sense	Q75	hsa-miR-30b-3p,hsa-miR-619-5p,hsa-miR-4787-5p,hsa-miR-6089	Leukocyte count,Lymphocyte count,-	TMIGD3	KBTBD3
ENSG00000231365	WARS2-AS1	-1.48469041366445	8.16700073488711e-4	LPS_vs_PBS	HSALNG0006479	integenic	Not conserved	NA	NA	HAO2	PTPN4
ENSG00000231407	GORAB-AS1	3.00766653388726	0.00695308472580083	LPS_vs_PBS	HSALNG0008377	anti_sense	Q50	hsa-miR-5011-3p,hsa-miR-8485	Bmi-adjusted waist-hip ratio,Adolescent idiopathic scoliosis,Bmi-adjusted waist circumference,Soluble triggering receptor expressed on myeloid cells 2 measurement,-,Androgenetic alopecia	KIFAP3	EHF
ENSG00000231535	LINC00278	6.85928688307934	6.84988707659192e-4	LPS_vs_PBS	HSALNG0140973	integenic	Not conserved	NA	NA	ZFY	ENSG00000228176
ENSG00000231560	CLEC12A-AS1	4.39906863113011	7.10653795744372e-7	LPS_vs_PBS	HSALNG0143571	anti_sense	Not conserved	NA	NA	CLEC2A	CTHRC1
ENSG00000231574	LINC02015	7.25341826433253	3.2938356433285997e-13	LPS_vs_PBS	HSALNG0030884	integenic	Q50	hsa-miR-619-5p,hsa-miR-4433a-3p,hsa-miR-4456,hsa-miR-4508,hsa-miR-6749-5p,hsa-miR-6807-3p,hsa-miR-7703,hsa-miR-4433b-3p,hsa-miR-8485	Systemic lupus erythematosus,Hba1c measurement; Hemoglobin a1 measurement,Hallux valgus,Anxiety disorder,Reaction time measurement,Visual perception measurement,Alcohol drinking,Unipolar depression,Brain volume measurement,Cortical surface area measurement,Chin morphology measurement,Corneal topography,Central corneal thickness,Cortical thickness,Heel bone mineral density,Cortical surface area measurement; Neuroimaging measurement,White matter microstructure measurement,Body height,Calcium measurement,Lobe attachment,Neuropsychological test,Venous thromboembolism,Pathological myopia,Gut microbiome measurement,Adolescent idiopathic scoliosis,Abnormality of the urinary system; Response to radiation,Neuroimaging measurement; Brain measurement,Cortical surface area measurement; Neuroimaging measurement; Brain measurement,Ovarian serous carcinoma; Ovarian carcinoma; Progression free survival,Response to cranial radiation therapy; Body mass index,-	KCNMB2	PLA1A
ENSG00000231607	DLEU2	-1.39004421788376	0.0158310150030218	LPS_vs_PBS	HSALNG0097094	anti_sense	Q90	hsa-miR-619-5p,hsa-miR-4483,hsa-miR-4649-5p,hsa-miR-6089,hsa-miR-6813-5p,hsa-miR-6826-3p	Bmi-adjusted waist-hip ratio,Heel bone mineral density,Lymphocyte percentage of leukocytes; Lymphocyte count,Body height,Creatinine measurement; Aspartate aminotransferase to alanine aminotransferase ratio,Diastolic blood pressure,Bmi-adjusted hip circumference,Bmi-adjusted hip circumference; Bmi-adjusted waist-hip ratio,Bmi-adjusted waist circumference; Bmi-adjusted waist-hip ratio,Lipoprotein a measurement,Sex hormone-binding globulin measurement,Sex hormone-binding globulin measurement; Glomerular filtration rate; Testosterone measurement; Body height; Triglyceride measurement,Lymphocyte count,Appendicular lean mass; Monocyte count,Body weight; Body mass index,Platelet-to-lymphocyte ratio,-	SPRYD7	TUT4
ENSG00000231711	LINC00899	-1.95142815410624	3.59582639969612e-4	LPS_vs_PBS	HSALNG0135993	integenic	Q50	hsa-miR-320a-5p,hsa-miR-762,hsa-miR-3178,hsa-miR-6763-3p	Birth weight,Smoking status measurement	WNT7B	COA7
ENSG00000231721	LINC-PINT	2.53424086134453	3.03335533002932e-6	LPS_vs_PBS	HSALNG0150064	integenic	Q50	NA	NA	KLF14	CCRL2
ENSG00000231808	LINC01388	5.39518913519794	3.05586350856582e-14	LPS_vs_PBS	HSALNG0069521	integenic	Not conserved	hsa-miR-4722-5p	-	FOXD4	SERPINB1
ENSG00000231811	NA	2.90724184728584	6.76282203639335e-4	LPS_vs_PBS	HSALNG0047724	integenic	Not conserved	hsa-miR-4447	NA	ECI2	CCT8
ENSG00000231858	STAT4-AS1	3.17058830226431	6.9483535598782e-7	LPS_vs_PBS	HSALNG0021145	anti_sense	Q75	hsa-miR-3666	-	GLS	RIGI
ENSG00000231881	NA	1.92451183678062	0.017535748538381	LPS_vs_PBS	HSALNG0050253	integenic	Q75	hsa-miR-4749-3p,hsa-miR-7106-5p	Hemoglobin measurement; Platelet crit; Urate measurement; Hematocrit; Red blood cell density measurement; Erythrocyte count,Disease progression measurement,Interleukin 12 measurement; Vascular endothelial growth factor measurement,Erythrocyte count,Lipid measurement,Coronary artery disease,Cortical surface area measurement; Neuroimaging measurement,-	TMEM63B	DNAH17
ENSG00000231964	NA	-4.15960246993136	1.3951811022004e-7	LPS_vs_PBS	HSALNG0077664	anti_sense	Not conserved	hsa-miR-520a-5p	Mean corpuscular volume,-	MARCHF8	AK4P4
ENSG00000231999	LRRC8C-DT	-1.41811072594098	0.0233374088377401	LPS_vs_PBS	HSALNG0005078	integenic	Q75	NA	NA	GBP5	ENSG00000287494
ENSG00000232043	NA	2.52749170601098	0.00427965775702212	LPS_vs_PBS	HSALNG0130783	anti_sense	Not conserved	NA	Heel bone mineral density,Duchenne muscular dystrophy; Disease progression measurement	RIPOR3	ENSG00000235869
ENSG00000232098	ZNF584-DT	-1.43750891402593	8.6709602603705e-4	LPS_vs_PBS	HSALNG0127962	anti_sense	Not conserved	NA	Mean platelet volume,-	ZNF837	RNASEL
ENSG00000232110	NA	4.62545495680283	7.62635879497786e-4	LPS_vs_PBS	HSALNG0079566	overlap_antisense,anti_sense,sense	Q75	hsa-miR-149-3p,hsa-miR-3620-5p,hsa-miR-1587,hsa-miR-5589-5p	Total blood protein measurement; Blood protein measurement,Protein measurement; Parental longevity,Heart failure,C-reactive protein measurement,C-reactive protein measurement; Neutrophil count; Myeloid white cell count; Myocardial infarction; Coronary artery disease,Lymphocyte percentage of leukocytes; Neutrophil count; Myeloid white cell count; Myocardial infarction; Leukocyte count; Abdominal aortic aneurysm; Neutrophil percentage of leukocytes; Coronary artery disease,Aspartate aminotransferase to alanine aminotransferase ratio; Myocardial infarction,Myocardial infarction,Fibrinogen measurement; Coronary artery disease,Red blood cell distribution width,Neutrophil count,Leukocyte count,Eosinophil count; Neutrophil count,Coronary artery disease,-	IFIT2	ENSG00000287216
ENSG00000232194	NA	3.0436456613829	0.0326737662014299	LPS_vs_PBS	HSALNG0008257	anti_sense	Not conserved	hsa-miR-619-5p,hsa-miR-6891-5p,hsa-miR-10392-3p	-	MPZL1	MMGT1
ENSG00000232229	LINC00865	-2.77079277466323	0.00809072053687331	LPS_vs_PBS	HSALNG0079601	integenic	Not conserved	hsa-miR-4534	Colorectal cancer,Self reported educational attainment,-	KIF20B	ENSG00000268912
ENSG00000232295	NA	2.20858921724647	0.0240164321189814	LPS_vs_PBS	HSALNG0051162	anti_sense	Q90	hsa-miR-619-5p,hsa-miR-6803-5p,hsa-miR-6813-5p	Antipsychotic drug related weight gain; Longitudinal bmi measurement,Beta-amyloid 1-42 measurement,Heel bone mineral density,Lung carcinoma,Body height,-	B3GAT2	MARCHF7
ENSG00000232442	MHENCR	-1.56322280212543	9.0219636397144e-5	LPS_vs_PBS	HSALNG0131657	anti_sense	Q90	hsa-miR-3620-5p,hsa-miR-4505,hsa-miR-1587,hsa-miR-6786-5p	-	RTEL1	ENSG00000271795
ENSG00000232618	HIVEP2-DT	5.39687957	2.72177477054359e-13	LPS_vs_PBS	HSALNG0054003	anti_sense	Q50	hsa-miR-4279	Mean platelet volume,-	AIG1	MMP12
ENSG00000232648	ING2-DT	-1.94573352431697	0.0109913950780126	LPS_vs_PBS	HSALNG0038941	integenic	Q50	hsa-miR-4492,hsa-miR-4508	-	RWDD4	VWF
ENSG00000232677	LINC00665	-2.00776166570523	0.0283484346714185	LPS_vs_PBS	HSALNG0125745	integenic	Not conserved	hsa-miR-619-5p,hsa-miR-1233-5p,hsa-miR-4472,hsa-miR-4492,hsa-miR-6089,hsa-miR-6090,hsa-miR-6795-5p,hsa-miR-6813-5p	Monocyte count	ZFP14	CENPE
ENSG00000232679	LINC01705	3.41396026480985	5.6410749557498e-4	LPS_vs_PBS	HSALNG0010821	integenic	Q50	hsa-miR-619-5p,hsa-miR-6728-3p,hsa-miR-6729-3p,hsa-miR-8485	Eosinophil percentage of leukocytes,Homa-ir,Self reported educational attainment,Colorectal cancer,Adolescent idiopathic scoliosis,C-reactive protein measurement,Serum alanine aminotransferase measurement; Sex hormone-binding globulin measurement; Low density lipoprotein triglyceride measurement; Body fat percentage; High density lipoprotein cholesterol measurement; Aspartate aminotransferase measurement,Colon carcinoma,Waist-hip ratio; Bmi-adjusted waist-hip ratio,Progressive supranuclear palsy,Tonsillectomy risk measurement,Thyroid stimulating hormone measurement,Self reported educational attainment; Intelligence,Fev/fec ratio; Response to bronchodilator,Colorectal cancer; Colorectal adenoma,Colorectal cancer; Progressive supranuclear palsy,Cluster headache,-	DUSP10	HCAR3
ENSG00000232680	NA	3.30334797849616	0.00221482630426615	LPS_vs_PBS	HSALNG0125614	integenic	Not conserved	NA	NA	KRTDAP	GCNT4
ENSG00000232759	STEAP1B-AS1	4.61999515154712	0.00226296007700223	LPS_vs_PBS	HSALNG0056606	anti_sense	Q50	hsa-miR-892b,hsa-miR-4472,hsa-miR-4534	Atopic asthma,C-reactive protein measurement,Unipolar depression,-	IL6	ENSG00000233817
ENSG00000232803	SLCO4A1-AS1	4.84827368147133	3.3113716912995597e-12	LPS_vs_PBS	HSALNG0146997	anti_sense	Q75	hsa-miR-5196-5p	Human papilloma virus infection; Oral cavity cancer,-	TCFL5	FOXO3
ENSG00000232931	LINC00342	-1.23427126894403	0.00227124593689475	LPS_vs_PBS	HSALNG0146543	integenic	Not conserved	NA	NA	ANKRD36C	SYNE1
ENSG00000232956	SNHG15	2.66278075460084	1.17849597797959e-17	LPS_vs_PBS	HSALNG0057702	anti_sense,sense	Q50	hsa-miR-4726-3p,hsa-miR-7107-5p	Body height,Diastolic blood pressure,-	MYO1G	TRA2A
ENSG00000232973	CYP1B1-AS1	1.48794508733587	3.26968019737168e-6	LPS_vs_PBS	HSALNG0014289	anti_sense	Q75	hsa-miR-4313,hsa-miR-3620-5p,hsa-miR-1587,hsa-miR-6775-5p,hsa-miR-6810-3p,hsa-miR-6816-5p,hsa-miR-6829-3p,hsa-miR-6872-3p	Suntan,Nevus count; Cutaneous melanoma,Cytokine measurement,Ischemic stroke; Coronary artery disease,Body height,Breast carcinoma,Non-melanoma skin carcinoma,Environmental tobacco smoke exposure measurement; Age at onset,Viral load; Hiv infection; Cd4-positive t-lymphocyte count; Disease progression measurement,-	RMDN2	CSRNP1
ENSG00000233016	SNHG7	-1.58073295321019	0.0135456431245517	LPS_vs_PBS	HSALNG0075291	anti_sense	Q90	hsa-miR-6089,hsa-miR-6829-3p	Body height,-	NA	GRAMD1B
ENSG00000233038	PTPRN2-AS1	-3.54877744688209	5.39738227366905e-6	LPS_vs_PBS	HSALNG0062762	anti_sense	Not conserved	hsa-miR-762,hsa-miR-3195,hsa-miR-4297,hsa-miR-5787,hsa-miR-6813-5p,hsa-miR-7113-3p	-	DNAJB6	TNFSF12
ENSG00000233058	ATP13A3-DT	1.83079563279303	6.6718276597468e-6	LPS_vs_PBS	HSALNG0031735	anti_sense	Q50	hsa-miR-619-5p,hsa-miR-4294	Lean mass-adjusted fat body mass; Femoral neck bone mineral density,3-hydroxypropylmercapturic acid measurement,-	FAM43A	ELF1
ENSG00000233175	FMNL1-AS1	-3.1725374622842	3.11662701277995e-5	LPS_vs_PBS	HSALNG0116843	anti_sense	Q90	hsa-miR-4286	-	SPATA32	ARHGAP39
ENSG00000233237	LINC00472	2.79938873107579	6.08672798073797e-4	LPS_vs_PBS	HSALNG0051173	integenic	Q50	NA	NA	B3GAT2	ENSG00000266378
ENSG00000233365	NA	-3.56729982933822	0.0404017342895511	LPS_vs_PBS	HSALNG0055076	integenic	Q50	hsa-miR-7106-5p,hsa-miR-8485	Protein measurement,-	CEP43	ENSG00000285081
ENSG00000233429	HOTAIRM1	-1.65500376612252	0.0091912400890578	LPS_vs_PBS	HSALNG0056850	anti_sense	Q90	hsa-miR-1224-3p,hsa-miR-3960	Bmi-adjusted waist circumference; Bmi-adjusted waist-hip ratio,Tonsillectomy risk measurement,-	EVX1	USF2
ENSG00000233461	NA	1.97412300577841	0.00375078543384242	LPS_vs_PBS	HSALNG0011452	anti_sense,sense	Q90	hsa-miR-619-5p	Pantothenic acid mesurement,-	NA	ENSG00000286674
ENSG00000233559	LINC00513	3.04653659652146	1.10733294791856e-4	LPS_vs_PBS	HSALNG0061393	integenic	Not conserved	NA	Parental genotype effect measurement; Vitamin d measurement	MKLN1	DPP4-DT
ENSG00000233621	ZC3H12A-DT	1.38574554481877	0.0119384887819336	LPS_vs_PBS	HSALNG0002623	integenic	Not conserved	NA	NA	MEAF6	PRELID1P1
ENSG00000233672	RNASEH2B-AS1	-2.29874752796163	0.00178782103461364	LPS_vs_PBS	HSALNG0097134	anti_sense	Q75	NA	Hemorrhoid,Prostate specific antigen measurement,Bmi-adjusted waist-hip ratio,Bmi-adjusted waist circumference; Bmi-adjusted waist-hip ratio,Mean corpuscular volume,Benign prostatic hyperplasia; Lower urinary tract symptom,-	DLEU7	EYA2
ENSG00000233695	GAS6-AS1	-1.77254646578095	0.00262210556237702	LPS_vs_PBS	HSALNG0099627	anti_sense	Not conserved	hsa-miR-6721-5p	NA	TMEM255B	TSPAN15
ENSG00000233785	NA	3.30299798609769	2.43033638827465e-5	LPS_vs_PBS	HSALNG0137010	sense	Q75	hsa-miR-619-5p	Shoulder impingement syndrome; Rotator cuff tear,Ribose-5-phosphate measurement; Ribulose-5-phosphate measurement	ACOT9	RUNX1
ENSG00000233806	LINC01237	2.64845873643002	0.0244665993078321	LPS_vs_PBS	HSALNG0023737	anti_sense	Not conserved	hsa-miR-891a-3p,hsa-miR-937-5p,hsa-miR-4505,hsa-miR-4722-5p,hsa-miR-6085,hsa-miR-6748-3p,hsa-miR-6792-3p,hsa-miR-6883-5p,hsa-miR-6889-3p,hsa-miR-7108-5p	Caudal anterior cingulate cortex volume measurement,Brain aneurysm,Eczema,Ovarian carcinoma,High density lipoprotein cholesterol measurement,Age at onset; Refractive error; Myopia,-	RTP5	MTCO2P4
ENSG00000233817	NA	3.69362980271532	0.0143664881582745	LPS_vs_PBS	HSALNG0073854	integenic	Not conserved	hsa-miR-505-5p	Heel bone mineral density,Hair colour measurement,-	RGS3	STEAP1B-AS1
ENSG00000233834	MACC1-DT	3.39377075977335	3.26253576483482e-10	LPS_vs_PBS	HSALNG0056475	anti_sense	Q50	hsa-miR-204-3p	Response to antineoplastic agent; Response to etoposide,-	ITGB8	LINC02895
ENSG00000233885	YEATS2-AS1	1.63586244149587	0.0134641068298276	LPS_vs_PBS	HSALNG0031185	anti_sense	Q50	NA	-	NA	RAB1AP1
ENSG00000233901	LINC01503	-1.91982314796816	5.983740805958131e-9	LPS_vs_PBS	HSALNG0074718	integenic	Q75	hsa-miR-185-3p,hsa-miR-762,hsa-miR-3620-5p,hsa-miR-4505,hsa-miR-4530,hsa-miR-1587,hsa-miR-6089,hsa-miR-6732-5p,hsa-miR-6791-5p,hsa-miR-8485	Atopic eczema,Protein measurement,Caudate nucleus measurement; Functional brain measurement; Response to reward,-	NA	RITA1
ENSG00000233975	LINC02574	4.03290757759616	8.82250197649703e-8	LPS_vs_PBS	HSALNG0002009	integenic	Q50	hsa-miR-619-5p	Body weight,Systolic blood pressure; Pulse pressure measurement; Mean arterial pressure,Body mass index,-	IFI6	PHACTR4
ENSG00000234072	GTF3C2-AS2	-1.64358574969845	4.50881438177408e-4	LPS_vs_PBS	HSALNG0013804	anti_sense	Q90	hsa-miR-194-3p,hsa-miR-619-5p,hsa-miR-7155-5p	C-reactive protein measurement; Sex hormone-binding globulin measurement; Testosterone measurement; Total cholesterol measurement; Apolipoprotein b measurement; Low density lipoprotein cholesterol measurement; Triglyceride measurement,Urinary albumin to creatinine ratio,Lactate measurement; Alpha-hydroxybutyric acid measurement,Triglyceride measurement,Sleep duration; Triglyceride measurement,Serum igg glycosylation measurement,-	SNX17	TBC1D9B
ENSG00000234148	LINC01961	6.12226575018945	1.4703322251959e-8	LPS_vs_PBS	HSALNG0018065	integenic	Not conserved	NA	-	FOXD4L1	ENSG00000234394
ENSG00000234199	LINC01191	2.26580271414117	0.00211545723619581	LPS_vs_PBS	HSALNG0018115	integenic	Not conserved	NA	NA	ACTR3	NCCRP1
ENSG00000234261	NA	2.9333572760412	0.00778744454942345	LPS_vs_PBS	HSALNG0048264	integenic	Not conserved	NA	Total blood protein measurement,Mean corpuscular hemoglobin,Mean corpuscular volume,Mean reticulocyte volume,Mean corpuscular volume; Mean corpuscular hemoglobin,Mean corpuscular volume; Mean corpuscular hemoglobin; Erythrocyte count,Mean reticulocyte volume; Erythrocyte count,Erythrocyte count,Red blood cell density measurement,Nucleus accumbens volume,Protein measurement,-	DTNBP1	LINC-PINT
ENSG00000234263	MAP3K5-AS1	4.00287541117618	9.33296385902769e-5	LPS_vs_PBS	HSALNG0053716	anti_sense	Q75	NA	Unipolar depression	PEX7	WFDC2
ENSG00000234362	LINC01914	4.45632649403031	0.00174584994999161	LPS_vs_PBS	HSALNG0014404	integenic	Q75	hsa-miR-622	Chronotype measurement,Fasting blood glucose measurement,Gastric carcinoma,Self reported educational attainment; Cognitive function measurement,Cognitive function measurement,Intelligence,Self reported educational attainment; Serum alanine aminotransferase measurement; Sex hormone-binding globulin measurement; Low density lipoprotein triglyceride measurement; Body mass index; Body fat percentage; Body height; High density lipoprotein cholesterol measurement; Aspartate aminotransferase measurement,Body mass index,Eye colour measurement,Lifestyle measurement,Triacylglycerol 48:0 measurement,Mathematical ability,Unipolar depression,Bmi-adjusted waist-hip ratio,Gut microbiome measurement,Rheumatoid arthritis,Hair colour measurement; Heel bone mineral density,Electrocardiography,Breast carcinoma,Fev/fec ratio; Response to bronchodilator,Conduct disorder; Parental emotion expression measurmement,Cingulate cortex measurement; Amyloid-beta measurement,Response to vaccine,-	COX7A2L	ENSG00000271830
ENSG00000234393	NA	4.67579226639647	3.56372237776838e-7	LPS_vs_PBS	HSALNG0080759	anti_sense	Q75	hsa-miR-5194	NA	NRAP	ADORA2A-AS1
ENSG00000234394	LINC03025	6.15842745454988	1.77513938036467e-8	LPS_vs_PBS	HSALNG0071679	sense	Q50	hsa-miR-762,hsa-miR-4447,hsa-miR-5787,hsa-miR-6124	-	PGM5	LINC01961
ENSG00000234432	LINC02983	-3.19941058214569	0.0350843278436526	LPS_vs_PBS	HSALNG0149872	integenic	Q50	hsa-miR-4733-3p	-	TNRC18	TET1
ENSG00000234506	LINC01506	2.55075334408951	0.00281756137251348	LPS_vs_PBS	HSALNG0071693	integenic	Not conserved	hsa-miR-5787	NA	TMEM252	ZNF132
ENSG00000234546	LNCTAM34A	-2.03325419392024	0.00888709961209339	LPS_vs_PBS	HSALNG0000685	integenic	Q50	hsa-miR-1249-5p,hsa-miR-6769b-5p,hsa-miR-7113-3p	Granulocyte percentage of myeloid white cells; Monocyte percentage of leukocytes; Monocyte count; Aspartate aminotransferase measurement,Lean body mass	H6PD	ENSG00000267503
ENSG00000234608	MAPKAPK5-AS1	-1.66074230544147	1.30050482334481e-6	LPS_vs_PBS	HSALNG0094063	anti_sense	Q90	hsa-miR-210-5p,hsa-miR-619-5p,hsa-miR-3197,hsa-miR-3960,hsa-miR-7974	-	TMEM116	DGKD
ENSG00000234622	NA	3.71588062998643	0.0441380708266475	LPS_vs_PBS	HSALNG0136369	integenic	Not conserved	NA	NA	ASMT	ENSG00000279349
ENSG00000234650	PCCA-AS1	-4.66588578138234	0.00242138916629782	LPS_vs_PBS	HSALNG0098980	anti_sense	Not conserved	NA	NA	GGACT	MALINC1
ENSG00000234694	CDC20-DT	-3.94896898388195	0.0388044469726198	LPS_vs_PBS	HSALNG0003089	anti_sense	Q50	hsa-miR-619-5p,hsa-miR-939-3p,hsa-miR-6798-5p,hsa-miR-6845-5p,hsa-miR-10392-3p	Platelet count,-	ELOVL1	ENO2
ENSG00000234717	TMEM212-AS1	5.59917623741483	6.12044203162501e-6	LPS_vs_PBS	HSALNG0030700	anti_sense	Q50	hsa-miR-5004-3p,hsa-miR-6089	Sex hormone-binding globulin measurement,Body mass index,Colorectal cancer,Corneal resistance factor,White matter hyperintensity measurement; Hypertension,-	PLD1	GATA6
ENSG00000234741	GAS5	-1.29925374157363	2.04356886002751e-4	LPS_vs_PBS	HSALNG0008545	anti_sense	Q50	hsa-miR-4292	Intelligence,Body height,Erythrocyte count,Hematocrit; Hemoglobin measurement,-,Red blood cell density measurement; Erythrocyte count	CENPL	LINC02019
ENSG00000234771	SLC25A25-AS1	-2.6878596471159	1.26119873825137e-9	LPS_vs_PBS	HSALNG0074573	anti_sense	Q90	hsa-miR-328-5p,hsa-miR-1228-5p,hsa-miR-3714,hsa-miR-2392,hsa-miR-6803-5p	-	PTGES2	XPOT
ENSG00000234869	LINC02925	-2.96857025140938	8.12509605723385e-6	LPS_vs_PBS	HSALNG0136023	integenic	Q50	hsa-miR-3620-5p,hsa-miR-1268b,hsa-miR-4437,hsa-miR-4505,hsa-miR-1587,hsa-miR-6131	Ocular sarcoidosis,Adolescent idiopathic scoliosis,-	GRAMD4	FRAT2
ENSG00000234883	MIR155HG	3.10271910981231	7.03638879484587e-5	LPS_vs_PBS	HSALNG0132382	anti_sense,sense	Q75	hsa-miR-6089,hsa-miR-8485	Neuropsychological test,Intelligence,Response to carboplatin,Nicotine dependence symptom count,Gout,Open-angle glaucoma,Triglyceride measurement,Erythrocyte count,Chronic lymphocytic leukemia,Cerebrospinal fluid biomarker measurement; Alpha synuclein measurement,Duchenne muscular dystrophy; Disease progression measurement,-,Amyloid plaque accumulation rate	JAM2	SUGCT-AS1
ENSG00000234912	SNHG20	-2.3195536852644	8.76570483353404e-6	LPS_vs_PBS	HSALNG0118895	sense	Q50	hsa-miR-619-5p,hsa-miR-762,hsa-miR-4449,hsa-miR-6069,hsa-miR-6089,hsa-miR-6777-3p	Heel bone mineral density,-	SEC14L1	KRT8P3
ENSG00000235027	PRADX	-3.3925467388891	1.18578839358045e-9	LPS_vs_PBS	NA	NA	NA	NA	NA	KRTAP5-6	INPPL1
ENSG00000235078	NA	-3.54407035529595	0.0201212832596069	LPS_vs_PBS	HSALNG0012580	anti_sense	Q90	NA	-	TRAPPC12	ENSG00000268355
ENSG00000235257	ITGA9-AS1	1.61184343026874	0.0192314226928078	LPS_vs_PBS	HSALNG0025195	anti_sense	Not conserved	NA	NA	PLCD1	ADGRG2
ENSG00000235314	LINC00957	-2.30386727341029	0.00338141244121353	LPS_vs_PBS	HSALNG0057613	integenic	Not conserved	hsa-miR-619-5p,hsa-miR-4466,hsa-miR-4505,hsa-miR-5585-3p,hsa-miR-6747-3p,hsa-miR-6784-5p	-	DBNL	ENSG00000272425
ENSG00000235366	LINC01055	5.81711248141823	3.53094890713727e-5	LPS_vs_PBS	HSALNG0096844	integenic	Not conserved	NA	-	ERICH6B	FKBP1BP1
ENSG00000235385	LINC02154	6.03456137427039	2.8544071766374097e-11	LPS_vs_PBS	HSALNG0136703	overlap_sense	Not conserved	NA	NA	ATXN3L	HIVEP2-DT
ENSG00000235437	LINC01278	-1.04564550156948	3.54313970456859e-4	LPS_vs_PBS	HSALNG0138225	sense	Not conserved	hsa-miR-4328,hsa-miR-4447	Periodontitis,Balding measurement	SPIN4	LINC02185
ENSG00000235513	L3MBTL2-AS1	1.7153528389706	0.00565107199494553	LPS_vs_PBS	HSALNG0135617	anti_sense	Q75	hsa-miR-6731-5p	Anorexia nervosa; Autism spectrum disorder; Depressive symptom measurement; Obsessive-compulsive disorder; Attention deficit hyperactivity disorder; Unipolar depression; Bipolar disorder; Tourette syndrome; Neuroticism measurement,Neuroticism measurement,Breast carcinoma,Red blood cell distribution width,Mood instability measurement,Anxiety measurement; Neuroticism measurement,Depressive symptom measurement; Unipolar depression; Wellbeing measurement; Bipolar disorder; Neuroticism measurement,-	CHADL	SLC25A37
ENSG00000235706	DICER1-AS1	1.93390356548369	0.037613361347873	LPS_vs_PBS	HSALNG0103422	anti_sense	Q90	hsa-miR-4472,hsa-miR-4787-5p,hsa-miR-6089,hsa-miR-6803-5p	-	GLRX5	METTL3
ENSG00000235843	NA	3.71730412283516	0.0234185541925839	LPS_vs_PBS	HSALNG0076814	sense	Not conserved	NA	NA	PDSS1	STON2
ENSG00000235865	GSN-AS1	-1.92888759909046	1.5011878217975e-5	LPS_vs_PBS	HSALNG0074167	anti_sense	Not conserved	NA	-	STOM	DPRXP4
ENSG00000235888	LINC02940	3.45331477706111	9.99503475770864e-7	LPS_vs_PBS	HSALNG0133099	integenic	Q50	hsa-miR-331-3p,hsa-miR-412-3p,hsa-miR-668-3p,hsa-miR-3189-5p,hsa-miR-4710,hsa-miR-5787,hsa-miR-6744-3p,hsa-miR-6748-3p,hsa-miR-6803-5p,hsa-miR-6780b-3p	Drugs affecting bone structure and mineralization use measurement; Osteoporosis; Heel bone mineral density,Bone density,Nicotine dependence,Covid-19,Nicotine dependence symptom count,Open-angle glaucoma,Female reproductive system disease,Colorectal cancer,Psoriasis; Neutrophil count; Mean corpuscular hemoglobin concentration; Platelet crit; Red blood cell distribution width; Ulcerative colitis; Ankylosing spondylitis; Mean corpuscular hemoglobin; Basophil count; Myeloid white cell count; Leukocyte count; Crohn's disease; Eosinophil count; Sclerosing cholangitis; Granulocyte count,Eye morphology measurement,C-reactive protein measurement; Inflammatory bowel disease; Alkaline phosphatase measurement; Ulcerative colitis; Crohn's disease; Triglyceride measurement,Ankylosing spondylitis; Takayasu arteritis,Ankylosing spondylitis,Inflammatory bowel disease; Ankylosing spondylitis; Takayasu arteritis; Hemoglobin measurement; Sclerosing cholangitis,Fibrinogen measurement,Autoimmune thyroid disease; Psoriasis; Common variable immunodeficiency; Alkaline phosphatase measurement; C-reactive protein measurement; Ulcerative colitis; Ankylosing spondylitis; Systemic lupus erythematosus; Crohn's disease; Celiac disease; Autoimmune disease; Hemoglobin measurement; Juvenile idiopathic arthritis,Hemoglobin measurement; Takayasu arteritis,Neutrophil count; Granulocyte percentage of myeloid white cells; Leukocyte count; Neutrophil percentage of leukocytes; Monocyte percentage of leukocytes,C-reactive protein measurement,Ulcerative colitis; Red blood cell distribution width,Alkaline phosphatase measurement; Mean corpuscular hemoglobin; Red blood cell distribution width,Red blood cell distribution width,Ulcerative colitis; Rheumatoid arthritis,C-reactive protein measurement; Takayasu arteritis,-	PSMG1	NDRG1
ENSG00000236088	COX10-DT	-1.23613641188073	0.0063512715333556204	LPS_vs_PBS	HSALNG0114686	anti_sense	Q50	hsa-miR-619-5p,hsa-miR-6786-3p,hsa-miR-6871-5p,hsa-miR-8485	Age at onset,Conduct disorder,Serum igg glycosylation measurement,Systemic lupus erythematosus,Endometriosis,Adipic acid mesurement,Adolescent idiopathic scoliosis,Serum albumin measurement,Sex hormone-binding globulin measurement,Eyelid sagging measurement,Temperament and character inventory,Chronic obstructive pulmonary disease,Polychlorinated biphenyls measurement; Gestational serum measurement,Stressful life event measurement; Depressive symptom measurement,Childhood trauma measurement; Alcohol consumption measurement,Educational attainment,-	HS3ST3A1	REPIN1-AS1
ENSG00000236120	NA	-1.70234786352803	3.97427271335665e-5	LPS_vs_PBS	HSALNG0136490	integenic	Not conserved	NA	Facial morphology measurement	NLGN4X	RPN2
ENSG00000236144	TMEM147-AS1	-2.13477279278522	1.64681012511705e-6	LPS_vs_PBS	HSALNG0125628	anti_sense	Q75	hsa-miR-3155b,hsa-miR-6089,hsa-miR-6826-3p	Systolic blood pressure change measurement; Diastolic blood pressure change measurement,-	ATP4A	RPRD2
ENSG00000236453	NA	4.05639913153647	0.0101092637884036	LPS_vs_PBS	HSALNG0059602	anti_sense	Q50	hsa-miR-619-5p,hsa-miR-3622b-5p	Eye colour measurement,Brcax breast cancer,Asparaginase hypersensitivity,Aging,Athletic endurance measurement,Circadian rhythm,-	GNG11	ENSG00000252985
ENSG00000236540	NA	-1.21805491445926	0.0231694826893037	LPS_vs_PBS	HSALNG0134085	anti_sense	Not conserved	hsa-miR-4443,hsa-miR-4722-5p,hsa-miR-6089,hsa-miR-6813-5p	-	ARVCF	ENOSF1
ENSG00000236591	UST-AS2	4.34968341095296	0.00118556863090013	LPS_vs_PBS	HSALNG0054229	anti_sense	Not conserved	hsa-miR-4284,hsa-miR-4292,hsa-miR-8485	NA	ZC3H12D	LINC02457
ENSG00000236682	MAP3K2-DT	-3.65839005387925	1.41840731669409e-10	LPS_vs_PBS	HSALNG0018617	anti_sense	Q50	hsa-miR-619-5p,hsa-miR-1237-5p,hsa-miR-4292,hsa-miR-3180,hsa-miR-4488,hsa-miR-3960	Protein c measurement,Self reported educational attainment,-	PROC	SPIN1
ENSG00000236772	NA	-2.89055089401894	0.028407973338736	LPS_vs_PBS	HSALNG0146822	anti_sense	Q90	hsa-miR-4261	-	ASXL1	ZNF396
ENSG00000236871	LINC00106	-1.78434117608873	0.00858049337880637	LPS_vs_PBS	HSALNG0136360	integenic	Not conserved	hsa-miR-1227-5p,hsa-miR-3178,hsa-miR-6089,hsa-miR-6816-5p,hsa-miR-8485	NA	IL3RA	UBE2L3
ENSG00000236901	MIR600HG	-2.01610621838316	0.00558218695314325	LPS_vs_PBS	HSALNG0074272	sense	Not conserved	NA	-	STRBP	ENSG00000254484
ENSG00000236939	BAALC-AS2	5.80535362198775	2.95858604613487e-20	LPS_vs_PBS	HSALNG0067505	anti_sense	Q50	hsa-miR-4447	Pelvic organ prolapse,Cognitive function measurement,Myopia,Late-onset alzheimers disease,Mathematical ability,Colorectal cancer; Breast carcinoma,Triglyceride measurement; Response to diuretic,Hemoglobin a1 measurement,-	AZIN1	HIVEP2
ENSG00000237036	ZEB1-AS1	-3.30777174890548	0.0181179512724639	LPS_vs_PBS	HSALNG0077083	anti_sense	Q90	hsa-miR-30b-3p,hsa-miR-3178,hsa-miR-3960,hsa-miR-4685-3p,hsa-miR-4707-5p,hsa-miR-5587-3p,hsa-miR-6089,hsa-miR-6769b-3p,hsa-miR-7113-3p,hsa-miR-9901	Lumbar disc degeneration,Mathematical ability,Sex hormone-binding globulin measurement,Glucose homeostasis measurement; Disposition index measurement,Tinnitus; Response to cisplatin,Peripheral arterial disease; Traffic air pollution measurement,-	ZNF438	ENSG00000260953
ENSG00000237181	PRKAR1B-AS1	2.18899539609137	9.68065147985369e-7	LPS_vs_PBS	HSALNG0055551	anti_sense	Not conserved	hsa-miR-874-3p,hsa-miR-4667-3p,hsa-miR-6749-3p	Erythrocyte count,-	DNAAF5	NUP98
ENSG00000237310	LINC03011	-1.90709603291431	0.0431129179514811	LPS_vs_PBS	HSALNG0058603	integenic	Not conserved	hsa-miR-619-5p,hsa-miR-4472,hsa-miR-6782-5p,hsa-miR-6803-5p,hsa-miR-6833-3p	-	TPST1	SNHG8
ENSG00000237352	LINC01358	1.46688837664126	0.0360314534924257	LPS_vs_PBS	HSALNG0003970	integenic	Q50	NA	Serum albumin measurement,Response to lithium ion; Bipolar disorder,Hematocrit; Pulse pressure measurement,-	FGGY	CYREN
ENSG00000237372	NA	3.3760894056435	0.0099890249337228	LPS_vs_PBS	HSALNG0072619	integenic	Not conserved	NA	NA	GADD45G	PLSCR2
ENSG00000237499	WAKMAR2	1.83339877034044	0.00202104300828937	LPS_vs_PBS	HSALNG0053791	anti_sense	Q50	hsa-miR-619-5p,hsa-miR-4472,hsa-miR-4492,hsa-miR-6728-3p,hsa-miR-6803-5p,hsa-miR-6842-3p	Systemic lupus erythematosus,Total blood protein measurement,Eosinophil count,Eczema; Allergic rhinitis,Rheumatoid arthritis; Systemic lupus erythematosus,C-reactive protein measurement,-	PERP	SLC44A2
ENSG00000237576	LINC01888	2.67105559354363	0.00203104974294173	LPS_vs_PBS	HSALNG0015714	integenic	Not conserved	NA	Rr interval	ARHGAP25	ACSM5
ENSG00000237605	DYRK3-AS1	3.21284287869697	0.0200828151061445	LPS_vs_PBS	HSALNG0010037	anti_sense	Q50	hsa-miR-149-3p,hsa-miR-1224-3p,hsa-miR-4297,hsa-miR-4492,hsa-miR-4749-3p,hsa-miR-6763-5p	-	EIF2D	EIF4A3
ENSG00000237753	SLC20A1-DT	-2.13422410011837	0.00200571056793783	LPS_vs_PBS	HSALNG0017985	anti_sense	Q75	hsa-miR-619-5p,hsa-miR-3652,hsa-miR-4443,hsa-miR-4508,hsa-miR-378j	-	CKAP2L	TOP1MT
ENSG00000237797	MACORIS	-2.69019935185467	6.48037481583918e-4	LPS_vs_PBS	HSALNG0077098	integenic	Q50	NA	Waist-hip ratio; Sex interaction measurement; Age at assessment; Bmi-adjusted waist-hip ratio	ARHGAP12	LIPT2-AS1
ENSG00000237927	NA	4.03351711681757	7.73190642965846e-5	LPS_vs_PBS	HSALNG0054755	integenic	Not conserved	hsa-miR-183-5p,hsa-miR-5585-3p,hsa-miR-6089	Lipoprotein a measurement,Atrophic macular degeneration,-	SOD2	GATA5
ENSG00000237940	LINC01238	2.87340663269115	0.0388642780376478	LPS_vs_PBS	HSALNG0023737	anti_sense	Not conserved	hsa-miR-891a-3p,hsa-miR-937-5p,hsa-miR-4505,hsa-miR-4722-5p,hsa-miR-6085,hsa-miR-6748-3p,hsa-miR-6792-3p,hsa-miR-6883-5p,hsa-miR-6889-3p,hsa-miR-7108-5p	Caudal anterior cingulate cortex volume measurement,Brain aneurysm,Eczema,Ovarian carcinoma,High density lipoprotein cholesterol measurement,Age at onset; Refractive error; Myopia,-	RTP5	UBE3AP2
ENSG00000237980	LINC02773	3.22362354079762	0.00101592476676568	LPS_vs_PBS	HSALNG0010379	integenic	Q50	hsa-miR-4313,hsa-miR-4466	-	BATF3	ENSG00000269973
ENSG00000238045	MVP-DT	2.22417661650654	6.86520429927615e-5	LPS_vs_PBS	HSALNG0144898	anti_sense	Q90	hsa-miR-4745-3p	NA	CDIPT	RNF213-AS1
ENSG00000238133	MAP3K20-AS1	2.75709217289635	0.0246226520582014	LPS_vs_PBS	HSALNG0020412	anti_sense	Q75	hsa-miR-4328,hsa-miR-4430,hsa-miR-6782-5p	Serum alanine aminotransferase measurement,Smoking behaviour measurement,Chronotype measurement,Fev/fec ratio,Smoking status measurement,Lung carcinoma,Parental longevity,Adiponectin measurement,Bmi-adjusted waist circumference; Bmi-adjusted waist-hip ratio,Hemoglobin measurement,Cognitive decline measurement,Self reported educational attainment,Gut microbiome measurement,Mathematical ability,Self reported educational attainment; Mathematical ability,Breast carcinoma,Mean reticulocyte volume; Mean corpuscular hemoglobin concentration; Red blood cell distribution width; Mean corpuscular hemoglobin; Mean corpuscular volume; Erythrocyte count,Cancer,Lung adenocarcinoma,Mean corpuscular volume,Cup-to-disc ratio measurement; Optic disc area measurement; Optic cup area measurement,Self reported educational attainment; Cognitive function measurement; Mathematical ability,-,Apolipoprotein a 1 measurement	SP3	ODAD3
ENSG00000238197	PAXBP1-AS1	-1.21761666916496	0.00699488075694409	LPS_vs_PBS	HSALNG0132711	anti_sense	Q90	hsa-miR-500b-3p	-	EVA1C	ENSG00000290796
ENSG00000238246	NA	-4.2236888693894	1.52351451068676e-6	LPS_vs_PBS	HSALNG0076534	anti_sense	Not conserved	hsa-miR-10394-5p	Heel bone mineral density	NEBL	LINC00852
ENSG00000238755	LINC02006	3.52332063502936	0.0295016801183864	LPS_vs_PBS	HSALNG0147951	integenic	Not conserved	NA	NA	DHX36	PPP1R27
ENSG00000239213	NCK1-DT	-2.87207424169257	7.816039142108789e-12	LPS_vs_PBS	HSALNG0029189	anti_sense	Q90	hsa-miR-23a-5p,hsa-miR-135a-3p,hsa-miR-619-5p,hsa-miR-1268b,hsa-miR-4447,hsa-miR-3960,hsa-miR-6089	Lymphocyte count,Body mass index,-	STAG1	SAP30BP
ENSG00000239445	ST3GAL6-AS1	-1.7283510208868	0.00125348258481259	LPS_vs_PBS	HSALNG0027499	anti_sense	Q50	hsa-miR-937-5p	Leukocyte count; Monocyte count,Vascular endothelial growth factor receptor 3 measurement,Monocyte percentage of leukocytes,Eosinophil count,Keratinocyte carcinoma; Basal cell carcinoma,Leukocyte count,Eosinophil count; Skin neoplasm,Eosinophil count; Eosinophil percentage of leukocytes,Unipolar depression,Non-melanoma skin carcinoma,-	DCBLD2	EPS8
ENSG00000239569	KMT2E-AS1	1.57886535645914	0.00611282068128226	LPS_vs_PBS	HSALNG0060291	anti_sense	Q90	hsa-miR-483-3p,hsa-miR-3620-5p,hsa-miR-1268b,hsa-miR-4505,hsa-miR-1587,hsa-miR-6779-3p,hsa-miR-6887-3p	Intelligence; Mathematical ability,Vital capacity,Intelligence,Risk-taking behaviour,Vitamin d measurement,Interleukin-6 measurement,Self reported educational attainment; Intelligence,-	SRPK2	ENSG00000289526
ENSG00000239911	PRKAG2-AS1	-2.89809399477844	1.86208442008457e-6	LPS_vs_PBS	HSALNG0062390	anti_sense	Q90	hsa-miR-1227-5p,hsa-miR-3620-5p,hsa-miR-1587,hsa-miR-6791-5p	-	GALNTL5	ACVR1
ENSG00000240057	NEPRO-AS1	2.604216162785	3.78115973864269e-6	LPS_vs_PBS	HSALNG0028082	integenic	Q90	hsa-miR-296-3p	Telomere length,Myopia,Body height	GTPBP8	ENSG00000253891
ENSG00000240288	GHRLOS	-2.37324451723257	1.28339514333358e-5	LPS_vs_PBS	HSALNG0024099	anti_sense,sense	Q90	hsa-miR-4650-5p	Self reported educational attainment,Ghrelin measurement,-	NA	RNASEH2B
ENSG00000240449	REPIN1-AS1	-2.21039472952808	0.020441099170239	LPS_vs_PBS	HSALNG0062263	anti_sense	Q75	hsa-miR-3620-5p,hsa-miR-1587,hsa-miR-6784-5p	Chemerin measurement,-	RARRES2	ENSG00000259635
ENSG00000240498	CDKN2B-AS1	1.72583906657941	0.00230453473304231	LPS_vs_PBS	HSALNG0070400	integenic	Not conserved	NA	Eosinophil count,Colorectal cancer,Coronary artery disease; Parental longevity,-	MTAP	BAALC-AS1
ENSG00000241155	ARHGAP31-AS1	1.99575514337161	0.0191121183594056	LPS_vs_PBS	HSALNG0028303	intronic_antisense	Not conserved	hsa-miR-4730	NA	B4GALT4	SMTNL2
ENSG00000241163	LINC00877	1.19995903539991	0.0186129356971301	LPS_vs_PBS	HSALNG0026804	integenic	Not conserved	NA	Protein measurement	RYBP	SPATA31E1
ENSG00000241764	CBLL1-AS1	1.13102471419994	0.0377163969057283	LPS_vs_PBS	HSALNG0060448	anti_sense	Q75	NA	Lymphocyte count,-	SLC26A3	MTRF1
ENSG00000241769	EOLA1-DT	-2.3541834036141	0.020133210266967	LPS_vs_PBS	HSALNG0140599	anti_sense,sense	Not conserved	hsa-miR-4257	NA	NA	GPC2
ENSG00000242048	PRKAG2-AS2	3.18663090546985	8.88051744715197e-6	LPS_vs_PBS	HSALNG0149841	anti_sense	Not conserved	NA	NA	GALNTL5	KIAA1522
ENSG00000242086	MUC20-OT1	-1.21024318392256	0.00274274718663422	LPS_vs_PBS	HSALNG0031831	sense	Q50	hsa-miR-29a-3p,hsa-miR-30b-3p,hsa-miR-339-5p,hsa-miR-619-5p,hsa-miR-1301-3p,hsa-miR-762,hsa-miR-1237-5p,hsa-miR-3180-3p,hsa-miR-3187-5p,hsa-miR-3180,hsa-miR-4447,hsa-miR-4722-5p,hsa-miR-4755-3p,hsa-miR-6089,hsa-miR-6769a-3p	Protein measurement,-	MUC20	SGSM2
ENSG00000242125	SNHG3	-1.99031654794991	1.79498817058987e-10	LPS_vs_PBS	HSALNG0002066	sense	Not conserved	hsa-miR-30b-3p,hsa-miR-4492,hsa-miR-5787,hsa-miR-6890-5p	Systolic blood pressure,Nighttime rest measurement,-	RCC1	METAP1
ENSG00000242258	LINC00996	3.2228552941065	2.3880964756228e-6	LPS_vs_PBS	HSALNG0062275	sense	Not conserved	NA	Electroencephalogram measurement	GIMAP8	IL1B
ENSG00000243055	GK-AS1	1.46826172184718	0.0383403037644823	LPS_vs_PBS	HSALNG0151186	anti_sense	Q50	hsa-miR-619-5p	-	TAB3	PDE4DIPP2
ENSG00000243224	TWF2-DT	-2.72795786434572	0.0285700685244768	LPS_vs_PBS	HSALNG0026122	integenic	Not conserved	hsa-miR-92a-2-5p,hsa-miR-3176	-	PPM1M	MIR3174
ENSG00000243701	DUBR	1.40787575346719	0.0110609385358697	LPS_vs_PBS	HSALNG0027862	integenic	Q50	NA	NA	CCDC54	CENPJ
ENSG00000243960	NA	-3.83271271012689	0.00493379418702856	LPS_vs_PBS	HSALNG0006050	sense	Q90	hsa-miR-3620-5p	-	WDR77	ENSG00000261468
ENSG00000244041	LINC01011	-1.41456167530013	0.0232968781300601	LPS_vs_PBS	HSALNG0047546	sense	Not conserved	NA	Urinary metabolite measurement,Protein measurement,-	NQO2	LDHB
ENSG00000244286	ITGB5-AS1	-3.39507271507903	0.00264700325899224	LPS_vs_PBS	HSALNG0028583	intronic_antisense	Q50	NA	NA	UMPS	ENSG00000272990
ENSG00000244491	NA	4.64478696565843	9.02872503997731e-5	LPS_vs_PBS	HSALNG0135439	anti_sense,sense	Q90	hsa-miR-1227-5p,hsa-miR-500b-3p	White matter microstructure measurement,-	GTPBP1	C1orf21
ENSG00000244701	NA	-2.75767636049204	0.00571386097003224	LPS_vs_PBS	HSALNG0061850	anti_sense,sense	Q75	NA	-	DENND11	ENSG00000270055
ENSG00000244879	GABPB1-AS1	-2.73757105177092	1.72338059033318e-6	LPS_vs_PBS	HSALNG0105872	anti_sense,sense	Q90	hsa-miR-619-5p,hsa-miR-4505	Superior frontal gyrus volume measurement,Adolescent idiopathic scoliosis,Testosterone measurement,Platelet crit,Breast carcinoma,Fev/fec ratio,Body height,Blood phosphate measurement,-	USP8	ENSG00000279495
ENSG00000244926	ALKBH3-AS1	-2.40364925980027	0.0170522151577239	LPS_vs_PBS	HSALNG0083844	anti_sense	Q75	hsa-miR-370-3p	Body mass index,Body height,-	ALX4	ZNF582
ENSG00000245105	A2M-AS1	-1.99340440693091	0.0182339438415903	LPS_vs_PBS	HSALNG0089113	anti_sense	Not conserved	hsa-miR-1228-5p,hsa-miR-4307,hsa-miR-3620-5p,hsa-miR-4505,hsa-miR-6090	-	KLRG1	SNAI3
ENSG00000245146	MALINC1	-1.8516798964327	0.0313255173031085	LPS_vs_PBS	HSALNG0045289	integenic	Not conserved	NA	NA	NRG2	PCCA-AS1
ENSG00000245213	GALNT7-DT	-2.13234044935267	0.00198609642420401	LPS_vs_PBS	HSALNG0038578	integenic	Not conserved	NA	NA	HMGB2	COL7A1
ENSG00000245498	MSANTD2-AS1	-1.84829159038882	0.0164620373724403	LPS_vs_PBS	HSALNG0087917	anti_sense	Q75	hsa-miR-328-5p,hsa-miR-6870-5p	-	ROBO3	PHETA1
ENSG00000245552	LNCRNA-IUR	2.22607666412918	3.6684165173854e-5	LPS_vs_PBS	HSALNG0086562	anti_sense	Q90	hsa-miR-483-3p,hsa-miR-619-5p,hsa-miR-3960	Mean reticulocyte volume; Mean corpuscular hemoglobin concentration; Mean corpuscular hemoglobin; Mean corpuscular volume; Red blood cell density measurement; Erythrocyte count,Red blood cell distribution width,Eosinophil count,Common carotid intimal medial thickness,-	ENDOD1	OGG1
ENSG00000245556	SCAMP1-AS1	1.08313581205855	0.0086228494457151	LPS_vs_PBS	HSALNG0042878	integenic	Q50	hsa-miR-619-5p	NA	AP3B1	DUSP22
ENSG00000245651	NA	3.84729866885088	0.0484052729828315	LPS_vs_PBS	HSALNG0091673	integenic	Q75	hsa-miR-920,hsa-miR-4763-3p,hsa-miR-6813-5p	Body mass index,Self reported educational attainment,Body height; Cognitive function measurement,-	CTDSP2	EHF
ENSG00000245667	NA	-2.68174269794328	0.00633179459740702	LPS_vs_PBS	HSALNG0088872	anti_sense	Not conserved	hsa-miR-329-5p,hsa-miR-619-5p	Bmi-adjusted waist-hip ratio	GAPDH	PIGCP1
ENSG00000245688	NA	-3.02986121147931	0.035020656997142303	LPS_vs_PBS	HSALNG0047024	sense	Not conserved	NA	NA	COL23A1	ENSG00000261611
ENSG00000245694	CRNDE	-2.03875504665105	2.22235653829414e-5	LPS_vs_PBS	HSALNG0111608	integenic	Q50	hsa-miR-619-5p,hsa-miR-4266,hsa-miR-6746-5p,hsa-miR-6754-5p,hsa-miR-10392-3p	Adolescent idiopathic scoliosis,Diet measurement; Body mass index,-	IRX3	PHF7
ENSG00000245849	RAD51-AS1	-1.09747968902353	0.0405342666099574	LPS_vs_PBS	HSALNG0105273	anti_sense	Not conserved	hsa-miR-619-5p,hsa-miR-6089	Body height,Lymphocyte count,Intelligence; Bmi-adjusted waist-hip ratio,Complement factor h-related protein 5 measurement,Prostate carcinoma,-	RMDN3	POLR2J4
ENSG00000245904	BTG1-DT	1.62664668931324	0.0450368328330805	LPS_vs_PBS	HSALNG0143464	integenic	Not conserved	hsa-miR-7703	Eosinophil count; Eosinophil percentage of leukocytes,Covid-19,-	PLEKHG7	GADD45A
ENSG00000245937	SLC12A2-DT	-1.50223416462521	2.62951888856584e-5	LPS_vs_PBS	HSALNG0044716	anti_sense	Q50	hsa-miR-140-3p,hsa-miR-4691-3p	Facial hair thickness measurement,Red blood cell distribution width; Apolipoprotein a 1 measurement; Myeloid white cell count; High density lipoprotein cholesterol measurement; Bmi-adjusted waist-hip ratio; Skin and soft tissue staphylococcus aureus infection,Serum alanine aminotransferase measurement; Sex hormone-binding globulin measurement; Low density lipoprotein triglyceride measurement; Body fat percentage; Waist-hip ratio; Total blood protein measurement; High density lipoprotein cholesterol measurement; Appendicular lean mass; Vital capacity; Aspartate aminotransferase measurement,Lean body mass,Systolic blood pressure,Varicose veins; Sex hormone-binding globulin measurement; Fev/fec ratio; High density lipoprotein cholesterol measurement; Serum albumin measurement,Red blood cell distribution width,Body height,Lymphocyte percentage of leukocytes; Lymphocyte count; Bmi-adjusted waist circumference; Nicotine dependence symptom count; Neutrophil percentage of leukocytes; Platelet-to-lymphocyte ratio,Serum alanine aminotransferase measurement; Appendicular lean mass,Bmi-adjusted waist-hip ratio,Body fat distribution; Lymphocyte count; Red blood cell distribution width,Calcium measurement; Sex hormone-binding globulin measurement; Serum albumin measurement; Red blood cell distribution width,Breast carcinoma,-	FBN2	DIS3L
ENSG00000246100	LINC00900	-1.21112803690882	0.00936599724309939	LPS_vs_PBS	HSALNG0087365	integenic	Q75	hsa-miR-665,hsa-miR-4281,hsa-miR-1268b,hsa-miR-3960	NA	CADM1	ENSG00000273565
ENSG00000246273	SBF2-AS1	-2.33556547612659	1.90489871771563e-6	LPS_vs_PBS	HSALNG0082633	integenic	Not conserved	NA	Platelet count	SWAP70	FAN1
ENSG00000246334	PRR7-AS1	-3.4263149569545	0.00166731696719297	LPS_vs_PBS	HSALNG0046927	anti_sense	Q75	hsa-miR-4763-3p,hsa-miR-6089,hsa-miR-7160-5p	Chronotype measurement,-	DBN1	GARIN5A
ENSG00000246363	LINC02458	2.68957409037161	0.0193913779025635	LPS_vs_PBS	HSALNG0092935	integenic	Not conserved	NA	NA	DUSP6	AADAC
ENSG00000247081	BAALC-AS1	3.2670868859949	0.00986506081062929	LPS_vs_PBS	HSALNG0067506	integenic	Q50	NA	NA	SLC25A32	TXNP5
ENSG00000247271	ZBED5-AS1	-1.09688913414545	0.00260455010469698	LPS_vs_PBS	HSALNG0082661	anti_sense	Q90	hsa-miR-4489	Heel bone mineral density,Bmi-adjusted waist circumference; Bmi-adjusted waist-hip ratio; Waist-hip ratio,-	CTR9	ZMYM4
ENSG00000247317	LY6E-DT	3.97042670158358	0.0311808703544208	LPS_vs_PBS	HSALNG0069213	anti_sense	Not conserved	hsa-miR-6132,hsa-miR-6779-5p,hsa-miR-6784-5p,hsa-miR-6869-3p,hsa-miR-8485	-	LY6S	RABGAP1L-IT1
ENSG00000247556	OIP5-AS1	-1.66454194435135	5.48838916839197e-15	LPS_vs_PBS	HSALNG0105345	anti_sense,sense	Not conserved	NA	NA	NUSAP1	CEP85
ENSG00000247572	CKMT2-AS1	-2.0604995511719	1.00954320176466e-4	LPS_vs_PBS	HSALNG0043022	overlap_antisense,sense	Not conserved	NA	Empathy measurement,-	ACOT12	CAMK2G
ENSG00000247828	TMEM161B-DT	-1.25039787378244	3.53432354889151e-4	LPS_vs_PBS	HSALNG0043363	integenic	Q90	hsa-miR-4438	NA	RASA1	ENSG00000267895
ENSG00000247934	NA	-2.01648560892091	0.0127081441487383	LPS_vs_PBS	HSALNG0090059	anti_sense	Q50	hsa-miR-619-5p,hsa-miR-3529-5p,hsa-miR-6089	Serum igg glycosylation measurement,Seasonal allergic rhinitis,Bmi-adjusted waist circumference,Balding measurement,Open-angle glaucoma,Gut microbiome measurement,Attention deficit hyperactivity disorder; Behavior,Bmi-adjusted waist circumference; Bmi-adjusted hip circumference,Blood protein measurement,Brain volume measurement,Cortical surface area measurement; Facial morphology measurement,Forced expiratory volume; Vital capacity,Reticulocyte measurement,Bmi-adjusted hip circumference,Volumetric bone mineral density,Chronic obstructive pulmonary disease,Body height,Neuroimaging measurement; Cortical thickness,Forced expiratory volume; Response to bronchodilator,Brain volume measurement; Neuroimaging measurement; Brain measurement,-	PTHLH	TESMIN
ENSG00000247982	LINC00926	-2.50551606647673	2.21425174681517e-4	LPS_vs_PBS	HSALNG0106171	sense	Q50	hsa-miR-4492,hsa-miR-4508,hsa-miR-6803-5p	-	TCF12	ZBED3-AS1
ENSG00000248019	FAM13A-AS1	-2.30680545880843	2.00873332219303e-8	LPS_vs_PBS	HSALNG0035768	anti_sense	Q75	NA	Fev/fec ratio,-	HERC3	PPIA
ENSG00000248092	NNT-AS1	-1.00090239994403	0.0164378246754476	LPS_vs_PBS	HSALNG0148848	integenic	Q90	NA	-	PAIP1	DGKZ
ENSG00000248275	TRIM52-AS1	-1.24360302124606	0.0100502150156801	LPS_vs_PBS	HSALNG0047244	anti_sense	Q50	hsa-miR-596,hsa-miR-619-5p,hsa-miR-4486,hsa-miR-4710,hsa-miR-5004-5p,hsa-miR-6085,hsa-miR-6129	-	TRIM41	CLN8
ENSG00000248356	NA	2.53242068617185	0.0457749644766878	LPS_vs_PBS	HSALNG0037665	anti_sense	Q75	NA	-	ZNF827	ENPP4
ENSG00000248371	LINC02056	4.49407403272956	2.19294707122681e-5	LPS_vs_PBS	HSALNG0042592	integenic	Not conserved	NA	NA	ZNF366	UBE2H
ENSG00000248429	GASK1B-AS1	-4.08130593282883	1.0491314039856199e-22	LPS_vs_PBS	HSALNG0038152	anti_sense,sense	Q50	hsa-miR-486-3p,hsa-miR-4466	Blood osmolality measurement,-	TMEM144	PMS1
ENSG00000248476	BACH1-IT1	2.09716913255661	0.00489383384185168	LPS_vs_PBS	HSALNG0132543	sense	Q75	NA	Red blood cell distribution width	BACH1	CTNNB1
ENSG00000248677	LINC02102	2.85713387585443	0.0209838409288944	LPS_vs_PBS	HSALNG0039917	integenic	Not conserved	hsa-miR-619-5p,hsa-miR-7160-3p	Body height,-	NSUN2	SLC25A28-DT
ENSG00000248719	PRDM8-AS1	4.81907422503919	7.62220600077105e-4	LPS_vs_PBS	HSALNG0035459	anti_sense	Q50	hsa-miR-3178,hsa-miR-4478,hsa-miR-4690-3p,hsa-miR-8485	Cognitive behavioural therapy,-	ANTXR2	AMZ2P2
ENSG00000248890	HHIP-AS1	3.84015747171416	0.00661692107049541	LPS_vs_PBS	HSALNG0037609	anti_sense,sense	Q50	hsa-miR-4692,hsa-miR-6826-3p	Bmi-adjusted waist circumference; Body height; Physical activity measurement,Infant body height; Bmi-adjusted waist circumference; Bmi-adjusted hip circumference; Physical activity measurement; Body height; Smoking behavior,Body height; Birth weight,Body fat distribution,Body height; Bmi-adjusted hip circumference,Bmi-adjusted waist circumference,Femoral neck size; Hip bone size,Susceptibility to chronic sinus infection measurement,Mean corpuscular volume,Bmi-adjusted hip circumference,-	NA	LINC02068
ENSG00000249096	LINC02362	2.90740409945656	4.82858907484442e-4	LPS_vs_PBS	HSALNG0039015	integenic	Not conserved	hsa-miR-6089,hsa-miR-6127,hsa-miR-6129	NA	IRF2	ENSG00000278969
ENSG00000249173	LINC01093	4.10297248713387	1.5596408695649e-7	LPS_vs_PBS	HSALNG0039055	integenic	Q50	hsa-miR-619-5p,hsa-miR-4505,hsa-miR-6808-5p,hsa-miR-6769b-5p	NA	ACSL1	MNDA
ENSG00000249249	TICAM2-AS1	1.89444519562385	0.00371768234317986	LPS_vs_PBS	HSALNG0044270	anti_sense	Q90	NA	-	AP3S1	MAP3K20
ENSG00000249252	C1QTNF7-AS1	4.89640461849509	4.3349807264153e-5	LPS_vs_PBS	HSALNG0033043	integenic	Not conserved	NA	Triglyceride measurement	FBXL5	GADD45B
ENSG00000249502	MED28-DT	3.64312848731693	5.26302948579728e-10	LPS_vs_PBS	HSALNG0033145	anti_sense	Q50	hsa-miR-619-5p,hsa-miR-4771	-	FAM184B	ENSG00000229664
ENSG00000249628	LINC00942	-2.52714365562747	0.0177193704420776	LPS_vs_PBS	HSALNG0088539	integenic	Q50	hsa-miR-619-5p,hsa-miR-4290,hsa-miR-1268b,hsa-miR-4505,hsa-miR-1587,hsa-miR-4673,hsa-miR-6803-5p	NA	ERC1	LINC02642
ENSG00000249740	OSMR-DT	3.99168698967025	0.00736760910456821	LPS_vs_PBS	HSALNG0041294	anti_sense	Not conserved	hsa-miR-6873-3p	Waist-hip ratio; Bmi-adjusted waist-hip ratio,Gut microbiome measurement,Bmi-adjusted waist circumference,Reticulocyte count,Hemoglobin measurement,Colorectal adenoma,Retinal vasculature measurement,Psoriasis; Inflammatory bowel disease; Ulcerative colitis; Ankylosing spondylitis; Crohn's disease; Sclerosing cholangitis,Response to selective serotonin reuptake inhibitor,Hematocrit; Hemoglobin measurement; Erythrocyte count,Hematocrit,Erythrocyte count,Heart rate variability measurement; Response to antipsychotic drug,-	LIFR	PRR9
ENSG00000249816	LINC00964	-3.38449294144072	0.0040176167053217	LPS_vs_PBS	HSALNG0068291	integenic	Not conserved	NA	NA	ZNF572	ENSG00000271009
ENSG00000249846	LINC02021	-2.75923262185402	0.0228642541975666	LPS_vs_PBS	HSALNG0147623	integenic	Not conserved	hsa-miR-4686	NA	ALG1L2	OR3A3
ENSG00000249859	PVT1	-1.6143985551971	8.78041692475057e-4	LPS_vs_PBS	HSALNG0068477	integenic	Q50	hsa-miR-619-5p,hsa-miR-665,hsa-miR-4281,hsa-miR-4279,hsa-miR-4434,hsa-miR-4492,hsa-miR-4505,hsa-miR-4526,hsa-miR-4535,hsa-miR-1587,hsa-miR-4690-3p,hsa-miR-4691-3p,hsa-miR-3064-5p,hsa-miR-4749-3p,hsa-miR-4436b-3p,hsa-miR-6069,hsa-miR-6757-5p,hsa-miR-6858-3p,hsa-miR-6883-5p	Allergic sensitization measurement,Allergic sensitization measurement; Allergic rhinitis,Inhalant adrenergic use measurement; Tonsillectomy risk measurement,Ovarian serous carcinoma; Ovarian carcinoma,Body height,Platelet count,Platelet crit,Cognitive decline measurement,Lung carcinoma,Susceptibility to scarlet fever measurement,Waist-hip ratio,Psychosis,Calcium measurement,Hematocrit,Left ventricular systolic function measurement,Mean corpuscular volume; Mean corpuscular hemoglobin,Mean corpuscular volume,Mean corpuscular volume; Mean corpuscular hemoglobin; Mean corpuscular hemoglobin concentration,Reticulocyte measurement; Mean corpuscular hemoglobin concentration,Hemoglobin measurement,Hematocrit; Hemoglobin measurement,Hematocrit; Hemoglobin measurement; Mean corpuscular volume,Eosinophil count; Lymphocyte count; Basophil count,Neutrophil count,Reticulocyte count,Eosinophil count; Lymphocyte count; Eosinophil percentage of leukocytes,Neutrophil percentage of granulocytes; Eosinophil count; Non-melanoma skin carcinoma; Eosinophil percentage of granulocytes,Leukocyte count; Platelet-to-lymphocyte ratio; Lymphocyte count; Myeloid white cell count,Gut microbiome measurement,Leukocyte count; Thyroid preparation use measurement,Eosinophil count; Basophil count,Neutrophil percentage of leukocytes; Eosinophil percentage of leukocytes,Phosphatidylcholine 40:6 measurement,Bell's palsy; Mean corpuscular hemoglobin concentration,Hematocrit; Hemoglobin measurement; Blood protein measurement; Serum non-albumin protein measurement,Total blood protein measurement,Mean corpuscular hemoglobin concentration,Chronic kidney disease,Hodgkins lymphoma,Neoplasm of mature b-cells; Central nervous system non-hodgkin lymphoma,Diffuse large b-cell lymphoma; Non-hodgkins lymphoma; Lymphoma,Serum non-albumin protein measurement,Facial morphology measurement,Reticulocyte measurement,Sporadic amyotrophic lateral sclerosis,C-reactive protein measurement,Colorectal cancer,Tonsillectomy risk measurement,Autoimmune thyroid disease,Birth weight; Lung adenocarcinoma; Primary biliary cirrhosis,Erythrocyte count,Systemic lupus erythematosus,Bmi-adjusted waist circumference,Breast carcinoma,Renal transplant outcome measurement; Donor genotype effect measurement; Apol1 risk genotype carrier status,Major depressive disorder; Major depressive episode,Hodgkins lymphoma; Chronic lymphocytic leukemia; Multiple myeloma,Hypothyroidism,-	MYC	TSPAN3
ENSG00000250132	NA	-1.96604426288682	0.0398215863089366	LPS_vs_PBS	HSALNG0088518	anti_sense,sense	Q50	hsa-miR-15b-5p,hsa-miR-637,hsa-miR-6799-5p	-	RAD52	ENSG00000228463
ENSG00000250133	HOXC-AS2	3.54046305639034	0.0428084163867215	LPS_vs_PBS	HSALNG0091321	anti_sense,intronic_antisense	Q90	NA	Leukocyte count; Bmi-adjusted waist-hip ratio; Waist-hip ratio; Bmi-adjusted waist circumference,Bmi-adjusted waist circumference; Bmi-adjusted waist-hip ratio,Bmi-adjusted waist-hip ratio,Bmi-adjusted waist circumference,Platelet crit,Vital capacity,-	SMUG1	MTATP6P26
ENSG00000250274	NA	3.15813795898387	9.88127607515635e-8	LPS_vs_PBS	NA	NA	NA	NA	NA	LCP2	USP15
ENSG00000250303	LINC02762	-2.47179528606179	7.18036628262773e-5	LPS_vs_PBS	HSALNG0087198	integenic	Not conserved	NA	NA	PTS	ENSG00000250726
ENSG00000250362	NA	3.54627291240912	0.017802321364579	LPS_vs_PBS	HSALNG0043626	integenic	Q50	NA	Blood protein measurement; Serum non-albumin protein measurement,-	RHOBTB3	PLS1
ENSG00000250397	NA	-3.39737786680585	7.14351495295336e-7	LPS_vs_PBS	NA	NA	NA	NA	NA	CHID1	CENPT
ENSG00000250519	NA	1.59634183444885	9.24153258289916e-4	LPS_vs_PBS	HSALNG0086510	integenic	Q50	NA	Serum alanine aminotransferase measurement,-	PANX1	STX5
ENSG00000250548	LINC01303	2.15840133404626	8.90394830535055e-4	LPS_vs_PBS	HSALNG0101771	anti_sense	Q75	NA	Susceptibility to vaginal yeast infection measurement,Asthma exacerbation measurement,-	TMEM30B	AFF1
ENSG00000250742	LINC02381	6.3367087649007	1.11114389209081e-6	LPS_vs_PBS	HSALNG0091335	anti_sense	Q90	hsa-miR-619-5p,hsa-miR-4667-3p,hsa-miR-4749-3p,hsa-miR-5001-3p,hsa-miR-6791-3p,hsa-miR-6803-5p,hsa-miR-6769b-3p	Coronary artery disease; Myocardial infarction,Bmi-adjusted waist-hip ratio,Red blood cell distribution width,Adolescent idiopathic scoliosis,-	HOXC4	ENSG00000197149
ENSG00000250777	NA	-2.25055484290931	2.33818721062656e-4	LPS_vs_PBS	HSALNG0037343	integenic	Q75	hsa-miR-6825-5p	Parental longevity,Energy intake,Systemic lupus erythematosus,Sleep duration; Triglyceride measurement,Triglyceride measurement; High density lipoprotein cholesterol measurement,-	PCDH18	LINC01422
ENSG00000250802	ZBED3-AS1	-2.2784275697151	3.15980899575924e-4	LPS_vs_PBS	HSALNG0042820	anti_sense,sense	Q50	hsa-miR-619-5p,hsa-miR-877-3p,hsa-miR-4505,hsa-miR-4722-5p,hsa-miR-6803-5p,hsa-miR-6892-3p	Self-injurious behavior,Fasting blood glucose measurement,Autism,Glucose measurement; Fasting blood glucose measurement,Hemoglobin a1 measurement; Bmi-adjusted waist-hip ratio,Body mass index,Glucose measurement,Waist-hip ratio; Bmi-adjusted waist-hip ratio,Hba1c measurement,Glucose measurement; Hba1c measurement,Hba1c measurement; Bmi-adjusted waist-hip ratio,Dental caries,Testosterone measurement,Hematocrit; Hemoglobin measurement,Hematocrit; Hemoglobin measurement; Red blood cell density measurement; Erythrocyte count,Thyroid stimulating hormone measurement; Erythrocyte count,Hematocrit; Hemoglobin measurement; Red blood cell density measurement,Hemoglobin measurement,Bmi-adjusted waist-hip ratio,-	NA	LINC00926
ENSG00000250929	LINC01181	5.37310259067661	5.31071315566119e-18	LPS_vs_PBS	HSALNG0067501	integenic	Q50	NA	Small vessel stroke,Idiopathic osteonecrosis of the femoral head,Attention deficit hyperactivity disorder,Growth-regulated alpha protein measurement,Pelvic organ prolapse,-	BAALC	BAALC-AS2
ENSG00000250988	SNHG21	-3.53753446044279	0.028250630158476	LPS_vs_PBS	HSALNG0107711	anti_sense	Q75	hsa-miR-1268b,hsa-miR-6089	Bmi-adjusted hip circumference,-	WHAMM	LINC01298
ENSG00000251009	NA	4.04866820053756	0.0374012792348571	LPS_vs_PBS	HSALNG0033446	anti_sense	Q75	hsa-miR-6724-5p	-	SEL1L3	ENSG00000285239
ENSG00000251136	RIPK2-DT	1.65087155993438	4.86501004007777e-4	LPS_vs_PBS	HSALNG0066822	integenic	Q50	NA	Human papilloma virus infection; Oropharynx cancer,-	NBN	ARHGEF2
ENSG00000251139	NA	2.75397620968303	9.00379602208046e-4	LPS_vs_PBS	HSALNG0039047	anti_sense	Not conserved	NA	Mean platelet volume,-	PRIMPOL	ITGA9-AS1
ENSG00000251230	MIR3945HG	6.65091818720947	1.47699379784675e-17	LPS_vs_PBS	HSALNG0039050	integenic	Not conserved	hsa-miR-619-5p	Mean platelet volume,Mean reticulocyte volume,-	ACSL1	SLCO5A1
ENSG00000251323	LINC02728	3.37283023405148	5.06351735923304e-4	LPS_vs_PBS	HSALNG0085981	integenic	Q75	hsa-miR-4530	Creatinine measurement; Body height,Total blood protein measurement	GAB2	TAL2
ENSG00000251364	SYT9-AS1	-3.18875566548655	2.39848826267614e-5	LPS_vs_PBS	HSALNG0082493	anti_sense	Q50	hsa-miR-6763-5p,hsa-miR-6895-5p	Serum igg glycosylation measurement,Stroke outcome severity measurement,-	CYB5R2	TMEM163
ENSG00000251442	LINC01094	-1.24415379473739	2.39185521991927e-4	LPS_vs_PBS	HSALNG0035402	integenic	Q50	hsa-miR-7150	Mean platelet volume,Total blood protein measurement; Serum albumin measurement; Aspartate aminotransferase measurement,Serum gamma-glutamyl transferase measurement,Monocyte count,Creatine kinase measurement; Serum non-albumin protein measurement,Protein measurement,Mean corpuscular volume; Mean corpuscular hemoglobin concentration,-	ANXA3	RIMS3
ENSG00000251615	NA	1.72493408650107	0.00186932833254054	LPS_vs_PBS	NA	NA	NA	NA	NA	ACOX3	ENSG00000286674
ENSG00000253123	NA	2.66750734718253	7.81352510837971e-4	LPS_vs_PBS	HSALNG0064558	integenic	Q90	hsa-miR-4483,hsa-miR-6743-3p,hsa-miR-7150,hsa-miR-8485	-	BRF2	LCP1
ENSG00000253210	DENND3-AS1	1.79430604367132	0.00196152043259929	LPS_vs_PBS	HSALNG0069052	anti_sense	Q75	hsa-miR-619-5p,hsa-miR-3155b,hsa-miR-4492,hsa-miR-4508,hsa-miR-6730-5p,hsa-miR-6797-5p,hsa-miR-6809-3p	-	SLC45A4	DENND3
ENSG00000253217	NA	3.84881195851259	0.0142091509825891	LPS_vs_PBS	HSALNG0067281	anti_sense	Q75	NA	Unipolar depression,Lymphocyte count,-	SPAG1	TLR8-AS1
ENSG00000253320	MAILR	2.43356621636402	7.93867964328987e-6	LPS_vs_PBS	HSALNG0067488	integenic	Q50	NA	NA	ATP6V1C1	TLR7
ENSG00000253351	LINC01298	-3.51769146032024	0.0427009232521164	LPS_vs_PBS	HSALNG0067084	integenic	Q50	hsa-miR-30b-3p,hsa-miR-331-3p,hsa-miR-4308,hsa-miR-5572	Low density lipoprotein cholesterol measurement	CFAP418	LINC01298
ENSG00000253392	NA	-2.49119548037515	0.0453876739540515	LPS_vs_PBS	HSALNG0123207	anti_sense	Not conserved	hsa-miR-619-5p,hsa-miR-6763-5p,hsa-miR-6791-3p	Reading and spelling ability,Alzheimer's disease neuropathologic change; Dementia,-	ZNF77	PPAT
ENSG00000253477	NA	4.72021821243423	0.0025373241235579	LPS_vs_PBS	HSALNG0067527	anti_sense,sense	Q90	hsa-miR-1233-5p,hsa-miR-6089,hsa-miR-6726-3p,hsa-miR-6748-3p,hsa-miR-7150,hsa-miR-8485	-	NA	SOCS2-AS1
ENSG00000253522	MIR3142HG	1.31712595226394	0.00329083833638928	LPS_vs_PBS	HSALNG0046249	integenic	Not conserved	NA	NA	PTTG1	RIPK2
ENSG00000253535	ADAM7-AS1	4.57161192792929	6.83317833080478e-16	LPS_vs_PBS	HSALNG0064058	integenic	Not conserved	NA	NA	NEFL	ENSG00000286162
ENSG00000253557	NA	2.1716155736204	9.06464550851683e-4	LPS_vs_PBS	HSALNG0063737	integenic	Q50	hsa-miR-7155-5p	Bone quantitative ultrasound measurement,Platelet count,Mean platelet volume,Gout,Smooth surface dental caries,Urate measurement,Intelligence,Insulin measurement,Telomere length,-	PSD3	RGMA
ENSG00000253669	GASAL1	-2.75511834614792	0.00332550503246787	LPS_vs_PBS	HSALNG0067472	anti_sense	Q50	NA	Alkaline phosphatase measurement,Leukocyte count,Eosinophil count; Neutrophil count; Basophil count; Granulocyte count,Bmi-adjusted waist circumference,-	ATP6V1C1	CSTBP1
ENSG00000253698	NA	-3.09682526996444	0.00442312214964857	LPS_vs_PBS	HSALNG0047021	anti_sense	Not conserved	NA	NA	HNRNPAB	RPL21P137
ENSG00000253716	MINCR	-1.55630727957328	0.0468411708834416	LPS_vs_PBS	HSALNG0069266	integenic	Not conserved	hsa-miR-4312,hsa-miR-4492	NA	TOP1MT	KRT8P31
ENSG00000253738	OTUD6B-AS1	-1.13836377403859	0.00195568197719511	LPS_vs_PBS	HSALNG0066885	anti_sense	Q50	NA	-	PIP4P2	ENSG00000289353
ENSG00000253838	NA	7.66763823727652	3.12663524055107e-22	LPS_vs_PBS	HSALNG0150187	sense	Q50	NA	-	IDO1	ENSG00000254287
ENSG00000253891	NA	8.66415166128771	6.810384168487539e-25	LPS_vs_PBS	HSALNG0064035	anti_sense	Q90	hsa-miR-619-5p,hsa-miR-1249-5p,hsa-miR-4447,hsa-miR-4463,hsa-miR-4505,hsa-miR-7106-5p	Bmi-adjusted waist circumference; Body height; Bmi-adjusted hip circumference,Bmi-adjusted waist circumference,Body height,Ankylosing spondylitis,Cleft palate,Necrotizing enterocolitis,Hair colour measurement,Susceptibility to scarlet fever measurement,White matter integrity,Corneal endothelial cell measurement,Idiopathic dilated cardiomyopathy,Mathematical ability,Age at onset,Nicotine withdrawal symptom count,Pallidum volume,Myopia,Brain volume measurement,Seasonality measurement,Interleukin-6 measurement,Forced expiratory volume; Fev/fec ratio; Response to bronchodilator,Fev/fec ratio; Response to bronchodilator,Myocarditis; Response to clozapine,Cingulate cortex measurement; Amyloid-beta measurement,Brain volume measurement; Neuroimaging measurement,-	STC1	GPR31
ENSG00000253939	NA	4.72664882766423	5.71105700578502e-5	LPS_vs_PBS	HSALNG0064732	anti_sense	Q50	NA	Blood metabolite measurement	ADAM2	ODF2L
ENSG00000253982	CLN8-AS1	-1.37178760561684	4.02209841639827e-5	LPS_vs_PBS	HSALNG0062950	anti_sense	Not conserved	hsa-miR-619-5p,hsa-miR-1225-3p,hsa-miR-6165,hsa-miR-6727-3p	NA	ERICH1	AGPAT4
ENSG00000254027	LNMICC	-2.45408361238421	0.00109485810183695	LPS_vs_PBS	HSALNG0066560	anti_sense	Not conserved	hsa-miR-3195,hsa-miR-4508	-	PMP2	LINC02976
ENSG00000254054	NA	-4.35372503482978	0.0107916415432294	LPS_vs_PBS	HSALNG0063689	anti_sense	Q50	hsa-miR-331-3p,hsa-miR-3194-3p,hsa-miR-4257,hsa-miR-2467-3p	NA	PCM1	GOLGA8J
ENSG00000254231	WWP1-AS1	-2.82119884550082	0.0053691135569	LPS_vs_PBS	HSALNG0066736	anti_sense	Not conserved	NA	Protein measurement,-	SLC7A13	DNM3-IT1
ENSG00000254287	NA	7.96628614189224	4.92100900466422e-30	LPS_vs_PBS	HSALNG0150387	anti_sense	Q50	NA	-	ADAM2	ENSG00000253838
ENSG00000254416	LINC02732	3.99409300424691	6.16644067417322e-6	LPS_vs_PBS	HSALNG0087054	integenic	Q75	hsa-miR-4505	Cognition,Serum metabolite measurement; Coronary artery disease,Angina pectoris; Antithrombotic agent use measurement; Aspirin use measurement; Myocardial infarction,Angina pectoris; Vasodilators used in cardiac diseases use measurement; Aspirin use measurement,Body height,Coronary artery disease,-	FDX1	ENSG00000291174
ENSG00000254495	NA	-3.64274288912062	0.0453346567078601	LPS_vs_PBS	HSALNG0085427	anti_sense	Not conserved	NA	NA	SHANK2	ENSG00000263657
ENSG00000254554	ADM-DT	2.93492632385969	4.71372782387273e-5	LPS_vs_PBS	HSALNG0082648	integenic	Q50	hsa-miR-6132	Waist-hip ratio; Bmi-adjusted waist-hip ratio,Appendicular lean mass,Total cholesterol measurement,Breast carcinoma,-	SBF2	ENSG00000271830
ENSG00000254635	WAC-AS1	-1.48646795127569	4.15947313907872e-4	LPS_vs_PBS	HSALNG0076905	anti_sense	Q90	hsa-miR-210-5p,hsa-miR-619-5p,hsa-miR-4430,hsa-miR-4492	Empathy measurement,Granulocyte percentage of myeloid white cells,Neutrophil percentage of leukocytes,-	MPP7	RNASEH2B
ENSG00000254827	SLC22A18AS	-2.19998036536469	0.00505934552199601	LPS_vs_PBS	NA	NA	NA	NA	NA	CDKN1C	ID3
ENSG00000254837	LIPT2-AS1	-4.13822806301487	1.54623741706461e-5	LPS_vs_PBS	HSALNG0143021	sense	Not conserved	NA	NA	POLD3	USP54
ENSG00000254966	IGSF22-AS1	-4.50847647321067	2.45318075161145e-4	LPS_vs_PBS	HSALNG0083030	anti_sense	Q75	hsa-miR-6086	-	TMEM86A	GUSBP11
ENSG00000255031	NA	-1.32581618824394	0.0396966611744135	LPS_vs_PBS	HSALNG0085213	anti_sense,sense	Q75	hsa-miR-1249-5p	-	TCIRG1	ENSG00000235078
ENSG00000255136	TPBGL-AS1	-3.582457819136	7.94260246465663e-5	LPS_vs_PBS	HSALNG0085758	anti_sense	Q90	hsa-miR-4281,hsa-miR-3622b-5p,hsa-miR-3960,hsa-miR-4787-5p,hsa-miR-6784-5p	-	ARRB1	ENSG00000267136
ENSG00000255142	NA	-3.49116491463664	0.0063742373058942	LPS_vs_PBS	HSALNG0082025	integenic	Q75	hsa-miR-4472	NA	PANO1	ENSG00000220614
ENSG00000255197	NA	-1.93143745682383	4.48560987907213e-13	LPS_vs_PBS	HSALNG0143174	anti_sense	Q90	NA	Alcohol consumption measurement	SPI1	ZMIZ1
ENSG00000255240	NA	-2.59620867501717	0.0245717394356297	LPS_vs_PBS	HSALNG0084381	anti_sense	Not conserved	hsa-miR-4492,hsa-miR-8485	Body height,Mathematical ability,Sex hormone-binding globulin measurement,-	GLYATL2	ENSG00000285591
ENSG00000255284	GATD1-DT	-1.3493395952284	0.0358408008169793	LPS_vs_PBS	HSALNG0082025	integenic	Q75	hsa-miR-4472	NA	PANO1	MFAP3L
ENSG00000255306	NA	-1.67451570493688	0.0305817883141041	LPS_vs_PBS	HSALNG0085208	anti_sense	Not conserved	NA	Uric acid measurement,-	UNC93B1	SCOC-AS1
ENSG00000255310	NA	-1.83496340721633	0.0208770334469271	LPS_vs_PBS	HSALNG0063412	sense	Q50	hsa-miR-370-3p	-	XKR6	ENSG00000257270
ENSG00000255337	TMEM123-DT	1.71721127519343	0.034568088416105	LPS_vs_PBS	HSALNG0086787	anti_sense	Not conserved	hsa-miR-7113-3p	-	BIRC2	BOLA3
ENSG00000255355	PATL1-DT	5.45288862912597	5.79134100050666e-10	LPS_vs_PBS	HSALNG0084422	integenic	Not conserved	hsa-miR-619-5p	NA	STX3	ENSG00000258581
ENSG00000255443	CD44-AS1	1.87960021260998	0.033711827265402	LPS_vs_PBS	HSALNG0083610	anti_sense	Q50	NA	-	SLC1A2	ENSG00000251194
ENSG00000255446	NA	-2.50129505764557	0.00207083272726294	LPS_vs_PBS	HSALNG0084600	anti_sense	Q50	hsa-miR-619-5p,hsa-miR-6879-5p	Bmi-adjusted waist-hip ratio,Waist-hip ratio,Bmi-adjusted hip circumference; Bmi-adjusted waist-hip ratio,Waist-hip ratio; Bmi-adjusted hip circumference; Bmi-adjusted waist-hip ratio,Lymphocyte count,Reticulocyte count; Reticulocyte measurement,Bmi-adjusted waist circumference,Comparative body size at age 10, self-reported,Chronic obstructive pulmonary disease; Cc16 measurement,-	AHNAK	EPHX3
ENSG00000255491	NA	-3.705659463951	1.0077471095033399e-12	LPS_vs_PBS	HSALNG0068289	integenic	Q50	hsa-miR-363-5p,hsa-miR-4505,hsa-miR-6089,hsa-miR-6754-5p	Platelet component distribution width,Triacylglycerol 58:6 measurement,Left ventricular ejection fraction measurement; Dilated cardiomyopathy; Left ventricular structural measurement; Left ventricular systolic function measurement; Hematocrit; Heart function measurement,Reticulocyte measurement,Hematocrit; Hemoglobin measurement; Pr interval,Pr interval; Left ventricular structural measurement; Atrial fibrillation,Left ventricular systolic function measurement,Platelet crit; Heart relative wall thickness; Left ventricular ejection fraction measurement; Fractional shortening; Left ventricular diastolic function measurement; Left ventricular systolic function measurement; Electrocardiography; Ejection fraction measurement,-	MTSS1	RHOBTB1
ENSG00000255517	DPP3-DT	-1.47050920153681	0.0157850064824544	LPS_vs_PBS	HSALNG0085026	anti_sense	Q75	hsa-miR-619-5p,hsa-miR-4763-3p,hsa-miR-2467-3p,hsa-miR-6085	Hematocrit,-	MRPL11	ENSG00000268947
ENSG00000255521	CD44-DT	3.02199117278606	0.00124960962957086	LPS_vs_PBS	HSALNG0083606	anti_sense	Q50	NA	Response to vitamin,-	SLC1A2	SPSB1
ENSG00000255717	SNHG1	-1.57044575398047	4.3697357937073e-8	LPS_vs_PBS	HSALNG0084672	integenic	Q50	NA	-	WDR74	CDK16
ENSG00000255921	NA	3.2686534367761	6.14278690113168e-5	LPS_vs_PBS	HSALNG0089886	anti_sense	Not conserved	hsa-miR-6763-5p,hsa-miR-7847-3p	-	IRAG2	BPGM
ENSG00000255946	NA	-3.56526303389813	0.0313664446344492	LPS_vs_PBS	HSALNG0094544	integenic	Not conserved	NA	Serum metabolite measurement,C-reactive protein measurement; Serum gamma-glutamyl transferase measurement,Serum metabolite measurement; Smoking behavior,Reticulocyte count; Serum metabolite measurement; Reticulocyte measurement,Total blood protein measurement,Leukocyte count,Myeloid white cell count,Anorexia nervosa; Autism spectrum disorder; Obsessive-compulsive disorder; Attention deficit hyperactivity disorder; Unipolar depression; Bipolar disorder; Tourette syndrome	SPPL3	ENSG00000225399
ENSG00000256262	USP30-AS1	4.13533544580482	3.41563073391724e-11	LPS_vs_PBS	HSALNG0093872	anti_sense	Not conserved	hsa-miR-4467,hsa-miR-3960	Platelet-to-lymphocyte ratio; Platelet count; Platelet crit,-	SVOP	CEBPD
ENSG00000256546	LINC02985	-2.35188630631398	8.90952906783955e-4	LPS_vs_PBS	HSALNG0094625	integenic	Q75	NA	Serum alanine aminotransferase measurement,Uric acid measurement; Body weight	BCL7A	NLRP12
ENSG00000256576	LINC02361	-2.03349614284926	7.64749894270431e-4	LPS_vs_PBS	HSALNG0095275	integenic	Q50	hsa-miR-1237-5p,hsa-miR-4685-3p	-	GALNT9	PLEC
ENSG00000256582	LINC02390	3.93081651670548	0.0356637215629314	LPS_vs_PBS	HSALNG0089168	integenic	Not conserved	NA	Sleep duration; High density lipoprotein cholesterol measurement	CLEC2D	ENSG00000258558
ENSG00000256633	PDE2A-AS2	-3.64671736862907	4.06373222994868e-4	LPS_vs_PBS	HSALNG0143016	anti_sense	Q90	hsa-miR-6749-5p,hsa-miR-6763-5p	-	ATG16L2	ZNF10
ENSG00000256706	NA	-4.71769612064745	1.47909090435252e-4	LPS_vs_PBS	HSALNG0088571	anti_sense	Not conserved	NA	-	CACNA1C	ENSG00000279365
ENSG00000256751	PLBD1-AS1	-1.06155836210358	0.0421416729740773	LPS_vs_PBS	HSALNG0089514	anti_sense	Q75	hsa-miR-7706	-	ATF7IP	TSPAN11
ENSG00000256973	NA	-1.85071256991748	0.0239020993565388	LPS_vs_PBS	HSALNG0143593	sense	Q75	NA	NA	C2CD5	LINC01355
ENSG00000257277	NA	3.32911940983764	0.00806590611572966	LPS_vs_PBS	HSALNG0019322	anti_sense	Q50	NA	Self reported educational attainment	GTDC1	CLIC5
ENSG00000257354	MIRLET7IHG	1.08613848756149	0.0125427191587916	LPS_vs_PBS	HSALNG0091856	integenic	Q50	hsa-miR-4286	Waist circumference,-	MON2	BMT2
ENSG00000257433	RPAP3-DT	1.61856930560464	0.0311534896410006	LPS_vs_PBS	HSALNG0090786	anti_sense	Q90	hsa-miR-4478,hsa-miR-4505,hsa-miR-1587,hsa-miR-4717-5p,hsa-miR-6744-3p,hsa-miR-6763-5p,hsa-miR-6855-5p,hsa-miR-8485	Cup-to-disc ratio measurement,Periodontitis,Blood protein measurement,-	SLC48A1	TMEM131
ENSG00000257621	PSMA3-AS1	-1.06935940664779	7.87768261458165e-4	LPS_vs_PBS	HSALNG0101614	overlap_antisense,anti_sense,sense	Q75	hsa-miR-619-5p,hsa-miR-5047,hsa-miR-6769b-5p,hsa-miR-8485	Smoking status measurement,Non-melanoma skin carcinoma,Triglyceride measurement,Red blood cell distribution width,Reticulocyte measurement,Mean corpuscular volume,Erythrocyte count,Mean corpuscular hemoglobin concentration,Mean corpuscular hemoglobin,Red blood cell density measurement,Bitter alcoholic beverage consumption measurement; Alcohol use disorder measurement; Alcohol consumption measurement,Venous thromboembolism,Mean corpuscular hemoglobin concentration; Red blood cell distribution width,Myocardial infarction,Bmi-adjusted waist-hip ratio,C-reactive protein measurement,Mean corpuscular hemoglobin; Bmi-adjusted waist-hip ratio,Ovarian carcinoma; Progression free survival,-,Alcohol consumption measurement,Mean corpuscular volume; Mean corpuscular hemoglobin	ARMH4	PHF10
ENSG00000257702	LBX2-AS1	-1.00846676291995	0.0141615353997009	LPS_vs_PBS	HSALNG0016063	anti_sense	Q90	hsa-miR-4492,hsa-miR-6726-5p	-	TTC31	FOXK2
ENSG00000257718	CPNE8-AS1	5.9367096394122	4.2247638845303296e-11	LPS_vs_PBS	HSALNG0090432	anti_sense	Q50	hsa-miR-6763-3p,hsa-miR-6878-3p	NA	ALG10B	RPS29P14
ENSG00000257906	LINC02156	6.70136897248903	5.39338526467329e-6	LPS_vs_PBS	HSALNG0090758	integenic	Q50	hsa-miR-30b-3p,hsa-miR-619-5p,hsa-miR-8485	5-hiaa measurement; Hva measurement,-	PCED1B	FGF5
ENSG00000257924	LINC02416	4.65440434512901	3.57070555845141e-7	LPS_vs_PBS	HSALNG0090757	integenic	Not conserved	hsa-miR-619-5p	-	PCED1B	MMP10
ENSG00000257964	NA	2.13195464285339	0.0383336413510386	LPS_vs_PBS	HSALNG0090959	anti_sense	Q50	NA	NA	FAM186B	ENSG00000289574
ENSG00000258018	LINC02457	6.60531220166532	1.3998579833813502e-9	LPS_vs_PBS	HSALNG0094325	integenic	Not conserved	NA	NA	MAP1LC3B2	PRRX1
ENSG00000258183	LINC02392	4.07670831557127	0.0133287914443029	LPS_vs_PBS	HSALNG0092974	integenic	Not conserved	hsa-miR-6756-5p,hsa-miR-6803-5p	Interleukin 2 receptor antagonist measurement,Heel bone mineral density,Family history of lung cancer; Lung adenocarcinoma,-	TMTC3	ABCC8
ENSG00000258376	PAPLN-AS1	-1.38044905576834	0.00898975876960452	LPS_vs_PBS	HSALNG0102336	anti_sense	Not conserved	NA	Red blood cell distribution width,Sapho syndrome,-	NUMB	SLC25A40
ENSG00000258515	NA	-2.38831765314384	0.0218035526770737	LPS_vs_PBS	HSALNG0099798	anti_sense	Q50	NA	NA	APEX1	LRP1-AS
ENSG00000258521	NA	5.48873467414186	8.57655784045169e-13	LPS_vs_PBS	HSALNG0103731	anti_sense	Not conserved	NA	NA	SLC25A47	NCOA4P2
ENSG00000258559	NA	-1.64397027470089	0.00284937162337469	LPS_vs_PBS	HSALNG0102422	sense	Not conserved	hsa-miR-604,hsa-miR-619-5p	-	ABCD4	TTI2
ENSG00000258634	NA	-1.26143970022666	0.00391500387349517	LPS_vs_PBS	HSALNG0005948	anti_sense,sense	Q90	NA	Cortical surface area measurement,-	STRIP1	OIP5-AS1
ENSG00000258768	NA	-2.52784947336437	0.0290995309500578	LPS_vs_PBS	HSALNG0099772	overlap_antisense,anti_sense,sense	Q50	hsa-miR-6809-3p	Cervical carcinoma,Alzheimer's disease biomarker measurement,-	TTC5	TWF2-DT
ENSG00000258777	HIF1A-AS1	3.28244294991518	7.37660636539181e-4	LPS_vs_PBS	HSALNG0101776	anti_sense	Q75	hsa-miR-619-5p,hsa-miR-5088-5p	Cd40 ligand measurement,Creatinine measurement,-	TMEM30B	ADRB2
ENSG00000258791	LINC00520	2.14607737764621	0.0288709321526911	LPS_vs_PBS	HSALNG0101489	integenic	Q50	hsa-miR-619-5p,hsa-miR-4505,hsa-miR-1587,hsa-miR-6165	Parental longevity,-	TBPL2	TMEM114
ENSG00000258810	NA	-1.66877909493103	0.0280011550088757	LPS_vs_PBS	HSALNG0099831	integenic	Not conserved	hsa-miR-4732-3p	NA	RNASE6	IGFLR1
ENSG00000258860	NA	4.86160895910825	5.27800364641905e-4	LPS_vs_PBS	HSALNG0144215	integenic	Not conserved	hsa-miR-4302,hsa-miR-4531,hsa-miR-6089	Psoriasis,Bmi-adjusted hip circumference	NFKBIA	LINC02694
ENSG00000258867	HISLA	-2.17267741473489	0.00394125740459584	LPS_vs_PBS	HSALNG0103023	integenic	Q50	hsa-miR-211-3p,hsa-miR-6763-5p,hsa-miR-6867-3p	Takayasu arteritis,Susceptibility to hepatitis b infection measurement,Congenital left-sided heart lesions,Serum igg measurement; Response to dietary antigen,Response to nitrofurantoin; Drug-induced liver injury,Bipolar disorder,-	GPR65	ENSG00000284719
ENSG00000259004	LINC02285	-2.49364338193292	0.0202032545922309	LPS_vs_PBS	HSALNG0144163	integenic	Not conserved	hsa-miR-4313	Protein measurement	DLK1	PRSS51
ENSG00000259062	ACTN1-DT	3.84844580209297	0.00349620705239897	LPS_vs_PBS	HSALNG0102131	anti_sense	Q75	hsa-miR-4726-3p	Mean platelet volume; Platelet count,Reticulocyte count,-	EXD2	CEP85L
ENSG00000259094	NA	4.12860102089153	0.0320555007755385	LPS_vs_PBS	HSALNG0018295	anti_sense	Not conserved	NA	-	EN1	SPOCK3
ENSG00000259116	HSPA2-AS1	-2.46225033334542	0.0018538258288828	LPS_vs_PBS	HSALNG0101893	anti_sense	Not conserved	hsa-miR-6845-3p	Platelet-to-lymphocyte ratio,Mean corpuscular hemoglobin,-	ZBTB25	SDHAF3
ENSG00000259248	USP3-AS1	-2.52186565495864	0.0015029456836095	LPS_vs_PBS	HSALNG0106502	anti_sense	Q90	hsa-miR-612,hsa-miR-1226-5p,hsa-miR-3176,hsa-miR-4472,hsa-miR-6769b-5p	Self reported educational attainment; Mathematical ability,Bmi-adjusted waist circumference,Bmi-adjusted waist-hip ratio,Forced expiratory volume; Fev/fec ratio; Peak expiratory flow,Electrocardiography,Thyroxine measurement,Qrs duration,Aortic root size,Reticulocyte count; Reticulocyte measurement,Inflammatory biomarker measurement; Ykl40 measurement,Heel bone mineral density,-	HERC1	HCRTR1
ENSG00000259285	ALDH1A2-AS1	5.12932515467504	0.00145743427914675	LPS_vs_PBS	HSALNG0106208	anti_sense	Q90	hsa-miR-4733-3p	Esophageal adenocarcinoma; Barrett's esophagus,-	AQP9	STON2
ENSG00000259342	NA	3.71865238689001	3.988943336652e-9	LPS_vs_PBS	HSALNG0105649	anti_sense	Q75	hsa-miR-4505	-	GATM	KRT8P45
ENSG00000259354	NA	4.27011892202637	5.1896401328308796e-23	LPS_vs_PBS	HSALNG0105653	intronic_antisense	Not conserved	NA	NA	C15orf48	ENSG00000254287
ENSG00000259380	LINC02895	4.59806112796966	9.14069150233613e-7	LPS_vs_PBS	HSALNG0105106	integenic	Q75	hsa-miR-103a-1-5p,hsa-miR-4535	Lycopene measurement,Femoral neck bone mineral density; Spine bone mineral density,Bone density,Body height,Tryptophan measurement,Self reported educational attainment; Mathematical ability,Chagas cardiomyopathy,Hypersomnia,Mathematical ability,Bipolar disorder,Lean body mass,Body weight,Fev/fec ratio; Response to bronchodilator,-	RASGRP1	INSL6
ENSG00000259426	KIF23-AS1	-2.96383420209445	0.0191928005140416	LPS_vs_PBS	HSALNG0106852	anti_sense	Q50	hsa-miR-619-5p,hsa-miR-1237-5p	-	ANP32A	SYNE4
ENSG00000259563	NA	-3.39455240303866	0.0388453194826607	LPS_vs_PBS	HSALNG0105563	anti_sense	Not conserved	hsa-miR-6089	NA	SPG11	ENSG00000259563
ENSG00000259595	CTDSPL2-DT	-3.66762597515919	0.0213594017738445	LPS_vs_PBS	HSALNG0105557	anti_sense	Q90	NA	-	SPG11	C3orf22
ENSG00000259635	NA	-2.72219464429291	0.0124191226348353	LPS_vs_PBS	HSALNG0106568	anti_sense	Q75	hsa-miR-762,hsa-miR-7160-3p,hsa-miR-8485	-	ZNF609	SAMD13
ENSG00000259649	NA	4.29740078081787	0.00628891246391274	LPS_vs_PBS	HSALNG0107626	anti_sense,sense	Not conserved	hsa-miR-920,hsa-miR-6803-5p	Response to statin; Low density lipoprotein cholesterol measurement,Cleft lip; Cleft palate,Hdl cholesterol change measurement; Response to statin,Periprosthetic osteolysis; Disease progression measurement,-	MESD	ENSG00000177359
ENSG00000259668	NA	-1.48817239254473	1.03706358396437e-4	LPS_vs_PBS	HSALNG0105911	anti_sense	Q75	hsa-miR-4443	C-reactive protein measurement,Body mass index,Self reported educational attainment,-,Waist-hip ratio; Smoking behavior; Body mass index,Body fat percentage	GLDN	KBTBD3
ENSG00000259721	GREM1-AS1	4.32747019169051	1.55403489646645e-7	LPS_vs_PBS	HSALNG0144495	anti_sense	Q50	hsa-miR-1228-5p,hsa-miR-3178,hsa-miR-3195,hsa-miR-7843-5p,hsa-miR-9899	Polyp of colon,Colorectal cancer; Colorectal adenoma,Colorectal cancer,-	FMN1	PDZD2
ENSG00000259768	ZFHX3-AS1	-1.39736484054191	0.0206587696481541	LPS_vs_PBS	HSALNG0112595	anti_sense	Not conserved	NA	NA	DHX38	BLM
ENSG00000259807	NA	-2.54097430436285	0.00332444340323295	LPS_vs_PBS	HSALNG0110565	integenic	Not conserved	hsa-miR-1228-5p,hsa-miR-4492	Lymphocyte count,-	NPIPB11	LEP
ENSG00000259895	TEDC2-AS1	-3.15822584844931	0.00575226428944628	LPS_vs_PBS	HSALNG0109012	anti_sense	Q50	hsa-miR-6840-3p	-	CEMP1	IL17D
ENSG00000259953	LINC02977	-1.04697874503286	0.00260976328827706	LPS_vs_PBS	HSALNG0073741	integenic	Not conserved	hsa-miR-619-5p	Physical activity	SUSD1	DLST
ENSG00000259972	NA	-1.70722587027996	1.10665930222287e-5	LPS_vs_PBS	HSALNG0112676	integenic	Not conserved	hsa-miR-7703	NA	CLEC18B	SACS
ENSG00000260005	NA	-1.72063419686146	0.0079776546257045	LPS_vs_PBS	HSALNG0145178	anti_sense	Q50	hsa-miR-6862-5p	Blood protein measurement,-	NDUFAF8	ENSG00000291129
ENSG00000260051	NA	-1.79253744728183	0.00315704824101938	LPS_vs_PBS	HSALNG0108901	anti_sense	Not conserved	hsa-miR-6798-5p	NA	PERCC1	PRX
ENSG00000260077	NA	-1.71958400031058	0.00125642729076174	LPS_vs_PBS	HSALNG0012948	anti_sense	Q50	hsa-miR-619-5p,hsa-miR-3183	Neuroticism measurement; Worry measurement,Mean corpuscular volume,Body height	CYS1	ENSG00000268912
ENSG00000260145	NA	3.08660718110611	0.0375165707062225	LPS_vs_PBS	HSALNG0111745	anti_sense	Not conserved	hsa-miR-6089,hsa-miR-6871-3p	-	PSME3IP1	ENSG00000289384
ENSG00000260231	KDM7A-DT	2.95514516228757	7.22682063167486e-7	LPS_vs_PBS	HSALNG0061777	anti_sense	Q90	NA	NA	TBXAS1	NUP98
ENSG00000260256	NA	3.68192804713376	5.0045057812265e-6	LPS_vs_PBS	HSALNG0133530	integenic	Not conserved	hsa-miR-1178-5p	-	CFAP410	LILRB1
ENSG00000260257	NA	-1.13671927195199	0.00607861823477413	LPS_vs_PBS	HSALNG0129600	integenic	Not conserved	NA	Attention deficit hyperactivity disorder,-	EFCAB8	ARHGAP26
ENSG00000260260	SNHG19	-1.68324031605122	0.012327528310538	LPS_vs_PBS	HSALNG0108990	anti_sense	Q50	NA	-	PKD1	MUC20P1
ENSG00000260293	NA	-2.35770807174719	0.0115888253968158	LPS_vs_PBS	HSALNG0144648	sense	Q75	NA	NA	TBC1D24	TBX6
ENSG00000260302	LINC01882	4.34201578583908	8.23420102896647e-4	LPS_vs_PBS	HSALNG0120126	integenic	Not conserved	hsa-miR-149-3p,hsa-miR-1268b,hsa-miR-4441,hsa-miR-8485	Interleukin 9 measurement; Macrophage inflammatory protein 1a measurement,Red blood cell density measurement,Psoriasis,Autoimmune disease; Celiac disease,Juvenile idiopathic arthritis,Sarcoidosis,Alopecia areata,-	PTPN2	PSMA6P1
ENSG00000260306	NA	-2.10481890009192	0.00649863024086621	LPS_vs_PBS	HSALNG0110138	integenic	Not conserved	NA	-	NPIPB4	SPATA7
ENSG00000260360	NA	2.57204075066861	1.15754632377335e-6	LPS_vs_PBS	HSALNG0008786	anti_sense	Q75	hsa-miR-619-5p,hsa-miR-10392-3p	Prostate carcinoma,-	TOR1AIP2	RPE
ENSG00000260361	NA	2.26350821583978	0.00898878644886775	LPS_vs_PBS	HSALNG0108254	sense	Q90	hsa-miR-6089	NA	FAM174B	GPC3
ENSG00000260367	NA	-1.63338902625083	0.0342191836181006	LPS_vs_PBS	HSALNG0110551	anti_sense	Q50	hsa-miR-4800-3p	Body mass index,-	RABEP2	DNAAF11
ENSG00000260441	NA	-3.0009439719231	0.00231488455424242	LPS_vs_PBS	HSALNG0112270	anti_sense	Q50	hsa-miR-23a-5p,hsa-miR-328-5p,hsa-miR-4447,hsa-miR-3960	Intelligence,Comparative body size at age 10, self-reported; Serum metabolite measurement,Self reported educational attainment; Cognitive function measurement; Glomerular filtration rate,-	ESRP2	ENSG00000261471
ENSG00000260454	LINC02957	4.12346013289053	0.0330002609521517	LPS_vs_PBS	HSALNG0072697	integenic	Not conserved	hsa-miR-619-5p	NA	SYK	EDIL3-DT
ENSG00000260475	SLC25A28-DT	3.26243169921382	2.59518384068868e-5	LPS_vs_PBS	HSALNG0080059	anti_sense	Q50	hsa-miR-10392-3p	Serum alanine aminotransferase measurement,Diverticular disease,-	ENTPD7	MUC1
ENSG00000260517	NA	-2.74097537823557	0.012503150506074	LPS_vs_PBS	HSALNG0110566	integenic	Not conserved	NA	Lymphocyte count,-	LAT	RNU6-1255P
ENSG00000260583	NA	3.07091564583347	4.24201949988911e-4	LPS_vs_PBS	HSALNG0147166	integenic	Not conserved	NA	NA	MRPL39	ARL5B
ENSG00000260588	NA	-1.57998600655656	0.0463247910849568	LPS_vs_PBS	HSALNG0064845	sense	Not conserved	hsa-miR-1268b	Mean reticulocyte volume	ANK1	CCDC136
ENSG00000260630	SNAI3-AS1	-1.43785306267445	0.0288729087015405	LPS_vs_PBS	HSALNG0113528	anti_sense	Q50	hsa-miR-665,hsa-miR-3195,hsa-miR-6089	Airway imaging measurement,Hair colour measurement,Reticulocyte count; Reticulocyte measurement,-	CTU2	LIMK1
ENSG00000260647	NA	-3.38163116890476	0.0425532025226825	LPS_vs_PBS	HSALNG0115032	integenic	Not conserved	hsa-miR-6813-5p	Mean arterial pressure	MIEF2	ENSG00000286972
ENSG00000260793	NA	-2.4875921366182	1.26429375274024e-6	LPS_vs_PBS	HSALNG0116712	anti_sense	Q90	hsa-miR-619-5p,hsa-miR-4695-5p,hsa-miR-6085,hsa-miR-6090	Heel bone mineral density,Body weight; Body mass index,Visceral adipose tissue measurement,Reticulocyte count,Appendicular lean mass; Bone density,Cortical thickness,Uric acid measurement; Calcium measurement,Mean corpuscular hemoglobin concentration,Cortical surface area measurement,Self reported educational attainment,Body fat distribution,Serum alanine aminotransferase measurement; Sex hormone-binding globulin measurement; Low density lipoprotein triglyceride measurement; Body fat percentage; High density lipoprotein cholesterol measurement; Aspartate aminotransferase measurement,-	TMUB2	CCDC149
ENSG00000260804	LINC01963	-2.41116919952549	7.3486541553684e-7	LPS_vs_PBS	HSALNG0022112	integenic	Q50	NA	NA	XRCC5	MORC2
ENSG00000260805	NA	2.38092515927067	2.1813970096301e-4	LPS_vs_PBS	HSALNG0010371	integenic	Q50	hsa-miR-6090,hsa-miR-10392-3p	-	BATF3	ENSG00000257390
ENSG00000260898	ADPGK-AS1	1.98969269231453	2.16297383833958e-4	LPS_vs_PBS	HSALNG0107094	anti_sense	Q75	hsa-miR-484,hsa-miR-6089,hsa-miR-6848-5p,hsa-miR-8485	Urate measurement,Grip strength measurement,Body weight,Vital capacity,Body mass index,Body mass index; Visceral adipose tissue measurement,Triglyceride measurement; Body mass index,-	BBS4	ENSG00000285103
ENSG00000260911	NA	-1.76555839787566	0.0276163361956368	LPS_vs_PBS	HSALNG0110810	integenic	Not conserved	NA	NA	STX4	NGLY1
ENSG00000260917	NA	-1.21085116443558	0.00395279294781663	LPS_vs_PBS	HSALNG0080703	integenic	Not conserved	NA	-	VTI1A	ENSG00000289727
ENSG00000260953	NA	-2.60312127595184	0.00529874049991889	LPS_vs_PBS	HSALNG0110584	integenic	Not conserved	hsa-miR-6783-3p	NA	NPIPB11	CHN2
ENSG00000260997	NA	2.76139284602051	2.5203947986418e-8	LPS_vs_PBS	NA	NA	NA	NA	NA	MYO1G	ENSG00000291144
ENSG00000261067	NA	-1.83688049180999	0.0311884600991122	LPS_vs_PBS	HSALNG0110553	sense	Not conserved	NA	NA	LAT	TNFRSF14-AS1
ENSG00000261087	ZNNT1	-2.5932417503791	0.00101592476676568	LPS_vs_PBS	HSALNG0067345	integenic	Not conserved	NA	NA	ZNF706	ENSG00000289958
ENSG00000261136	NA	-2.62892647682949	0.00127224529595903	LPS_vs_PBS	HSALNG0105179	anti_sense	Not conserved	NA	NA	EIF2AK4	ZNF396
ENSG00000261189	DSP-AS1	3.51122367315217	0.0200179743334101	LPS_vs_PBS	HSALNG0047891	anti_sense	Q90	hsa-miR-6508-3p,hsa-miR-6769b-5p	-	CAGE1	ENSG00000275630
ENSG00000261267	NA	1.95269079941553	0.0418444778785967	LPS_vs_PBS	HSALNG0111253	anti_sense	Not conserved	NA	Eosinophil count; Eosinophil percentage of leukocytes,Eosinophil count,-	LONP2	TANC1
ENSG00000261342	NA	-3.25097432158493	0.0449201035814062	LPS_vs_PBS	HSALNG0123190	intronic_sense	Not conserved	hsa-miR-619-5p,hsa-miR-6845-3p	Sex hormone-binding globulin measurement,-	NA	HNRNPA3P16
ENSG00000261416	CORO1A-AS1	-2.70370634697137	0.00497569821801438	LPS_vs_PBS	HSALNG0110699	anti_sense	Q75	hsa-miR-92a-2-5p,hsa-miR-3178,hsa-miR-4308,hsa-miR-3689a-3p,hsa-miR-3689b-3p,hsa-miR-4447,hsa-miR-3689c,hsa-miR-4505,hsa-miR-4690-5p,hsa-miR-4734,hsa-miR-5787,hsa-miR-6085,hsa-miR-6737-5p,hsa-miR-7152-5p	-	BOLA2B	RIMS3
ENSG00000261468	NA	-5.52941116223617	1.56146668636367e-6	LPS_vs_PBS	HSALNG0024922	integenic	Not conserved	hsa-miR-6165	NA	TGFBR2	ZNF540
ENSG00000261471	NA	-4.41037550779046	6.1851021527474e-4	LPS_vs_PBS	HSALNG0144804	anti_sense	Not conserved	hsa-miR-6089	Carotid artery intima media thickness; Smoking status measurement	KLHL36	ENSG00000260441
ENSG00000261488	TBILA	3.50736039124668	0.0261590143975035	LPS_vs_PBS	HSALNG0028028	integenic	Not conserved	NA	NA	C3orf52	RIPK2-DT
ENSG00000261504	LINC01686	5.66168470070711	1.0261410822881e-5	LPS_vs_PBS	HSALNG0141969	integenic	Not conserved	hsa-miR-194-3p	NA	RGSL1	PTPN1
ENSG00000261512	NA	2.05627838857861	0.00207099826575727	LPS_vs_PBS	NA	NA	NA	NA	NA	SHCBP1	KDM4D
ENSG00000261526	NA	-2.27964025609966	0.0051191231806224	LPS_vs_PBS	HSALNG0123094	integenic	Not conserved	NA	NA	ABHD17A	SLC19A1
ENSG00000261618	LINC02605	4.86861785337045	7.73124696366922e-5	LPS_vs_PBS	HSALNG0150243	integenic	Not conserved	NA	Platelet-to-lymphocyte ratio; Lymphocyte count	ZC2HC1A	HIVEP2-DT
ENSG00000261644	CYLD-AS1	1.83491382223777	1.61180668175066e-5	LPS_vs_PBS	HSALNG0111361	anti_sense	Q50	hsa-miR-6089,hsa-miR-8485	Psoriasis; Inflammatory bowel disease; Ulcerative colitis; Ankylosing spondylitis; Crohn's disease; Sclerosing cholangitis,Psoriasis; Ulcerative colitis; Ankylosing spondylitis; Crohn's disease; Sclerosing cholangitis,-	SNX20	CAPSL
ENSG00000261646	NA	-3.35980474623148	0.0495768623362871	LPS_vs_PBS	HSALNG0038603	integenic	Q75	NA	NA	HAND2	AK4P4
ENSG00000261762	NA	3.07794046584732	0.0497138978439403	LPS_vs_PBS	HSALNG0107484	anti_sense	Q90	NA	Forced expiratory volume; Chronic obstructive pulmonary disease; Time to first cigarette measurement; Nicotine dependence symptom count; Fev/fec ratio; Cigarettes per day measurement; Response to bronchodilator,-	CHRNA3	GNG4
ENSG00000261795	NA	-3.17197037667088	0.0119526096919832	LPS_vs_PBS	HSALNG0055499	integenic	Not conserved	NA	NA	PDGFA	TFF2
ENSG00000261888	NA	-1.56207840160795	0.0138959063678106	LPS_vs_PBS	HSALNG0145190	integenic	Not conserved	NA	Hematocrit	METRNL	LINC01694
ENSG00000261997	NA	-4.36492251393539	3.66857427311124e-12	LPS_vs_PBS	NA	NA	NA	NA	NA	LPCAT2	SAMD13
ENSG00000262050	NA	-4.41569520346864	0.00185225787146835	LPS_vs_PBS	HSALNG0113932	anti_sense	Q50	hsa-miR-619-5p	-	PAFAH1B1	ENSG00000265678
ENSG00000262097	LINC02185	-3.09752716940975	3.01972467095599e-4	LPS_vs_PBS	HSALNG0109713	integenic	Q50	hsa-miR-645,hsa-miR-4330,hsa-miR-4453	-	PARN	LINC01278
ENSG00000262223	LINC03048	3.38812323493879	4.42254128746412e-7	LPS_vs_PBS	HSALNG0119251	integenic	Q50	hsa-miR-132-5p,hsa-miR-619-5p,hsa-miR-3620-5p,hsa-miR-4492,hsa-miR-4505,hsa-miR-1587,hsa-miR-6769b-5p,hsa-miR-4433b-3p	Dental caries; Bmi-adjusted hip circumference; Dentures,Self reported educational attainment,Body height,Systolic blood pressure,Beta blocking agent use measurement,-	SLC38A10	IL7
ENSG00000262370	NA	-1.21570054072898	0.00573222121100885	LPS_vs_PBS	HSALNG0109115	anti_sense	Not conserved	hsa-miR-4329	Body height,-	ZSCAN10	OPHN1
ENSG00000262580	NA	-2.09862018301196	8.53669179638302e-8	LPS_vs_PBS	HSALNG0119173	anti_sense	Q50	NA	Fasting blood glucose measurement,-,Psoriasis; Hirschsprung disease	SGSH	ARL4C
ENSG00000262879	NA	-1.6362625503881	4.38052293832883e-8	LPS_vs_PBS	HSALNG0116971	integenic	Not conserved	NA	NA	RPRML	FPR3
ENSG00000263069	RNF213-AS1	3.80214026783952	4.27128159426608e-12	LPS_vs_PBS	HSALNG0119191	anti_sense	Q50	NA	-	NPTX1	MVP-DT
ENSG00000263072	ZNF213-AS1	-1.1937943667717	0.00594766342696377	LPS_vs_PBS	HSALNG0109122	anti_sense	Q50	hsa-miR-30b-3p,hsa-miR-513a-5p,hsa-miR-619-5p,hsa-miR-1237-5p,hsa-miR-4492,hsa-miR-4508,hsa-miR-6089,hsa-miR-6769b-3p	Hydroxy-leucine measurement,Cognitive function measurement,-	ZSCAN10	ME2
ENSG00000263089	NA	-3.29758561905488	0.00566983943414105	LPS_vs_PBS	HSALNG0145332	intronic_antisense	Q75	NA	NA	COIL	KLHL25P1
ENSG00000263167	NA	-3.88907336167438	0.0126025610900699	LPS_vs_PBS	HSALNG0119229	anti_sense	Not conserved	NA	NA	BAIAP2	ENSG00000287599
ENSG00000263272	NA	-1.80454170980498	9.26555475382915e-4	LPS_vs_PBS	HSALNG0114128	anti_sense,sense	Not conserved	NA	Age at menopause,-	C1QBP	ZNF512
ENSG00000263345	SGSM2-AS1	-1.39720922127993	0.0442490287228771	LPS_vs_PBS	HSALNG0113905	anti_sense	Q75	hsa-miR-4313,hsa-miR-6132	Self reported educational attainment; Autism spectrum disorder,Lifestyle measurement,-,Household income	MNT	ENSG00000279365
ENSG00000263466	NA	-2.51607307190039	0.00365193363039236	LPS_vs_PBS	HSALNG0116202	anti_sense	Not conserved	NA	NA	FBXO47	KCNJ5
ENSG00000263718	SEPTIN9-DT	3.70020062385234	6.76894828423778e-5	LPS_vs_PBS	HSALNG0118918	anti_sense	Q50	hsa-miR-1227-5p,hsa-miR-8485	Virologic response measurement; Response to abacavir,-	SRSF2	PLAT
ENSG00000263731	NA	-1.53370266510937	0.00291428999047206	LPS_vs_PBS	HSALNG0119325	integenic	Not conserved	NA	NA	ALYREF	HASPIN
ENSG00000263753	LINC00667	-1.06243310360396	0.00130153842002962	LPS_vs_PBS	HSALNG0119753	anti_sense	Q90	hsa-miR-4270,hsa-miR-6084	Intelligence,-	ARHGAP28	ZNF345
ENSG00000264456	NA	-2.67723926065476	4.51078737358593e-22	LPS_vs_PBS	HSALNG0115675	intronic_sense	Not conserved	hsa-miR-6089	NA	RNF135	ARHGAP35
ENSG00000264520	NA	-1.84698899958218	0.0444375700057304	LPS_vs_PBS	HSALNG0057012	anti_sense	Not conserved	NA	NA	GARS1	ENSG00000279837
ENSG00000264739	NA	2.80308456439998	0.0328027644424144	LPS_vs_PBS	HSALNG0114851	anti_sense	Not conserved	hsa-miR-1182,hsa-miR-4447,hsa-miR-6764-5p	Beta-amyloid 1-42 measurement	LRRC75A	LRIG1
ENSG00000264895	NA	-4.26398302243909	0.01674564824839	LPS_vs_PBS	HSALNG0145324	intronic_sense	Not conserved	NA	NA	MBTD1	PDE3A
ENSG00000264937	NA	-1.95411121805905	0.0360370623222359	LPS_vs_PBS	HSALNG0106567	anti_sense	Q75	hsa-miR-885-3p,hsa-miR-4253	-	ZNF609	LINC01614
ENSG00000265443	NA	-3.86806779822566	0.0130370340696854	LPS_vs_PBS	HSALNG0145258	integenic	Not conserved	NA	NA	CRLF3	ENSG00000272305
ENSG00000265458	NARF-AS2	1.27451555491878	0.00146589387525027	LPS_vs_PBS	HSALNG0119438	anti_sense	Not conserved	hsa-miR-3192-5p,hsa-miR-6089,hsa-miR-6871-5p	Forced expiratory volume,-	CYBC1	CASP5
ENSG00000265511	NA	-4.02775788540593	0.00553515158100856	LPS_vs_PBS	HSALNG0114961	anti_sense	Q50	hsa-miR-3620-5p,hsa-miR-1587,hsa-miR-4665-5p,hsa-miR-4781-5p,hsa-miR-6075	Bmi-adjusted hip circumference,Body weight,Sex interaction measurement; Waist-hip ratio; Bmi-adjusted hip circumference; Age at assessment; Smoking behavior; Bmi-adjusted waist-hip ratio,Bmi-adjusted waist-hip ratio,Triglyceride measurement; Body height,Bmi-adjusted hip circumference; Bmi-adjusted waist-hip ratio,High density lipoprotein cholesterol measurement,-	MED9	ZNF33B
ENSG00000265666	RARA-AS1	-2.22356686099416	0.021453036935196	LPS_vs_PBS	HSALNG0116345	anti_sense	Q90	hsa-miR-1237-5p,hsa-miR-6809-3p,hsa-miR-6861-3p	-	GJD3	MIER2
ENSG00000265688	MILIP	1.54700220122457	0.049219108749214	LPS_vs_PBS	HSALNG0119342	integenic	Not conserved	hsa-miR-5585-3p	-	NPB	BMPER
ENSG00000265743	LINC02978	-2.2186861606531	4.2247638845303296e-11	LPS_vs_PBS	HSALNG0145260	integenic	Not conserved	hsa-miR-619-5p,hsa-miR-4492	NA	TEFM	FAM78A
ENSG00000265778	ZNF516-AS1	-2.42975404054181	0.0163700610122632	LPS_vs_PBS	HSALNG0122568	anti_sense	Q90	hsa-miR-4667-3p,hsa-miR-4675	NA	ZNF236	ENSG00000269836
ENSG00000266340	NA	-2.39574889974708	6.14807544538943e-4	LPS_vs_PBS	HSALNG0115676	intronic_antisense	Not conserved	NA	NA	TEFM	C8orf58
ENSG00000266378	NA	4.77917082818342	2.18425373401133e-8	LPS_vs_PBS	HSALNG0114722	intronic_sense	Q50	NA	NA	HS3ST3B1	ENSG00000271947
ENSG00000266473	HELZ-AS1	-2.23808797988378	0.00772618480983	LPS_vs_PBS	HSALNG0118281	anti_sense	Q75	hsa-miR-3663-5p,hsa-miR-4447,hsa-miR-1343-3p,hsa-miR-6089,hsa-miR-6803-5p,hsa-miR-7704,hsa-miR-8485	Lymphocyte count,Protein measurement,Sex hormone-binding globulin measurement,-	PITPNC1	ASGR1
ENSG00000266709	NA	4.43229300398896	6.71066576619132e-21	LPS_vs_PBS	HSALNG0114719	intronic_sense	Q50	NA	NA	HS3ST3B1	IL10
ENSG00000266947	NA	1.99895044777027	0.00939308252955592	LPS_vs_PBS	HSALNG0115929	integenic	Not conserved	hsa-miR-619-5p	-	SLC35G3	OTUD4P1
ENSG00000266970	SOCS3-DT	6.12400413518276	3.53024242529765e-15	LPS_vs_PBS	HSALNG0119032	integenic	Q50	hsa-miR-619-5p,hsa-miR-4472,hsa-miR-4639-3p,hsa-miR-6089,hsa-miR-6794-5p,hsa-miR-6803-5p	Creativity measurement,Heel bone mineral density,C-reactive protein measurement,-	PGS1	CR1L
ENSG00000266978	NA	2.47181502641659	0.00391321751217529	LPS_vs_PBS	HSALNG0123918	integenic	Not conserved	NA	-	ZGLP1	ENSG00000272078
ENSG00000267002	NA	-2.11113983328012	9.8851142011134e-8	LPS_vs_PBS	HSALNG0116617	anti_sense,sense	Q90	hsa-miR-30b-3p,hsa-miR-6782-5p,hsa-miR-6803-5p	-	BRCA1	FPR3
ENSG00000267064	UXT-AS1	1.37412494211106	0.0141218585759153	LPS_vs_PBS	HSALNG0137730	anti_sense	Q75	NA	NA	TIMP1	BPGM
ENSG00000267080	ASB16-AS1	-1.08533169416136	0.0143491950149124	LPS_vs_PBS	HSALNG0116707	overlap_antisense	Q75	hsa-miR-3178,hsa-miR-4722-5p,hsa-miR-6089,hsa-miR-6132	Hematocrit; Red blood cell density measurement,-	ATXN7L3	TRMT2B
ENSG00000267100	ILF3-DT	-1.36656142564315	2.55070601798697e-4	LPS_vs_PBS	HSALNG0123950	integenic	Not conserved	hsa-miR-619-5p,hsa-miR-4784	NA	AP1M2	RAB4A
ENSG00000267108	NA	-2.54204167639757	0.0342224318493166	LPS_vs_PBS	HSALNG0120110	anti_sense	Q75	NA	-	PRELID3A	RNF208
ENSG00000267121	FMNL1-DT	-1.59762786729534	2.00178711777309e-6	LPS_vs_PBS	HSALNG0116830	anti_sense	Q75	hsa-miR-30b-3p,hsa-miR-185-3p,hsa-miR-619-5p,hsa-miR-675-5p,hsa-miR-5589-5p,hsa-miR-6089,hsa-miR-6791-5p,hsa-miR-7108-3p,hsa-miR-8485	Body fat distribution,White matter microstructure measurement,Body height,Thyroid stimulating hormone measurement,Bmi-adjusted hip circumference,-	SPATA32	PLXNB2
ENSG00000267123	SCAT1	-3.00356516075408	2.9882922813472e-6	LPS_vs_PBS	HSALNG0119047	integenic	Not conserved	hsa-miR-4433a-3p,hsa-miR-4505,hsa-miR-4436b-3p,hsa-miR-7108-5p	Bilirubin measurement	DNAH17	CYP2R1
ENSG00000267136	NA	-3.27752690982418	9.4157712517469e-5	LPS_vs_PBS	HSALNG0120178	anti_sense	Not conserved	NA	-	FAM210A	MLPH
ENSG00000267199	NA	-4.16155058749001	4.50246105617562e-13	LPS_vs_PBS	HSALNG0120110	anti_sense	Q75	NA	-	PRELID3A	RHOBTB1
ENSG00000267254	ZNF790-AS1	-1.68469853600151	0.00150115098161595	LPS_vs_PBS	HSALNG0125793	anti_sense	Q50	hsa-miR-363-5p,hsa-miR-619-5p,hsa-miR-4505,hsa-miR-6089	-	ZNF345	DLG1
ENSG00000267272	LINC01140	4.35323999717766	0.00242262567357368	LPS_vs_PBS	HSALNG0004949	sense	Q90	NA	Smoking behavior,Cortical surface area measurement,-	NA	KLHDC7B-DT
ENSG00000267278	MAP3K14-AS1	-1.97567301234778	0.00258352679416612	LPS_vs_PBS	HSALNG0116845	anti_sense	Q50	hsa-miR-4316,hsa-miR-7160-3p	Atopic asthma,Protein measurement,Respiratory system disease,Leukocyte count; Myeloid white cell count,Lymphocyte count,Platelet crit,-	FMNL1	NLGN3
ENSG00000267296	CEBPA-DT	-4.40248303003359	1.63320964972222e-10	LPS_vs_PBS	HSALNG0125425	integenic	Q50	hsa-miR-1303,hsa-miR-6764-5p	Bmi-adjusted waist circumference,Reticulocyte count; Reticulocyte measurement,-	CEBPG	DUSP7
ENSG00000267321	SNHG30	-1.76915013237221	0.00101592476676568	LPS_vs_PBS	HSALNG0115960	anti_sense	Q75	hsa-miR-619-5p,hsa-miR-7107-5p	Mean platelet volume; Platelet component distribution width; Platelet count,-	AP2B1	CNST
ENSG00000267325	LINC01415	3.95446303550663	0.0157946695474121	LPS_vs_PBS	HSALNG0121699	sense	Q50	hsa-miR-3960,hsa-miR-8072	Corneal hysteresis; Body mass index; Intraocular pressure measurement; Body height; Urinary albumin to creatinine ratio; Corneal resistance factor; Uric acid measurement; Urate measurement,Household income,Age at first sexual intercourse measurement,Social interaction measurement; Loneliness measurement,Grip strength measurement; Loneliness measurement,Leukocyte count; Household income; Feeling """"fed-up"""" measurement; Mood instability measurement,Fuchs endothelial corneal dystrophy; Potassium measurement; Worry measurement; Urinary albumin to creatinine ratio; Sodium measurement; Gait measurement; Albuminuria,Wellbeing measurement; Sitting height ratio,Autism spectrum disorder; Bmi-adjusted waist-hip ratio; Irritability measurement,Risk-taking behaviour; Risky sexual behaviour measurement,Risky sexual behaviour measurement,Chronotype measurement,Heel bone mineral density,Waist-hip ratio,Mood disorder; Unipolar depression,Attention deficit hyperactivity disorder; Antisocial behaviour measurement; Substance abuse,-	TCF4	SFRP1
ENSG00000267365	KCNJ2-AS1	1.76298146527595	0.0172698597741374	LPS_vs_PBS	HSALNG0118455	anti_sense	Q50	NA	Body weight,-	ABCA5	RIMS2
ENSG00000267366	NA	-3.00105253304767	0.00179347154523007	LPS_vs_PBS	HSALNG0120177	anti_sense	Q75	NA	NA	FAM210A	SPATS2
ENSG00000267372	NA	-3.53915942589278	0.0363279101939321	LPS_vs_PBS	HSALNG0123007	integenic	Not conserved	NA	Parental genotype effect measurement; Peanut allergy measurement,-	EFNA2	ENSG00000289379
ENSG00000267387	NA	2.19204735271766	0.00628891246391274	LPS_vs_PBS	HSALNG0123890	anti_sense	Q75	NA	-	ANGPTL6	CCNJ
ENSG00000267416	HEATR6-DT	2.04737615686568	0.0291658215486976	LPS_vs_PBS	HSALNG0117818	anti_sense	Q50	hsa-miR-619-5p,hsa-miR-6779-3p	-	CA4	SLFN5
ENSG00000267454	ZNF582-DT	-1.67922073063822	0.0134603751212035	LPS_vs_PBS	HSALNG0127758	anti_sense,sense	Q90	hsa-miR-557,hsa-miR-619-5p,hsa-miR-887-5p,hsa-miR-3178,hsa-miR-4492,hsa-miR-6089	-	ZNF583	ACAD10
ENSG00000267461	NA	3.04708296026631	0.00482663581375229	LPS_vs_PBS	HSALNG0118375	anti_sense	Q50	NA	Breast carcinoma,3-hydroxy-1-methylpropylmercapturic acid measurement,Body height,-	PRKAR1A	HAS1
ENSG00000267491	NA	-3.39864705296084	0.00758922313842082	LPS_vs_PBS	HSALNG0119077	anti_sense	Not conserved	hsa-miR-619-5p,hsa-miR-1228-5p	NA	C1QTNF1	C3orf22
ENSG00000267523	NA	-1.51447288268126	0.00914829403189007	LPS_vs_PBS	HSALNG0127701	anti_sense	Q90	NA	3-hydroxypropylmercapturic acid measurement,High density lipoprotein cholesterol measurement,-	NLRP9	GUSBP11
ENSG00000267529	NA	-2.34867230991694	0.0403492055366398	LPS_vs_PBS	HSALNG0120172	anti_sense	Q50	hsa-miR-7977	NA	FAM210A	CXXC5-AS1
ENSG00000267607	ICAM4-AS1	3.51115396403424	2.79235287505228e-8	LPS_vs_PBS	HSALNG0123921	anti_sense	Q50	hsa-miR-361-3p,hsa-miR-4472,hsa-miR-4632-3p,hsa-miR-6803-5p,hsa-miR-7111-3p	Icam-1 measurement,Covid-19; Blood protein measurement,Icam-1 measurement; Adhesion molecule measurement,-,Protein measurement,Blood protein measurement; Sex hormone-binding globulin measurement	ZGLP1	MRPL44
ENSG00000267694	NA	-3.37856110447079	0.0369376055835585	LPS_vs_PBS	HSALNG0120171	anti_sense	Not conserved	hsa-miR-4483,hsa-miR-6722-3p	-	FAM210A	RPL21P137
ENSG00000267712	LINC01539	6.0017926752654	2.601747159527e-6	LPS_vs_PBS	HSALNG0121712	integenic	Q75	hsa-miR-4492,hsa-miR-4505,hsa-miR-1587,hsa-miR-7108-3p	Risk-taking behaviour,Risky sexual behaviour measurement,Smoking status measurement,Smoking initiation,Smoking behavior; Smoking status measurement,Diabetic retinopathy,Self reported educational attainment; Mathematical ability,Diverticular disease,Unipolar depression,Hiv-1 infection,Attention deficit hyperactivity disorder; Antisocial behaviour measurement; Substance abuse,Systolic blood pressure; Smoking behaviour measurement,-	TCF4	ENSG00000287303
ENSG00000267737	NA	6.78620684892879	3.1876683800842e-13	LPS_vs_PBS	HSALNG0119029	integenic	Not conserved	NA	NA	PGS1	CHI3L2
ENSG00000267751	BSG-AS1	-2.37791525818342	0.0231505501172211	LPS_vs_PBS	HSALNG0122891	integenic	Not conserved	NA	NA	POLRMT	ENSG00000289357
ENSG00000267764	NA	-3.30085831306015	7.94285199974546e-6	LPS_vs_PBS	HSALNG0121453	anti_sense	Q90	hsa-miR-6089,hsa-miR-6892-3p	Balding measurement,-	SMAD7	TLR6
ENSG00000267801	NA	-3.02827999668462	7.92760942638465e-4	LPS_vs_PBS	HSALNG0118795	anti_sense	Q90	hsa-miR-874-3p,hsa-miR-3178	Brain measurement,-	UNK	VCL
ENSG00000267904	NA	-2.0014546704188	9.32461995134529e-5	LPS_vs_PBS	HSALNG0124459	sense	Not conserved	hsa-miR-7113-3p	NA	SMIM7	KLHL8
ENSG00000267980	NA	-2.6950958181445	0.00117231172425706	LPS_vs_PBS	HSALNG0145651	anti_sense	Q90	NA	-	MPND	ENSG00000288863
ENSG00000268087	NA	-1.43311666043472	0.0345957132392518	LPS_vs_PBS	HSALNG0124349	overlap_antisense,overlap_sense,anti_sense,sense	Not conserved	hsa-miR-619-5p,hsa-miR-3612,hsa-miR-4492,hsa-miR-1587	Phosphatidylcholine 38:5 measurement,Bronchitis,Response to trauma exposure,Inositol measurement,Pulse pressure measurement,Anti-toxoplasma gondii igg measurement,Mean corpuscular volume; Mean corpuscular hemoglobin,Platelet crit,Systolic blood pressure,Body height; Mean reticulocyte volume,Reticulocyte measurement,Ccl5 measurement,Platelet count,Trauma exposure measurement,Red blood cell distribution width,Vital capacity,Alkaline phosphatase measurement,Red blood cell density measurement,Reaction time measurement,Mean corpuscular volume; Mean corpuscular hemoglobin; Mean corpuscular hemoglobin concentration,Body height,Mean corpuscular volume; Mean corpuscular hemoglobin concentration,Erythrocyte count,Monocyte percentage of leukocytes,Lymphocyte count,Eosinophil count; Lymphocyte count,Blood protein measurement,Response to drug,Cytokine measurement,Response to fenofibrate,Coronary artery disease,Low density lipoprotein cholesterol measurement,Total cholesterol measurement; Low density lipoprotein cholesterol measurement,Glioma,Cleft lip,Heel bone mineral density,Serum metabolite measurement,Serum alanine aminotransferase measurement; Aspartate aminotransferase measurement,Urinary metabolite measurement,Aspartate aminotransferase measurement,Serum alanine aminotransferase measurement,Covid-19,Mean platelet volume; Platelet count,Platelet component distribution width; Platelet count,Longevity,Mean platelet volume; Platelet count; Platelet crit,Mean platelet volume; Liver fibrosis measurement; Platelet count,Mean platelet volume; Liver fibrosis measurement; Platelet component distribution width; Platelet crit; Platelet count; Platelet-to-lymphocyte ratio,Mean platelet volume; Platelet component distribution width,Platelet component distribution width,Mean corpuscular hemoglobin,Mean platelet volume,Myeloperoxidase measurement,Mean corpuscular hemoglobin concentration,Mean corpuscular volume,Mean corpuscular hemoglobin concentration; Red blood cell distribution width,Health study participation,Platelet-to-lymphocyte ratio; Lymphocyte count,Platelet-to-lymphocyte ratio,Monocyte count,Neutrophil percentage of granulocytes; Eosinophil percentage of granulocytes; Basophil count; Eosinophil percentage of leukocytes; Eosinophil count,Eosinophil count,Unipolar depression,Colorectal cancer,Eosinophil percentage of leukocytes,Neutrophil percentage of granulocytes; Eosinophil count; Eosinophil percentage of granulocytes; Eosinophil percentage of leukocytes,Lymphocyte percentage of leukocytes; Lymphocyte count; Neutrophil-to-lymphocyte ratio; Neutrophil percentage of leukocytes; Platelet-to-lymphocyte ratio,Neutrophil-to-lymphocyte ratio,Multiple myeloma,Systemic lupus erythematosus,Eosinophil count; Eosinophil percentage of leukocytes,Neutrophil percentage of leukocytes,Lymphocyte percentage of leukocytes,Leukocyte count,Protein measurement; Total blood protein measurement,Neutrophil percentage of leukocytes; White matter integrity,Neutrophil percentage of granulocytes; Eosinophil percentage of granulocytes,Leukocyte count; Myeloid white cell count,Neutrophil count,Leukocyte count; Lymphocyte percentage of leukocytes; Lymphocyte count; Monocyte percentage of leukocytes,Basophil count,Neutrophil percentage of leukocytes; Lymphocyte percentage of leukocytes,Platelet-to-lymphocyte ratio; Neutrophil-to-lymphocyte ratio; Lymphocyte count,Self reported educational attainment; Intelligence,Susceptibility to hepatitis a infection measurement,Comparative body size at age 10, self-reported,Squamous cell lung carcinoma; Family history of lung cancer,Ischemic stroke; Coronary artery disease,Fev/fec ratio; Response to bronchodilator,Cleft lip; Cleft palate,Hodgkins lymphoma; Chronic lymphocytic leukemia; Multiple myeloma,Age at onset; Myopia,Colorectal cancer; Colorectal adenoma,Serum metabolite measurement; Response to anticoagulant; Vitamin k measurement; Vitamin e measurement; Response to vitamin; Metabolite measurement,Diastolic blood pressure; Varicose veins,-,Loneliness measurement	TMEM38A	GEMIN4
ENSG00000268205	NA	1.1663710425746	0.0274377700483273	LPS_vs_PBS	HSALNG0127823	integenic	Not conserved	NA	NA	ZNF460	RASA2
ENSG00000268316	NA	-3.1305352772627	9.86569907511868e-6	LPS_vs_PBS	HSALNG0127262	anti_sense,sense	Not conserved	NA	High density lipoprotein cholesterol measurement,Tourette syndrome,Serum albumin measurement,Hdl cholesterol change measurement; Physical activity,Bipolar disorder; Body mass index,Apolipoprotein a 1 measurement; High density lipoprotein cholesterol measurement,-	ZNF577	PGBD2
ENSG00000268573	NA	-1.25243380118415	0.0411124940142903	LPS_vs_PBS	NA	NA	NA	NA	NA	ZSCAN30	MRO
ENSG00000268858	NA	-1.9570498710959	3.6544714733530197e-13	LPS_vs_PBS	HSALNG0131701	anti_sense	Q75	hsa-miR-1227-5p,hsa-miR-4281,hsa-miR-6791-5p,hsa-miR-6816-5p,hsa-miR-6852-5p	-	ZBTB46	ATG16L2
ENSG00000268912	NA	-3.45307752661021	5.70273314843818e-4	LPS_vs_PBS	HSALNG0127967	integenic	Not conserved	NA	NA	ZNF132	LINC00865
ENSG00000268947	NA	-2.10445080728223	0.00608633389654034	LPS_vs_PBS	HSALNG0125591	sense	Not conserved	hsa-miR-619-5p,hsa-miR-6089	NA	LSR	ENSG00000283236
ENSG00000269019	HOMER3-AS1	-1.78314736050427	0.00144500420342819	LPS_vs_PBS	HSALNG0124679	anti_sense	Q50	NA	NA	DDX49	ENSG00000259807
ENSG00000269044	NA	-1.38042864049762	0.00145743427914675	LPS_vs_PBS	HSALNG0124458	sense	Not conserved	hsa-miR-665	NA	SMIM7	CHAD
ENSG00000269053	NA	3.18152251318685	3.89795639067691e-5	LPS_vs_PBS	HSALNG0124523	anti_sense	Q50	hsa-miR-619-5p	Blood phosphate measurement	BST2	ENSG00000266446
ENSG00000269066	NA	-2.8558004722925	0.00901719181187785	LPS_vs_PBS	HSALNG0124484	anti_sense	Not conserved	NA	Hba1c measurement	HAUS8	LEP
ENSG00000269303	GRAMD1A-AS1	4.71709773335842	3.71542815780009e-4	LPS_vs_PBS	HSALNG0125556	anti_sense	Not conserved	hsa-miR-619-5p,hsa-miR-5787,hsa-miR-6791-3p	Triacylglycerol 54:4 measurement	ZNF792	ITGB3
ENSG00000269318	NA	-2.15352843684903	0.00610761245699324	LPS_vs_PBS	HSALNG0123367	anti_sense	Q90	hsa-miR-4763-3p,hsa-miR-7160-3p	-	SH3GL1	METTL25
ENSG00000269352	PTOV1-AS2	-1.50143556591003	0.00600162508137189	LPS_vs_PBS	HSALNG0127039	anti_sense	Q90	hsa-miR-612,hsa-miR-615-5p,hsa-miR-1207-5p,hsa-miR-4472,hsa-miR-4508,hsa-miR-4535,hsa-miR-5587-3p,hsa-miR-6813-5p	-	PNKP	CDC20
ENSG00000269427	NA	-1.87397895958176	0.0060651619061371	LPS_vs_PBS	HSALNG0124349	overlap_antisense,overlap_sense,anti_sense,sense	Not conserved	hsa-miR-619-5p,hsa-miR-3612,hsa-miR-4492,hsa-miR-1587	Phosphatidylcholine 38:5 measurement,Bronchitis,Response to trauma exposure,Inositol measurement,Pulse pressure measurement,Anti-toxoplasma gondii igg measurement,Mean corpuscular volume; Mean corpuscular hemoglobin,Platelet crit,Systolic blood pressure,Body height; Mean reticulocyte volume,Reticulocyte measurement,Ccl5 measurement,Platelet count,Trauma exposure measurement,Red blood cell distribution width,Vital capacity,Alkaline phosphatase measurement,Red blood cell density measurement,Reaction time measurement,Mean corpuscular volume; Mean corpuscular hemoglobin; Mean corpuscular hemoglobin concentration,Body height,Mean corpuscular volume; Mean corpuscular hemoglobin concentration,Erythrocyte count,Monocyte percentage of leukocytes,Lymphocyte count,Eosinophil count; Lymphocyte count,Blood protein measurement,Response to drug,Cytokine measurement,Response to fenofibrate,Coronary artery disease,Low density lipoprotein cholesterol measurement,Total cholesterol measurement; Low density lipoprotein cholesterol measurement,Glioma,Cleft lip,Heel bone mineral density,Serum metabolite measurement,Serum alanine aminotransferase measurement; Aspartate aminotransferase measurement,Urinary metabolite measurement,Aspartate aminotransferase measurement,Serum alanine aminotransferase measurement,Covid-19,Mean platelet volume; Platelet count,Platelet component distribution width; Platelet count,Longevity,Mean platelet volume; Platelet count; Platelet crit,Mean platelet volume; Liver fibrosis measurement; Platelet count,Mean platelet volume; Liver fibrosis measurement; Platelet component distribution width; Platelet crit; Platelet count; Platelet-to-lymphocyte ratio,Mean platelet volume; Platelet component distribution width,Platelet component distribution width,Mean corpuscular hemoglobin,Mean platelet volume,Myeloperoxidase measurement,Mean corpuscular hemoglobin concentration,Mean corpuscular volume,Mean corpuscular hemoglobin concentration; Red blood cell distribution width,Health study participation,Platelet-to-lymphocyte ratio; Lymphocyte count,Platelet-to-lymphocyte ratio,Monocyte count,Neutrophil percentage of granulocytes; Eosinophil percentage of granulocytes; Basophil count; Eosinophil percentage of leukocytes; Eosinophil count,Eosinophil count,Unipolar depression,Colorectal cancer,Eosinophil percentage of leukocytes,Neutrophil percentage of granulocytes; Eosinophil count; Eosinophil percentage of granulocytes; Eosinophil percentage of leukocytes,Lymphocyte percentage of leukocytes; Lymphocyte count; Neutrophil-to-lymphocyte ratio; Neutrophil percentage of leukocytes; Platelet-to-lymphocyte ratio,Neutrophil-to-lymphocyte ratio,Multiple myeloma,Systemic lupus erythematosus,Eosinophil count; Eosinophil percentage of leukocytes,Neutrophil percentage of leukocytes,Lymphocyte percentage of leukocytes,Leukocyte count,Protein measurement; Total blood protein measurement,Neutrophil percentage of leukocytes; White matter integrity,Neutrophil percentage of granulocytes; Eosinophil percentage of granulocytes,Leukocyte count; Myeloid white cell count,Neutrophil count,Leukocyte count; Lymphocyte percentage of leukocytes; Lymphocyte count; Monocyte percentage of leukocytes,Basophil count,Neutrophil percentage of leukocytes; Lymphocyte percentage of leukocytes,Platelet-to-lymphocyte ratio; Neutrophil-to-lymphocyte ratio; Lymphocyte count,Self reported educational attainment; Intelligence,Susceptibility to hepatitis a infection measurement,Comparative body size at age 10, self-reported,Squamous cell lung carcinoma; Family history of lung cancer,Ischemic stroke; Coronary artery disease,Fev/fec ratio; Response to bronchodilator,Cleft lip; Cleft palate,Hodgkins lymphoma; Chronic lymphocytic leukemia; Multiple myeloma,Age at onset; Myopia,Colorectal cancer; Colorectal adenoma,Serum metabolite measurement; Response to anticoagulant; Vitamin k measurement; Vitamin e measurement; Response to vitamin; Metabolite measurement,Diastolic blood pressure; Varicose veins,-,Loneliness measurement	TMEM38A	TSSK5P
ENSG00000269473	ZNF132-DT	-3.65615572835341	0.0177681511432247	LPS_vs_PBS	HSALNG0127971	integenic	Not conserved	hsa-miR-6837-5p	Platelet count,Platelet crit,-	ZNF324B	ENSG00000272305
ENSG00000269609	C10orf95-AS1	-1.19178043819273	0.0199981936520047	LPS_vs_PBS	HSALNG0080293	anti_sense	Q50	hsa-miR-619-5p,hsa-miR-920,hsa-miR-1233-5p,hsa-miR-4297,hsa-miR-4516,hsa-miR-4534,hsa-miR-6089	Autism spectrum disorder symptom,Intelligence,Body mass index,Parental genotype effect measurement; Birth weight,-	MFSD13A	KDM3B
ENSG00000269667	NA	5.21643504480124	0.00155742325543193	LPS_vs_PBS	HSALNG0144810	integenic	Not conserved	hsa-miR-4516	Monocyte count,Leukocyte count; Rheumatoid arthritis; Monocyte percentage of leukocytes,Neutrophil count; Granulocyte percentage of myeloid white cells; Myeloid white cell count; Leukocyte count; Monocyte count; Monocyte percentage of leukocytes,Oral ulcer,Eosinophil count,Leukocyte count; Lymphocyte count	IRF8	STK25P1
ENSG00000269680	NA	2.84293345226068	0.00447315377198543	LPS_vs_PBS	HSALNG0123591	anti_sense	Q75	hsa-miR-4258,hsa-miR-4800-3p	-,Body height	SH2D3A	ARL14EPP1
ENSG00000269815	NA	-2.46718198099252	0.00278285755164212	LPS_vs_PBS	HSALNG0124499	sense,intronic_antisense	Not conserved	NA	NA	ABHD8	ZFP14
ENSG00000269906	NA	2.27533504464457	0.0095642768549049	LPS_vs_PBS	HSALNG0101196	sense	Q50	NA	NA	SAV1	GK
ENSG00000269934	NA	-2.0242480967348	0.0166939696655392	LPS_vs_PBS	HSALNG0011224	anti_sense	Not conserved	NA	-	TRIM11	ENSG00000278989
ENSG00000269951	NA	-2.27863677096622	0.0183344587080965	LPS_vs_PBS	HSALNG0107375	sense	Q75	NA	NA	TSPAN3	ENSG00000260911
ENSG00000269956	MKNK1-AS1	-2.14042205484412	4.24791516437998e-5	LPS_vs_PBS	HSALNG0003339	anti_sense	Q90	NA	-	DMBX1	LINC02860
ENSG00000269970	NA	-4.5584399330704	3.66038848395412e-10	LPS_vs_PBS	HSALNG0074238	sense	Not conserved	NA	NA	PTGS1	CCDC106
ENSG00000269973	NA	1.13400820961704	0.0358097720143651	LPS_vs_PBS	HSALNG0012933	sense	Not conserved	NA	-	TAF1B	TBX15
ENSG00000269982	NA	-1.70893905349968	0.00970282457985944	LPS_vs_PBS	HSALNG0024078	anti_sense	Q50	NA	Blood protein measurement,-	CRELD1	PNN
ENSG00000270039	NA	2.24584374422194	0.0250780895600649	LPS_vs_PBS	HSALNG0091665	anti_sense,sense	Not conserved	NA	NA	TSFM	ENSG00000279805
ENSG00000270049	ATP6V0D1-DT	-2.75070735597608	1.12574831888677e-5	LPS_vs_PBS	HSALNG0112213	anti_sense	Q75	hsa-miR-619-5p,hsa-miR-4433a-3p,hsa-miR-4740-3p	Agouti-related protein measurement,Mean corpuscular hemoglobin concentration,Mean reticulocyte volume; Mean corpuscular volume; Mean corpuscular hemoglobin,-	RIPOR1	ENSG00000288573
ENSG00000270055	NA	-2.70484465963512	1.12525016805095e-6	LPS_vs_PBS	HSALNG0104765	integenic	Not conserved	NA	NA	GOLGA8Q	LINC03034
ENSG00000270120	NA	1.91419489790869	0.00219210745720272	LPS_vs_PBS	HSALNG0111360	sense	Q50	NA	NA	NOD2	TMED7
ENSG00000270157	NA	-2.60275861464324	1.67596069292347e-10	LPS_vs_PBS	HSALNG0061852	intronic_sense	Not conserved	NA	NA	DENND11	ZNF33A
ENSG00000270175	NA	-4.21953878577721	0.00154804069414404	LPS_vs_PBS	HSALNG0091285	anti_sense	Q75	NA	-	MAP3K12	IGSF22
ENSG00000270177	PPP2CA-DT	2.9965689487479	4.45478633403692e-5	LPS_vs_PBS	HSALNG0044954	integenic	Q50	hsa-miR-432-3p,hsa-miR-4257	NA	TCF7	IL12A
ENSG00000270194	GOLGA4-AS1	1.29427847198701	0.0151873644559103	LPS_vs_PBS	HSALNG0025176	anti_sense	Q90	NA	-	LRRFIP2	KCNQ4
ENSG00000270426	NA	2.64975047730223	3.55560552587534e-5	LPS_vs_PBS	HSALNG0039018	sense	Q90	NA	NA	IRF2	SSTR2
ENSG00000270605	NA	-4.10854842540305	1.08477478454114e-6	LPS_vs_PBS	HSALNG0002045	anti_sense	Q50	hsa-miR-19b-2-5p,hsa-miR-619-5p,hsa-miR-3620-5p,hsa-miR-4505,hsa-miR-4508,hsa-miR-1587,hsa-miR-5693,hsa-miR-5787,hsa-miR-6089	Aspartate aminotransferase measurement,-	DNAJC8	ENSG00000288065
ENSG00000270607	NAV2-AS6	5.20674615696153	8.23096268376801e-8	LPS_vs_PBS	HSALNG0083062	anti_sense	Q75	NA	-	DBX1	ITK
ENSG00000271009	NA	-3.4171881567054	9.754194813689e-6	LPS_vs_PBS	HSALNG0112602	anti_sense	Q90	NA	Serum alanine aminotransferase measurement; Sex hormone-binding globulin measurement; Low density lipoprotein triglyceride measurement; Body fat percentage; High density lipoprotein cholesterol measurement; Body weight; Aspartate aminotransferase measurement,-	DHX38	LINC02860
ENSG00000271032	NA	3.27183033132598	1.90078080162005e-9	LPS_vs_PBS	HSALNG0125561	anti_sense	Not conserved	NA	Calcium measurement; Serum albumin measurement,Serum albumin measurement,-	ZNF792	L2HGDH
ENSG00000271216	LINC01050	2.18453176958074	0.00601761207549245	LPS_vs_PBS	HSALNG0096679	anti_sense	Q75	hsa-miR-6735-3p	Cognitive decline measurement,-	EPSTI1	TRIM9
ENSG00000271270	TMCC1-DT	-2.71784642658063	6.02100234330587e-7	LPS_vs_PBS	HSALNG0028917	integenic	Q75	hsa-miR-486-3p,hsa-miR-3162-5p	Bmi-adjusted waist circumference; Bmi-adjusted hip circumference	TRH	GPR65
ENSG00000271327	NA	-3.4134006719944	0.00809711406927312	LPS_vs_PBS	HSALNG0092942	integenic	Not conserved	NA	NA	TMTC3	SCTR
ENSG00000271474	UNC5C-AS1	7.19310090993141	3.04989801509779e-14	LPS_vs_PBS	HSALNG0035909	anti_sense	Q50	NA	-	PDHA2	TRGC1
ENSG00000271631	NA	-3.38561929566783	0.00168593337290928	LPS_vs_PBS	HSALNG0073796	intronic_antisense	Not conserved	NA	NA	SNX30	HNRNPA3P11
ENSG00000271646	IRF2-DT	3.6903254261725	2.3041327219173804e-9	LPS_vs_PBS	HSALNG0039019	integenic	Q75	hsa-miR-4466,hsa-miR-6749-3p	-	PRIMPOL	TEAD4
ENSG00000271789	NA	-3.18242278115099	0.0013650034832431	LPS_vs_PBS	HSALNG0052772	sense	Not conserved	NA	NA	MFSD4B	ENSG00000289466
ENSG00000271795	NA	-3.78639400424691	2.00225760037952e-10	LPS_vs_PBS	HSALNG0148747	anti_sense	Q90	NA	NA	SLC36A1	ENSG00000269970
ENSG00000271830	NA	4.56654595081994	0.00398686683529395	LPS_vs_PBS	HSALNG0067527	anti_sense,sense	Q90	hsa-miR-1233-5p,hsa-miR-6089,hsa-miR-6726-3p,hsa-miR-6748-3p,hsa-miR-7150,hsa-miR-8485	-	NA	LINC01914
ENSG00000271856	LINC01215	2.68116461462712	0.0176467226778539	LPS_vs_PBS	HSALNG0027888	integenic	Q50	NA	NA	HHLA2	ENSG00000289530
ENSG00000271889	NA	-3.09647026099853	0.00981053545756404	LPS_vs_PBS	HSALNG0015290	anti_sense	Q75	hsa-miR-4507,hsa-miR-4748	Neuroticism measurement,Epithelial cell adhesion molecule measurement,Reticulocyte measurement,Chronotype measurement,-	USP34	DIP2A-IT1
ENSG00000271947	NA	5.46775714133879	1.79304085936425e-6	LPS_vs_PBS	HSALNG0012731	integenic	Not conserved	hsa-miR-8485	NA	CMPK2	ENSG00000266378
ENSG00000272078	NA	2.79546732433191	1.8793204564787e-7	LPS_vs_PBS	HSALNG0000789	anti_sense	Q50	hsa-miR-505-3p	NA	PEX14	LIMASI
ENSG00000272183	NA	-2.35236434798836	0.031628531268616	LPS_vs_PBS	HSALNG0016066	anti_sense	Q50	hsa-miR-4472,hsa-miR-4787-5p,hsa-miR-6836-5p	NA	TTC31	ENSG00000284606
ENSG00000272205	POU2F1-DT	-3.00813962913509	0.00840574860325948	LPS_vs_PBS	HSALNG0008218	integenic	Q50	hsa-miR-1237-5p	NA	GPA33	RNF215
ENSG00000272211	NA	-1.48871528382639	0.0399357427319492	LPS_vs_PBS	HSALNG0021303	anti_sense	Not conserved	hsa-miR-619-5p,hsa-miR-6089	NA	SLC39A10	ENSG00000197670
ENSG00000272247	NA	-3.9363860432217	0.0100897349442943	LPS_vs_PBS	HSALNG0030170	intronic_antisense	Not conserved	NA	Periodontitis,-	RARRES1	POU2F2-AS2
ENSG00000272335	NA	-1.40121913816486	0.0285461571116779	LPS_vs_PBS	HSALNG0041565	integenic	Not conserved	NA	-	MRPS30	KIF11
ENSG00000272338	NA	-3.69409466025188	0.0215177468262316	LPS_vs_PBS	HSALNG0064463	integenic	Not conserved	NA	NA	FUT10	MIR4298
ENSG00000272341	NA	-2.16418474779957	0.00446408388758682	LPS_vs_PBS	HSALNG0048332	anti_sense	Q75	hsa-miR-6799-5p	-	STMND1	RMDN2
ENSG00000272462	LINC02980	-1.54275772661013	0.0113872530318461	LPS_vs_PBS	HSALNG0048722	anti_sense,sense	Not conserved	hsa-miR-383-3p,hsa-miR-3178,hsa-miR-6089	Iron biomarker measurement,Glomerular filtration rate; Lung carcinoma; Upper aerodigestive tract neoplasm,Calcium measurement,Mean corpuscular volume,High density lipoprotein cholesterol measurement; Alcohol consumption measurement; Alcohol drinking,Bmi-adjusted hip circumference,Mean corpuscular hemoglobin concentration,Intelligence,Venous thromboembolism,Liver iron measurement,Glomerular filtration rate,Mean reticulocyte volume,Red blood cell distribution width; Hemoglobin a1 measurement; Mean corpuscular hemoglobin; Hematocrit; Hemoglobin measurement; Liver iron measurement; Mean corpuscular volume,Hemoglobin measurement; Red blood cell distribution width,Serum hepcidin measurement; Transferrin measurement; Ferritin measurement; Erythrocyte count; Osteoarthritis, hip; Serum alanine aminotransferase measurement; Bilirubin measurement; Iron biomarker measurement; Total cholesterol measurement; Platelet count; Mean corpuscular volume; Total iron binding capacity; Mean corpuscular hemoglobin; Hepcidin:ferritin ratio; Alcohol drinking; Hba1c measurement; Liver disease biomarker; Serum iron measurement; Reticulocyte count; Hemoglobin measurement; Reticulocyte measurement; Aspartate aminotransferase measurement; Diastolic blood pressure; Mean corpuscular hemoglobin concentration; Red blood cell distribution width; Low density lipoprotein cholesterol measurement; Hematocrit; Transferrin saturation measurement; Liver fat measurement,Mean corpuscular hemoglobin concentration; Red blood cell distribution width; Mean corpuscular hemoglobin; Mean arterial pressure; Hematocrit; Hemoglobin measurement; Mean corpuscular volume; Erythrocyte count,Apolipoprotein a 1 measurement; High density lipoprotein cholesterol measurement,Neutrophil count; Bmi-adjusted hip circumference; Monocyte count,Serum alanine aminotransferase measurement; Osteoarthritis, hip; Mean corpuscular hemoglobin concentration; Red blood cell distribution width; Apolipoprotein b measurement; Low density lipoprotein cholesterol measurement; Platelet count; Reticulocyte count; Hematocrit; Reticulocyte measurement; Physical activity,Heel bone mineral density,Autism spectrum disorder,Hemoglobin measurement,Mean corpuscular volume; Mean corpuscular hemoglobin; Mean corpuscular hemoglobin concentration,Mean corpuscular hemoglobin concentration; Mean arterial pressure; Hba1c measurement; Hemoglobin measurement; Mean corpuscular volume,C-reactive protein measurement; Diuretic use measurement; Platelet component distribution width; Diastolic blood pressure; Mean corpuscular hemoglobin concentration; Reticulocyte measurement; Red blood cell distribution width; Mean corpuscular hemoglobin; Alcohol drinking; Systolic blood pressure; Mean arterial pressure; Hematocrit; Reticulocyte count; Hemoglobin measurement; Liver iron measurement; Mean corpuscular volume; Alcohol consumption measurement; Urate measurement,Refractive error,Bmi-adjusted waist circumference,Wellbeing measurement,Bmi-adjusted waist-hip ratio,Mean corpuscular volume; Platelet crit,Body height,Erythrocyte count,Protein measurement; Bilirubin measurement,Bmi-adjusted waist circumference; Skin and soft tissue staphylococcus aureus infection; Osteoarthritis, hip; Hemoglobin measurement,Unipolar depression,Reticulocyte count; Platelet crit; Platelet count; Erythrocyte count,Brain volume measurement,Pulse pressure measurement; Squamous cell lung carcinoma; Lung carcinoma; Upper aerodigestive tract neoplasm,Cocaine dependence; Triglyceride measurement,Risk-taking behaviour,Neuroticism measurement,Red blood cell distribution width,Intelligence; Prostate carcinoma,Bmi-adjusted waist circumference; Body height; Bmi-adjusted waist-hip ratio,Neutrophil count; Smoking status measurement; Susceptibility to childhood ear infection measurement; Monocyte count,Bmi-adjusted hip circumference; Parental longevity; Body mass index,Self reported educational attainment; Lifestyle measurement; Bmi-adjusted waist circumference; Testosterone measurement; Brain volume measurement; Bmi-adjusted hip circumference,C-reactive protein measurement,Bmi-adjusted waist circumference; Bmi-adjusted hip circumference; Smoking status measurement; Mathematical ability,Bmi-adjusted waist circumference; Bmi-adjusted hip circumference,Body fat percentage,Diet measurement; Bmi-adjusted hip circumference,Self reported educational attainment; Cognitive function measurement; Breast carcinoma,Lymphocyte count; Neutrophil count; Mathematical ability,Unipolar depression; Anti-varicella zoster virus igg measurement,Bmi-adjusted waist circumference; Birth weight; Bmi-adjusted hip circumference; Urate measurement,Parental longevity,Cigarettes per day measurement; Body height,Bmi-adjusted hip circumference; Body weight,Hip circumference; Bmi-adjusted waist circumference; Waist circumference; Physical activity measurement; Bmi-adjusted hip circumference; Body height; Diet measurement; Parental longevity,Gout,Serum alanine aminotransferase measurement; Sex hormone-binding globulin measurement; Low density lipoprotein triglyceride measurement; Body fat percentage; Visceral adipose tissue measurement; High density lipoprotein cholesterol measurement; Aspartate aminotransferase measurement,Body height; Diet measurement,Intelligence; Guilt measurement,Mosquito bite reaction size measurement,Platelet-to-lymphocyte ratio,Body height; Physical activity measurement,Body fat distribution,Interleukin 10 measurement,Linoleic acid measurement,Immunosuppressant use measurement,Bmi-adjusted hip circumference; Smoking behaviour measurement,Parental genotype effect measurement; Birth weight,Total iron binding capacity,Transferrin saturation measurement; Serum iron measurement,Ferritin measurement,Worry measurement,Varicose veins; Bmi-adjusted waist circumference; Bmi-adjusted hip circumference; Smoking behavior; Platelet-to-lymphocyte ratio,Bipolar i disorder,Diastolic blood pressure; Smoking status measurement; Systolic blood pressure,Mean arterial pressure; Alcohol drinking,Heel bone mineral density; Eczema; Allergic rhinitis,-,Anxiety,Serum iga measurement,Mean corpuscular hemoglobin,Diastolic blood pressure; Mean corpuscular hemoglobin concentration; Red blood cell distribution width; Hypertension; Mean corpuscular hemoglobin; Transferrin saturation measurement; Systolic blood pressure; Mean arterial pressure; Hba1c measurement; Ferritin measurement; Hematocrit; Platelet count; Smoking status measurement; Serum iron measurement; Reticulocyte count; Hemoglobin measurement; Agents acting on the renin-angiotensin system use measurement; Reticulocyte measurement,Intelligence; Depressive symptom measurement; Systolic blood pressure; Wellbeing measurement; Cognitive function measurement; Neuroticism measurement; Risky sexual behaviour measurement,Monocyte percentage of leukocytes	TRIM38	PTPDC1
ENSG00000272463	NA	3.2157063084812	2.03420598291627e-6	LPS_vs_PBS	HSALNG0047304	integenic	Q50	NA	-	EXOC2	C1orf21
ENSG00000272476	NA	1.71887136765891	0.0149359168011758	LPS_vs_PBS	HSALNG0052540	anti_sense	Q90	hsa-miR-504-3p,hsa-miR-4467,hsa-miR-3960	-	NR2E1	NUAK2
ENSG00000272512	NA	5.20007791470261	1.072512597213e-6	LPS_vs_PBS	HSALNG0000065	integenic	Not conserved	NA	Apolipoprotein a 1 measurement,Parental longevity,-	HES4	SOX8
ENSG00000272582	NA	2.77177461348882	0.00945277443500751	LPS_vs_PBS	HSALNG0135368	anti_sense	Q75	NA	-	POLR2F	ENSG00000234394
ENSG00000272668	NA	-3.89522645150978	2.71618294245578e-4	LPS_vs_PBS	HSALNG0007790	anti_sense	Q90	hsa-miR-574-5p,hsa-miR-5586-5p,hsa-miR-6878-3p	Red blood cell density measurement,C-reactive protein measurement,Bilirubin measurement,-	SLAMF8	LINC00954
ENSG00000272669	NA	3.42018680113627	6.63888038250688e-13	LPS_vs_PBS	HSALNG0135442	anti_sense	Not conserved	hsa-miR-210-5p,hsa-miR-6763-3p	NA	GTPBP1	ABTB2
ENSG00000272734	ADIRF-AS1	-1.32576358209242	0.00155662842757574	LPS_vs_PBS	HSALNG0079425	anti_sense,sense	Q75	hsa-miR-3620-5p,hsa-miR-4447,hsa-miR-4505,hsa-miR-1587	-	MMRN2	FGFRL1
ENSG00000272777	NA	-2.35463920943563	0.0350780621628461	LPS_vs_PBS	HSALNG0035980	integenic	Not conserved	NA	NA	ADH5	ENSG00000224387
ENSG00000272849	NA	-1.89191678246135	4.75009690231054e-4	LPS_vs_PBS	HSALNG0094607	anti_sense	Q75	hsa-miR-619-5p,hsa-miR-1287-5p,hsa-miR-4472	-	SETD1B	ZNF81
ENSG00000272902	TBC1D8-AS1	-3.87569372104073	2.61495498791573e-4	LPS_vs_PBS	HSALNG0017347	anti_sense	Q50	NA	Reticulocyte count	CNOT11	LINC02762
ENSG00000272941	NA	2.26586893089931	7.0300842534789e-6	LPS_vs_PBS	HSALNG0061535	anti_sense	Q50	NA	-	TMEM140	FBXO22
ENSG00000272986	NA	3.84457443162355	4.6089850447494e-4	LPS_vs_PBS	HSALNG0035038	anti_sense	Q50	NA	NA	JCHAIN	LINC02895
ENSG00000272990	NA	-3.14876356704083	0.0274911073893615	LPS_vs_PBS	HSALNG0030055	anti_sense	Q75	NA	-	SSR3	ENSG00000267515
ENSG00000273032	DGCR5	-3.72598475678063	0.0213319627002112	LPS_vs_PBS	HSALNG0133984	integenic	Not conserved	hsa-miR-619-5p,hsa-miR-764	NA	FAM246C	MIR4312
ENSG00000273033	LINC02035	-2.53832699651887	3.57126145381035e-13	LPS_vs_PBS	HSALNG0028514	integenic	Q75	NA	Protein measurement,-	SLC49A4	VAV3
ENSG00000273108	NA	-2.49433972601877	0.0294507270210672	LPS_vs_PBS	HSALNG0080381	anti_sense	Not conserved	NA	NA	NEURL1	ENSG00000260536
ENSG00000273117	INSIG1-DT	1.36009315658327	0.0387137746287392	LPS_vs_PBS	HSALNG0062567	anti_sense	Not conserved	NA	Angina pectoris; Coronary artery disease,Neuroticism measurement,Hair colour measurement,Age at onset,Thyroid peroxidase antibody measurement; Anti-thyroglobulin antibody measurement,Visual perception measurement,Coronary artery calcification,Stem cell growth factor beta measurement,Response to carboplatin; Ovarian carcinoma; Response to paclitaxel; Progression free survival,-	CNPY1	ENSG00000272717
ENSG00000273124	NA	5.77790417375081	6.08350513446091e-16	LPS_vs_PBS	HSALNG0079637	integenic	Q50	hsa-miR-4650-5p,hsa-miR-6132,hsa-miR-6763-5p	Fibroblast growth factor basic measurement,-	ANKRD1	AMPD3
ENSG00000273137	SELENOO-AS1	1.43340669092383	0.00862282253173666	LPS_vs_PBS	HSALNG0147440	anti_sense	Not conserved	hsa-miR-3620-5p,hsa-miR-4447,hsa-miR-4505,hsa-miR-1587,hsa-miR-4763-3p,hsa-miR-6085	Platelet count,-	TUBGCP6	INTU
ENSG00000273143	DUSP5-DT	4.23040603749544	1.65921974336957e-4	LPS_vs_PBS	HSALNG0080582	integenic	Q50	NA	Heel bone mineral density,Bone density,-	SMNDC1	CYP4F11
ENSG00000273145	NA	-2.22637807815656	0.0233313106400563	LPS_vs_PBS	HSALNG0135987	sense	Not conserved	hsa-miR-3622b-3p,hsa-miR-1268b,hsa-miR-5001-3p,hsa-miR-6089,hsa-miR-6132,hsa-miR-6803-5p,hsa-miR-6870-5p,hsa-miR-10394-5p	Risk-taking behaviour; Smoking status measurement,Body height,Dupuytren contracture,Unipolar depression,Birth weight,Wellbeing measurement; Dupuytren contracture,Alcohol use disorder measurement; Alcohol consumption measurement,Body weight,Body height; Body weight,Smoking status measurement,Ovarian carcinoma,Sex hormone-binding globulin measurement,Chemokine (c-c motif) ligand 27 measurement,Protein measurement,Electroencephalogram measurement,Total cholesterol measurement; Low density lipoprotein cholesterol measurement,Alkaline phosphatase measurement; Igf-1 measurement,Triglyceride measurement,Behavioural disinhibition measurement,Eosinophil count; Bmi-adjusted hip circumference; Body height; Eosinophil percentage of leukocytes,-,Attention deficit hyperactivity disorder; Bipolar disorder; Major depressive disorder; Autism spectrum disorder	PPARA	TSPAN15
ENSG00000273151	NA	-1.50065169725177	0.00817475776281086	LPS_vs_PBS	NA	NA	NA	NA	NA	ADAP1	MRPL40
ENSG00000273174	NA	2.95077434720891	1.48233776418332e-7	LPS_vs_PBS	HSALNG0028857	anti_sense	Q50	NA	-	GP9	PABIR3
ENSG00000273199	NA	3.63348973494678	1.00209977079824e-8	LPS_vs_PBS	NA	NA	NA	NA	NA	CLDN14	RNF149
ENSG00000273216	NA	-2.12053642729631	0.0413792462713656	LPS_vs_PBS	HSALNG0134823	sense	Not conserved	hsa-miR-4447	NA	RASL10A	ENSG00000228692
ENSG00000273314	NA	2.48898309080716	1.02084627230174e-4	LPS_vs_PBS	HSALNG0062087	anti_sense	Q50	hsa-miR-668-5p	NA	EZH2	PTPN1
ENSG00000273356	LINC02019	-2.20355527519629	0.0124231118125607	LPS_vs_PBS	HSALNG0026057	integenic	Q90	NA	-	DOCK3	GAS5
ENSG00000273373	SLC16A4-AS1	-2.19870062487721	8.42838034346386e-4	LPS_vs_PBS	HSALNG0005977	anti_sense	Q75	NA	-	RBM15	ENSG00000268316
ENSG00000273445	NA	3.88202241800611	0.0211827914982394	LPS_vs_PBS	HSALNG0016643	integenic	Not conserved	hsa-miR-1587	NA	RGPD2	ENSG00000253295
ENSG00000273472	NA	3.00952214364979	4.27248199547538e-10	LPS_vs_PBS	HSALNG0148201	integenic	Q50	NA	NA	ELMOD2	TBC1D9
ENSG00000273486	NA	-2.47423809281316	4.28076624926621e-5	LPS_vs_PBS	HSALNG0029189	anti_sense	Q90	hsa-miR-23a-5p,hsa-miR-135a-3p,hsa-miR-619-5p,hsa-miR-1268b,hsa-miR-4447,hsa-miR-3960,hsa-miR-6089	Lymphocyte count,Body mass index,-	STAG1	ZMAT1
ENSG00000273669	NA	-2.45010671180162	0.0446131741505652	LPS_vs_PBS	HSALNG0122476	integenic	Q50	hsa-miR-4650-5p,hsa-miR-4695-5p,hsa-miR-6763-5p	Total blood protein measurement; Insomnia,-	ZNF407	ENSG00000288065
ENSG00000273805	NA	4.06225206883459	0.0057051797723555	LPS_vs_PBS	HSALNG0091671	integenic	Q50	hsa-miR-619-5p	Trochanter size,Hematocrit,Bmi-adjusted waist circumference; Body height,Platelet component distribution width,Body mass index,Intelligence,Self reported educational attainment,Body height; Cognitive function measurement,-	ATP23	ENSG00000223642
ENSG00000273812	LINC02970	2.71771003717796	9.8577505358767e-9	LPS_vs_PBS	HSALNG0131544	integenic	Q75	hsa-miR-1207-3p,hsa-miR-4505,hsa-miR-1587,hsa-miR-3064-5p,hsa-miR-7160-3p	-	GATA5	BPGM
ENSG00000274213	NA	3.74598881080793	1.08183413480779e-6	LPS_vs_PBS	HSALNG0117605	integenic	Not conserved	hsa-miR-500b-3p	-	DGKE	TENT5C
ENSG00000274370	NA	-1.91354688549195	0.0013345272775987	LPS_vs_PBS	HSALNG0119502	integenic	Not conserved	hsa-miR-6784-5p	NA	METRNL	TMEM163
ENSG00000274441	NA	2.43118651088732	0.00853455611587053	LPS_vs_PBS	HSALNG0041204	anti_sense	Q75	hsa-miR-6726-5p	Alkaline phosphatase measurement,Hair colour measurement; Alkaline phosphatase measurement; Blood phosphate measurement,Heel bone mineral density,Fev/fec ratio,Unipolar depression,Aggressive periodontitis,Malaria,-	RANBP3L	ENSG00000285103
ENSG00000274461	LINC02930	-3.53425462385246	3.88126361919813e-7	LPS_vs_PBS	HSALNG0081109	integenic	Not conserved	NA	Adolescent idiopathic scoliosis,Left inferior lateral ventricle volume measurement; T-tau measurement; Cerebrospinal fluid biomarker measurement,-	PLPP4	ARHGAP33
ENSG00000274536	MIR223HG	-6.14246114868734	5.525833898358329e-23	LPS_vs_PBS	HSALNG0138297	anti_sense	Q50	hsa-miR-331-3p	Balding measurement,Eosinophil count,Alopecia,Mean platelet volume; Platelet count,Eosinophil percentage of leukocytes	HEPH	ZNF577
ENSG00000274605	PCCA-DT	-3.14033851768538	6.76382365985788e-5	LPS_vs_PBS	HSALNG0098967	integenic	Q50	NA	NA	ZIC5	CIPC
ENSG00000274818	NA	3.0093691756817	1.16189180640916e-5	LPS_vs_PBS	HSALNG0102246	integenic	Q75	NA	NA	MAP3K9	ITPKC
ENSG00000274833	NA	3.71648717432979	0.0219119754885984	LPS_vs_PBS	HSALNG0119253	integenic	Q50	hsa-miR-1296-3p,hsa-miR-4508,hsa-miR-7106-5p	Dental caries; Bmi-adjusted hip circumference; Dentures	BAHCC1	KCNJ2
ENSG00000274929	NA	-2.91442978595491	0.00167073721599825	LPS_vs_PBS	HSALNG0096999	anti_sense,sense	Not conserved	NA	NA	RCBTB2	GCOM1
ENSG00000275210	NA	4.38938060172108	3.28424596445416e-11	LPS_vs_PBS	NA	NA	NA	NA	NA	LILRA4	ENSG00000253891
ENSG00000275294	LINC02340	4.79079382260601	1.52676768834042e-8	LPS_vs_PBS	HSALNG0095919	integenic	Q50	NA	Creatinine measurement; Serum gamma-glutamyl transferase measurement; Glomerular filtration rate,Glomerular filtration rate,Aspartate aminotransferase measurement,Serum gamma-glutamyl transferase measurement,Creatinine measurement,-	USP12	LIMS2
ENSG00000275413	NA	-2.74673668488142	0.0198416883601916	LPS_vs_PBS	HSALNG0114830	anti_sense	Not conserved	NA	NA	NCOR1	ENSG00000279267
ENSG00000275630	NA	4.13660028691768	0.0154322793138822	LPS_vs_PBS	HSALNG0102240	integenic	Not conserved	NA	NA	PCNX1	DSP-AS1
ENSG00000275897	NA	-3.61169476681857	0.0393713403599012	LPS_vs_PBS	NA	NA	NA	NA	NA	RSAD1	ZNF507
ENSG00000276317	NA	3.4503010490559	1.44545970313995e-5	LPS_vs_PBS	HSALNG0131550	anti_sense	Not conserved	hsa-miR-940,hsa-miR-4492,hsa-miR-6752-3p,hsa-miR-6810-5p,hsa-miR-6810-3p,hsa-miR-7160-3p	Hemoglobin a1 measurement	GATA5	LNX1
ENSG00000276462	LINC03025	5.81329599877802	1.1417655549465301e-10	LPS_vs_PBS	HSALNG0071581	integenic	Not conserved	NA	NA	FOXD4L6	LINC00158
ENSG00000276488	NA	-2.44333532226159	9.97202386441377e-4	LPS_vs_PBS	HSALNG0127686	anti_sense	Q50	hsa-miR-4472	-	ZNF784	ENSG00000260793
ENSG00000276900	NA	-2.14288034107476	0.0230422898508802	LPS_vs_PBS	HSALNG0143376	anti_sense	Not conserved	hsa-miR-363-5p,hsa-miR-6089	-	ETFBKMT	B3GNT5
ENSG00000277007	NA	-3.41279855358477	0.0285700685244768	LPS_vs_PBS	HSALNG0010635	sense	Q75	NA	Bmi-adjusted hip circumference; Bmi-adjusted waist-hip ratio,Bmi-adjusted waist circumference; Bmi-adjusted waist-hip ratio,Bmi-adjusted hip circumference,Fev/fec ratio; Heel bone mineral density,Erythrocyte count,Chronic obstructive pulmonary disease,Fev/fec ratio,Gut microbiome measurement,Pulse pressure measurement,Bmi-adjusted waist circumference,Bmi-adjusted waist-hip ratio,Bmi-adjusted waist circumference; Bmi-adjusted hip circumference; Bmi-adjusted waist-hip ratio,Heel bone mineral density,Triglyceride measurement; Bmi-adjusted waist circumference,Protein measurement,Lean body mass,Hematocrit,-	LYPLAL1	KCTD9P1
ENSG00000277232	GTSE1-DT	-4.49852574614564	6.48673949127301e-4	LPS_vs_PBS	HSALNG0136018	integenic	Q50	hsa-miR-939-3p	-	PKDREJ	ELFN2
ENSG00000277496	SLCO4A1-AS2	3.25026056725134	2.42903836427142e-8	LPS_vs_PBS	HSALNG0131550	anti_sense	Not conserved	hsa-miR-940,hsa-miR-4492,hsa-miR-6752-3p,hsa-miR-6810-5p,hsa-miR-6810-3p,hsa-miR-7160-3p	Hemoglobin a1 measurement	GATA5	DUSP5
ENSG00000277511	NA	2.48922688220281	3.7159308219245e-6	LPS_vs_PBS	HSALNG0115754	integenic	Not conserved	hsa-miR-6089,hsa-miR-7847-3p	-	RHOT1	STIMATE
ENSG00000277566	NA	-3.05461684148252	5.14709053749254e-4	LPS_vs_PBS	HSALNG0094145	sense	Not conserved	NA	NA	TPCN1	ENSG00000259563
ENSG00000277782	NA	2.32432391063452	3.44425410710478e-4	LPS_vs_PBS	HSALNG0107630	anti_sense	Q90	hsa-miR-5787	-	MESD	IFI16
ENSG00000277895	NA	2.67471864795494	3.20859956872006e-4	LPS_vs_PBS	HSALNG0091934	anti_sense	Q75	NA	NA	C12orf56	TPM4
ENSG00000277978	NA	-2.50913128228366	0.0138310616629162	LPS_vs_PBS	HSALNG0112104	anti_sense	Q50	hsa-miR-4433a-3p,hsa-miR-4492,hsa-miR-4433b-3p	-	TK2	C20orf144
ENSG00000278017	NA	2.2828585935394	9.34879524025412e-4	LPS_vs_PBS	HSALNG0121991	anti_sense	Q90	NA	NA	PIGN	C4orf45
ENSG00000278112	NA	-4.73677534088221	0.0036897512121909	LPS_vs_PBS	HSALNG0094744	sense	Q50	hsa-miR-204-3p,hsa-miR-4508,hsa-miR-4722-5p	NA	RILPL1	DAG1
ENSG00000278206	NA	-2.41932837804861	0.00901458866811836	LPS_vs_PBS	HSALNG0054036	anti_sense,sense	Q90	NA	-	PEX3	SLC46A2-AS1
ENSG00000278330	NA	-4.37746079800649	6.0668618039032696e-18	LPS_vs_PBS	HSALNG0122607	anti_sense	Not conserved	NA	-	GALR1	TBC1D22A
ENSG00000278464	NA	4.46782821977827	0.00554561282786501	LPS_vs_PBS	HSALNG0120842	anti_sense	Q90	hsa-miR-4271,hsa-miR-4463,hsa-miR-6089,hsa-miR-6132,hsa-miR-6763-5p	-	ZSCAN30	DDX43
ENSG00000278765	NA	-2.60522955775057	0.0100639265764879	LPS_vs_PBS	HSALNG0117071	integenic	Q75	NA	NA	CBX1	GDPD3
ENSG00000278768	BACE1-AS	-1.98738536904551	9.41133011864597e-4	LPS_vs_PBS	HSALNG0087449	anti_sense	Q90	hsa-miR-6089	Apolipoprotein a 1 measurement,-	RNF214	OGG1
ENSG00000278869	NA	4.15619031981959	4.37061137389588e-15	LPS_vs_PBS	HSALNG0136238	anti_sense	Q90	hsa-miR-874-3p,hsa-miR-4447,hsa-miR-4463,hsa-miR-1343-5p,hsa-miR-5088-3p,hsa-miR-6799-5p,hsa-miR-6877-3p	-	ALG12	BCL2L13
ENSG00000278921	EPB41L4A-DT	3.84784492180544	0.0113021950228082	LPS_vs_PBS	HSALNG0141607	integenic	Q75	NA	-	APC	KRT23
ENSG00000279110	NA	-3.28801318431275	0.0412420782708794	LPS_vs_PBS	HSALNG0147383	anti_sense	Not conserved	hsa-miR-4505	NA	LHFPL7	RTRAFP1
ENSG00000279277	NA	1.65909812576895	0.00585942393181305	LPS_vs_PBS	HSALNG0027881	integenic	Q50	hsa-miR-5787	Bipolar disorder,-	CD47	HCG4B
ENSG00000279278	NA	-2.19256407861128	0.00223859794309366	LPS_vs_PBS	HSALNG0134311	integenic	Not conserved	hsa-miR-198,hsa-miR-210-5p	NA	VPREB1	NLGN3
ENSG00000279342	NA	-1.51425974583938	0.0402780537841642	LPS_vs_PBS	HSALNG0087913	sense	Q50	NA	NA	MSANTD2	TUT4
ENSG00000279762	NA	4.45344912820022	1.30105901077171e-11	LPS_vs_PBS	HSALNG0115783	anti_sense	Q90	hsa-miR-30b-3p,hsa-miR-6089	Systolic blood pressure,-	MYO1D	MDK
ENSG00000279833	NA	-3.61008708573236	4.6586937916312e-6	LPS_vs_PBS	NA	NA	NA	NA	NA	APOBEC3H	RAB26
ENSG00000279873	LINC01126	-3.79987092870341	0.0122713066934315	LPS_vs_PBS	HSALNG0014530	anti_sense	Q75	hsa-miR-663a,hsa-miR-4685-3p,hsa-miR-4749-3p,hsa-miR-6819-3p,hsa-miR-8485,hsa-miR-10392-3p	Neutrophil count; Intraocular pressure measurement; Creatinine measurement; Appendicular lean mass; Bmi-adjusted waist-hip ratio; Reticulocyte measurement,Bmi-adjusted waist-hip ratio; Myocardial infarction,-	PLEKHH2	NRBF2P6
ENSG00000280011	NA	-3.70849405822061	0.00873509375748606	LPS_vs_PBS	HSALNG0135836	anti_sense	Not conserved	NA	NA	SHISAL1	ENSG00000234428
ENSG00000280273	NA	1.7547005247393	0.0101645341017835	LPS_vs_PBS	HSALNG0063429	anti_sense	Q50	hsa-miR-1199-3p,hsa-miR-6785-5p	-	XKR6	GHITM
ENSG00000280303	ERICD	3.70341765179766	3.69161357332594e-5	LPS_vs_PBS	HSALNG0069026	anti_sense	Q50	hsa-miR-4526,hsa-miR-4656,hsa-miR-4749-3p,hsa-miR-6749-3p,hsa-miR-8072	Age-related hearing impairment	CHRAC1	C17orf58
ENSG00000280798	LINC00294	-2.40092681266913	4.62395879675142e-15	LPS_vs_PBS	HSALNG0083507	anti_sense,sense	Not conserved	NA	-	TCP11L1	TBC1D14
ENSG00000280927	CTBP1-AS	-1.30791383619955	0.0291498287729036	LPS_vs_PBS	HSALNG0141602	anti_sense	Q90	NA	-	MAEA	ENSG00000269044
ENSG00000281005	LINC00921	-2.33401609059819	2.5384276473177e-5	LPS_vs_PBS	HSALNG0109143	sense	Not conserved	hsa-miR-3925-3p	NA	NA	ELP2
ENSG00000281162	LINC01127	-3.79761587826874	5.27922075345404e-4	LPS_vs_PBS	HSALNG0017393	integenic	Q50	hsa-miR-939-3p,hsa-miR-6728-3p,hsa-miR-6737-3p	Eosinophil count,Protein measurement,St2 protein measurement,Neutrophil count,-	IL1R2	ZNF229
ENSG00000281398	SNHG4	-1.81624424543794	9.47640186769906e-5	LPS_vs_PBS	HSALNG0045213	anti_sense,sense	Q50	hsa-miR-3170,hsa-miR-6089,hsa-miR-6736-5p	-	MATR3	TBC1D8
ENSG00000281404	LINC01176	1.76356307775641	7.69865107771376e-5	LPS_vs_PBS	HSALNG0149630	sense	Not conserved	NA	NA	NA	SNORA41B
ENSG00000281501	SEPSECS-AS1	-2.12064774463422	7.53965281708677e-4	LPS_vs_PBS	HSALNG0033386	anti_sense,sense	Q75	hsa-miR-6089,hsa-miR-6816-5p	Idiopathic osteonecrosis of the femoral head,Cannabis dependence measurement,-	PI4K2B	TMEM51-AS1
ENSG00000281756	C2-AS1	2.04222558058688	0.0499867089929605	LPS_vs_PBS	HSALNG0049350	anti_sense	Q50	hsa-miR-619-5p,hsa-miR-4492	Age-related macular degeneration,Von willebrand factor measurement,Bmi-adjusted waist circumference; Autism spectrum disorder,Blood protein measurement,Atrophic macular degeneration; Age-related macular degeneration; Wet macular degeneration,-	NELFE	HSPE1P11
ENSG00000282024	NA	3.85652119360892	4.68050077730977e-4	LPS_vs_PBS	HSALNG0048327	anti_sense	Not conserved	hsa-miR-3620-5p,hsa-miR-1587,hsa-miR-3064-5p,hsa-miR-6769b-5p	Xanthosine measurement; Mean corpuscular volume; Mean corpuscular hemoglobin,Red blood cell distribution width,Heart rate,-	ATXN1	OGFRL1
ENSG00000282221	NA	4.65205743162408	8.37164563094474e-4	LPS_vs_PBS	HSALNG0009643	anti_sense	Q50	hsa-miR-23b-5p,hsa-miR-615-5p	-	PKP1	EXOC3L4
ENSG00000282851	BISPR	2.00756838128356	3.62835657259776e-11	LPS_vs_PBS	HSALNG0124521	sense	Not conserved	hsa-miR-6775-3p	Blood phosphate measurement,-	MVB12A	SLCO5A1
ENSG00000283213	NA	-3.24653522917095	4.17365263267754e-4	LPS_vs_PBS	HSALNG0110217	anti_sense	Q90	NA	-	USP31	CT69
ENSG00000283265	NA	6.52095706039912	2.28478608483623e-8	LPS_vs_PBS	HSALNG0053773	integenic	Q50	hsa-miR-3665	Hodgkins lymphoma,C-reactive protein measurement; Inflammatory bowel disease; Ulcerative colitis; Systemic lupus erythematosus; Primary biliary cirrhosis; Rheumatoid arthritis,Rheumatoid arthritis,Diffuse plaque measurement,Rheumatoid arthritis; Inflammatory bowel disease; Celiac disease,Oral ulcer; Tonsillectomy risk measurement; Celiac disease; Autoimmune disease; Rheumatoid arthritis,C-reactive protein measurement,Empathy measurement,Psoriasis,Breast milk measurement,Leukocyte count,Neutrophil percentage of leukocytes; Lymphocyte percentage of leukocytes,-	TNFAIP3	HSPD1P6
ENSG00000283648	NA	5.00347709569473	2.23772438492576e-4	LPS_vs_PBS	HSALNG0062073	anti_sense	Q50	hsa-miR-6791-3p	Protein measurement,Parkinson's disease symptom measurement,Psoriasis; Inflammatory bowel disease; Ulcerative colitis; Ankylosing spondylitis; Crohn's disease; Sclerosing cholangitis,Gut microbiome measurement,Crohn's disease,Asparagine measurement,Uterine fibroid measurement,Chronic kidney disease; Diabetic nephropathy,Cardiovascular event measurement; Response to angiotensin-converting enzyme inhibitor; Response to angiotensin receptor blocker,-	EZH2	PRKCH
ENSG00000283674	NA	-2.21058533809379	0.00569207090618884	LPS_vs_PBS	HSALNG0063498	integenic	Not conserved	hsa-miR-1304-3p,hsa-miR-6803-5p	-	FAM86B2	ENSG00000278918
ENSG00000283839	NA	-1.40266822327241	0.00210958786499517	LPS_vs_PBS	HSALNG0020893	anti_sense	Q50	NA	Anxiety measurement; Depressive symptom measurement; Serum gamma-glutamyl transferase measurement; Wellbeing measurement; Bipolar disorder; Neuroticism measurement; Neurotic disorder,Wellbeing measurement; Neuroticism measurement,Neuroticism measurement; Feeling emotionally hurt measurement,-	NCKAP1	OLFML2B
ENSG00000283849	NA	3.38755062264384	6.17529325695747e-6	LPS_vs_PBS	HSALNG0025266	anti_sense	Q90	hsa-miR-3620-5p,hsa-miR-4492,hsa-miR-1587,hsa-miR-6850-3p	Sex hormone-binding globulin measurement,Memory performance; Paragraph delayed recall measurement,-	TTC21A	GATA5
ENSG00000284633	NA	2.34652992465006	0.00546674738463469	LPS_vs_PBS	HSALNG0135492	anti_sense	Q50	hsa-miR-4463,hsa-miR-4776-5p,hsa-miR-6769b-5p	Fev/fec ratio,Ulcerative colitis; Crohn's disease; Inflammatory bowel disease,Psoriasis; Inflammatory bowel disease; Ulcerative colitis; Ankylosing spondylitis; Crohn's disease; Sclerosing cholangitis,Body weight,Platelet crit,Biliary liver cirrhosis,Hair colour measurement,Psoriasis; Ulcerative colitis; Ankylosing spondylitis; Crohn's disease; Sclerosing cholangitis,-	SYNGR1	KRT8P31
ENSG00000284669	NA	3.15907380544355	7.57267794760932e-4	LPS_vs_PBS	HSALNG0025266	anti_sense	Q90	hsa-miR-3620-5p,hsa-miR-4492,hsa-miR-1587,hsa-miR-6850-3p	Sex hormone-binding globulin measurement,Memory performance; Paragraph delayed recall measurement,-	TTC21A	PDE4DIPP2
ENSG00000284719	NA	-2.99324958619393	0.00295547586075956	LPS_vs_PBS	HSALNG0002807	integenic	Q75	hsa-miR-619-5p,hsa-miR-659-5p,hsa-miR-6089,hsa-miR-1273h-5p	Hemorrhoid,-	PPIE	HISLA
ENSG00000284977	NA	1.50598321296148	0.017837517926491	LPS_vs_PBS	HSALNG0074045	sense	Q50	hsa-miR-8485	Ischemic stroke,Pepsinogen i/ii ratio,Susceptibility to strep throat measurement,Low density lipoprotein cholesterol measurement,Body mass index,Response to antipsychotic drug,Behavioural disinhibition measurement,Self reported educational attainment,-	NA	AGAP5
ENSG00000285103	NA	1.6882051725491	0.00121117562677236	LPS_vs_PBS	HSALNG0070557	anti_sense	Q75	hsa-miR-874-3p	Sporadic amyotrophic lateral sclerosis,Heart failure,-	IFNK	ENSG00000251922
ENSG00000285108	NA	3.87691635756203	0.0439355329777045	LPS_vs_PBS	HSALNG0068596	integenic	Q50	NA	Beta-aminoisobutyric acid measurement,High density lipoprotein cholesterol measurement; Balding measurement,Skin aging measurement,Eosinophil count; Eosinophil percentage of leukocytes,Bmi-adjusted waist circumference; Body height; Osteoarthritis, hip,Body height; Heel bone mineral density,Heel bone mineral density,Back pain,Body height,Bmi-adjusted waist circumference,Hemorrhoid,Body weight,Bmi-adjusted hip circumference,Body height; Bmi-adjusted hip circumference; Infant body height,Body fat distribution,Total hip arthroplasty,Bmi-adjusted waist circumference; Bmi-adjusted hip circumference,Lean body mass,Sciatica; Lumbar disc herniation; Ldh-related sciatica symptom severity measurement,-	GSDMC	SULT6B1
ENSG00000285165	NA	-2.81547599482048	0.0338220787709506	LPS_vs_PBS	HSALNG0057946	anti_sense	Q75	NA	Clostridium difficile infection,Mean corpuscular volume,Acute lymphoblastic leukemia,-	FIGNL1	ENSG00000272744
ENSG00000285331	NA	-1.4357314902347	0.0321193707355963	LPS_vs_PBS	HSALNG0106164	sense	Not conserved	NA	NA	NA	KRT7
ENSG00000285410	GABPB1-IT1	-1.01807600206328	0.032893720204601	LPS_vs_PBS	HSALNG0105871	anti_sense,sense	Q90	hsa-miR-5585-3p	Superior frontal gyrus volume measurement,Adolescent idiopathic scoliosis,Testosterone measurement,Platelet crit,Breast carcinoma,Fev/fec ratio,Body height,Blood phosphate measurement,Mean reticulocyte volume,Mean arterial pressure,Systolic blood pressure; Heel bone mineral density,Leukocyte count,Hypertension,Electrocardiography,Granulocyte percentage of myeloid white cells,Intelligence,Eosinophil count,Lymphocyte count,Qt interval,Serum alanine aminotransferase measurement; Aspartate aminotransferase measurement,Lean body mass,Self reported educational attainment,Pulse pressure measurement,Serum alanine aminotransferase measurement,Serum gamma-glutamyl transferase measurement,Pulse pressure measurement; Systolic blood pressure,Aspartate aminotransferase measurement,Coronary artery disease,Uric acid measurement,Urate measurement,Monocyte count,Chronic obstructive pulmonary disease,Hematocrit,Calcium measurement,Fibrinogen measurement,Late-onset alzheimers disease,Lymphocyte count; Myeloid white cell count; Leukocyte count; Calcium measurement; Monocyte count,Sex hormone-binding globulin measurement; Blood phosphate measurement; Serum gamma-glutamyl transferase measurement; Calcium measurement; High density lipoprotein cholesterol measurement,Estradiol measurement,Osteoarthritis, knee,Osteoarthritis, knee; Osteoarthritis, hip, osteoarthritis, knee,Monocyte percentage of leukocytes,-,Neutrophil count; Myeloid white cell count; Leukocyte count; Eosinophil count; Granulocyte count,Total cholesterol measurement; Apolipoprotein b measurement; Low density lipoprotein cholesterol measurement; Blood protein measurement; Triglyceride measurement; Serum non-albumin protein measurement; Aspartate aminotransferase measurement,Ankylosing spondylitis; Aspartate aminotransferase to alanine aminotransferase ratio; Total cholesterol measurement,Household income	GABPB1	EEF1AKMT2
ENSG00000285427	SOD2-OT1	3.4041942821003	0.00155558082029087	LPS_vs_PBS	HSALNG0054780	anti_sense,sense	Not conserved	hsa-miR-619-5p,hsa-miR-6791-3p	-	SOD2	IGF2BP3
ENSG00000285448	NA	2.84919847069223	0.0100699569963545	LPS_vs_PBS	HSALNG0098910	integenic	Not conserved	hsa-miR-3620-5p,hsa-miR-4505,hsa-miR-1587,hsa-miR-4722-5p,hsa-miR-6089	Tyrosine measurement,-	GPR183	ENSG00000286710
ENSG00000285676	NA	-1.52584236662269	0.0138288034922741	LPS_vs_PBS	HSALNG0142864	anti_sense	Not conserved	hsa-miR-1268b,hsa-miR-7703	NA	ZDHHC6	RASGEF1C
ENSG00000285693	NA	-2.30362666927199	5.33940130492007e-4	LPS_vs_PBS	HSALNG0085586	sense	Q50	hsa-miR-4279,hsa-miR-4492,hsa-miR-5589-5p	Protein measurement,Platelet count,Aspartate aminotransferase measurement,Serum alanine aminotransferase measurement	STARD10	EVI2A
ENSG00000285728	NA	-1.7559878823955	0.00974125963331026	LPS_vs_PBS	HSALNG0003014	anti_sense	Q50	hsa-miR-619-5p,hsa-miR-1285-5p	-	CLDN19	ENSG00000230113
ENSG00000285744	NA	8.19869520923626	3.63557795212957e-53	LPS_vs_PBS	HSALNG0066417	integenic	Not conserved	NA	NA	ZC2HC1A	ATP10A
ENSG00000285761	NA	3.05370896145947	8.32015969898072e-4	LPS_vs_PBS	HSALNG0049090	integenic	Not conserved	hsa-miR-6085	Crohn's disease,Small cell lung carcinoma,Sleep duration,Lymphocyte count,Bmi-adjusted waist-hip ratio,-	HLA-F	TAF5LP1
ENSG00000285774	SAMD4A-AS1	3.221929825452	3.90623945273191e-4	LPS_vs_PBS	HSALNG0101421	anti_sense	Not conserved	hsa-miR-4492	Platelet crit,Sleep quality,Maximal midexpiratory flow rate,Cerebral amyloid deposition measurement,Creatine kinase measurement,Heel bone mineral density,-	GCH1	PPP1R15B
ENSG00000285847	NA	2.4217162391298	0.00149563488258724	LPS_vs_PBS	HSALNG0009013	anti_sense	Q90	hsa-miR-4505	Systolic blood pressure,-	EDEM3	MTND5P14
ENSG00000285865	NA	-3.40806660659604	3.16965469913146e-5	LPS_vs_PBS	HSALNG0148792	anti_sense	Not conserved	NA	-	SQSTM1	HCRTR1
ENSG00000285906	NA	1.16700092757943	0.0140505829038113	LPS_vs_PBS	HSALNG0024144	anti_sense	Q50	hsa-miR-363-5p,hsa-miR-619-5p,hsa-miR-1233-5p,hsa-miR-1303,hsa-miR-4266,hsa-miR-6089	Bmi-adjusted hip circumference,Blood urea nitrogen measurement,Appendicular lean mass,Pulse pressure measurement; Diastolic blood pressure; Systolic blood pressure,Lean body mass; Bone measurement; Fat body mass	VGLL4	ACHE
ENSG00000285967	NIPBL-DT	-1.68049984438977	2.62409500529383e-6	LPS_vs_PBS	HSALNG0041218	integenic	Q50	hsa-miR-1268b	-	CPLANE1	CAPN7
ENSG00000286153	NA	1.70970203579902	0.0303035956669552	LPS_vs_PBS	HSALNG0132875	anti_sense	Not conserved	NA	Erythrocyte count; Response to vaccine; Mean corpuscular hemoglobin; Cognitive decline measurement; Monocyte percentage of leukocytes,Balding measurement,Alopecia,Eosinophil count,Monocyte count,-	CLIC6	PELI1
ENSG00000286154	NA	-2.96510052981269	0.0162666635100581	LPS_vs_PBS	HSALNG0146718	intronic_antisense	Not conserved	NA	NA	PRKAG3	ENSG00000280200
ENSG00000286162	NA	5.63852741414679	2.29884587214455e-15	LPS_vs_PBS	HSALNG0069800	integenic	Q50	NA	NA	PLGRKT	ADAM7-AS1
ENSG00000286194	NA	-3.06723959160329	2.55122540994225e-13	LPS_vs_PBS	HSALNG0145040	integenic	Not conserved	hsa-miR-4463	NA	RNF135	RAP2B
ENSG00000286196	NA	-3.3935377996257	0.0322604034794172	LPS_vs_PBS	HSALNG0150729	anti_sense	Not conserved	NA	Blood protein measurement,-	TTC16	ENSG00000272953
ENSG00000286248	NA	2.69400420402784	1.19596183470289e-4	LPS_vs_PBS	HSALNG0094569	anti_sense	Not conserved	hsa-miR-1268b	Interleukin-8 measurement; C-reactive protein measurement; Chronic obstructive pulmonary disease,C-reactive protein measurement,C-reactive protein measurement; Serum gamma-glutamyl transferase measurement,-	CAMKK2	ENSG00000289942
ENSG00000286337	NA	3.84673177396435	0.0217830174088687	LPS_vs_PBS	HSALNG0067511	anti_sense	Q50	NA	-	SLC25A32	ENSG00000205444
ENSG00000286369	NA	3.31487168530545	1.09290870951173e-4	LPS_vs_PBS	HSALNG0085227	integenic	Not conserved	hsa-miR-619-5p,hsa-miR-4281,hsa-miR-3665,hsa-miR-4443,hsa-miR-4453,hsa-miR-5047,hsa-miR-6089,hsa-miR-6510-5p	Body height	LRP5	TFPI2
ENSG00000286375	NA	4.12818574811076	0.00547157344588637	LPS_vs_PBS	HSALNG0073114	anti_sense	Q50	NA	Response to bisphosphonate; Atypical femoral fracture,Abnormality of refraction,-	TSTD2	MTCYBP23
ENSG00000286430	NA	-3.56506454949566	0.0477868500717486	LPS_vs_PBS	HSALNG0114961	anti_sense	Q50	hsa-miR-3620-5p,hsa-miR-1587,hsa-miR-4665-5p,hsa-miR-4781-5p,hsa-miR-6075	Bmi-adjusted hip circumference,Body weight,Sex interaction measurement; Waist-hip ratio; Bmi-adjusted hip circumference; Age at assessment; Smoking behavior; Bmi-adjusted waist-hip ratio,Bmi-adjusted waist-hip ratio,Triglyceride measurement; Body height,Bmi-adjusted hip circumference; Bmi-adjusted waist-hip ratio,High density lipoprotein cholesterol measurement,-	MED9	ENSG00000285923
ENSG00000286511	NA	4.61701575321853	4.36703327475053e-7	LPS_vs_PBS	HSALNG0052591	integenic	Not conserved	hsa-miR-619-5p	Serum albumin measurement,Risk-taking behaviour,-	ARMC2	RCSD1
ENSG00000286545	NA	-1.56069280664715	0.0136833413706597	LPS_vs_PBS	HSALNG0017935	anti_sense	Not conserved	NA	NA	ZC3H6	ZNF736
ENSG00000286548	NA	5.33839023543583	8.73289456074585e-10	LPS_vs_PBS	HSALNG0005059	anti_sense	Q50	NA	Prostate carcinoma,Blood protein measurement,Total blood protein measurement,Mathematical ability,Adolescent idiopathic scoliosis,Bilirubin measurement,-	GBP5	ENSG00000228330
ENSG00000286558	NA	-4.9884382079885	3.3493958794305e-4	LPS_vs_PBS	HSALNG0148220	integenic	Not conserved	NA	-	TMEM144	MELTF-AS1
ENSG00000286608	NA	1.99381843964337	0.0421182349008943	LPS_vs_PBS	HSALNG0143459	integenic	Q50	hsa-miR-6779-5p	Self reported educational attainment; Serum alanine aminotransferase measurement; Sex hormone-binding globulin measurement; Low density lipoprotein triglyceride measurement; Body mass index; Attention deficit hyperactivity disorder; Body fat percentage; Waist-hip ratio; Unipolar depression; Visceral adipose tissue measurement; High density lipoprotein cholesterol measurement; Platelet count; Aspartate aminotransferase measurement,Attention deficit hyperactivity disorder; Cannabis use,Attention deficit hyperactivity disorder; Antisocial behaviour measurement; Substance abuse,-	TMTC3	VPS50
ENSG00000286672	NA	1.65914492076739	0.0211590928403982	LPS_vs_PBS	HSALNG0149417	anti_sense	Not conserved	NA	NA	TMEM217	FDPSP3
ENSG00000286674	NA	4.75996449089517	1.21513725313522e-5	LPS_vs_PBS	HSALNG0055150	anti_sense,sense	Not conserved	NA	Self reported educational attainment,Neuritic plaque measurement,Parental longevity,Response to alcohol,Urinary metabolite measurement,Serum metabolite measurement,Skin pigmentation measurement,Serum igg glycosylation measurement,Seasonal gut microbiome measurement,Cognitive function measurement,Uterine fibroid measurement,-	GPR31	ENSG00000286511
ENSG00000286681	NA	-1.97229977284186	0.00460043115604695	LPS_vs_PBS	HSALNG0069476	integenic	Not conserved	NA	NA	COMMD5	GUSBP11
ENSG00000286729	NA	1.49130726170453	0.0240944002478263	LPS_vs_PBS	HSALNG0028872	anti_sense	Q50	hsa-miR-3198,hsa-miR-6803-5p	NA	H1-10	ARPC5
ENSG00000286742	NA	-2.25141100010881	0.0290995309500578	LPS_vs_PBS	HSALNG0059553	anti_sense	Q50	hsa-miR-326,hsa-miR-6750-5p	Pulse pressure measurement; Birth weight; Diastolic blood pressure; Systolic blood pressure; Body height,Body height; Mean corpuscular volume,Leukocyte count; Bmi-adjusted hip circumference; Platelet count,Mean corpuscular volume,Bmi-adjusted hip circumference,Bmi-adjusted waist circumference; Bmi-adjusted hip circumference; Erythrocyte count,Atrial fibrillation,Monocyte percentage of leukocytes,Calcium measurement,Mean corpuscular hemoglobin,-	RBM48	ENSG00000272211
ENSG00000286757	NA	-3.3104393833474	0.00508428567376321	LPS_vs_PBS	HSALNG0098950	integenic	Q75	hsa-miR-6730-3p	Sleep measurement,-	ZIC5	PANK1
ENSG00000286802	NA	4.59979672510917	0.0215702613151842	LPS_vs_PBS	HSALNG0005047	anti_sense	Q50	hsa-miR-6089,hsa-miR-8485	Body height,Executive function measurement,Serum metabolite measurement,Temporal horn of lateral ventricle volume measurement,Response to selective serotonin reuptake inhibitor; Openness measurement,-	GBP6	ENSG00000232110
ENSG00000286940	MICB-DT	1.46135051743727	0.00658095453170719	LPS_vs_PBS	HSALNG0049272	anti_sense	Not conserved	hsa-miR-4701-3p,hsa-miR-6089	Renal system measurement,Myositis,Polymyositis; Physical activity measurement; Bmi-adjusted waist-hip ratio; Myositis,Eosinophil count; Platelet count,Squamous cell lung carcinoma; Mmr-related febrile seizures; Bmi-adjusted waist circumference; Lung carcinoma; Eosinophil count,Appendicular lean mass,Glucose measurement,Visual perception measurement,Carpal tunnel syndrome,Herpes zoster,Thyrotoxic periodic paralysis,Bmi-adjusted waist-hip ratio,Bmi-adjusted waist circumference; Bmi-adjusted waist-hip ratio,Eosinophil percentage of leukocytes,Bmi-adjusted hip circumference,Eosinophil count,Susceptibility to childhood ear infection measurement,Body height,Neonatal systemic lupus erythematosus; Myositis; Metabolic syndrome,Hodgkins lymphoma,Lymphocyte count; Basophil count; Myositis; Leukocyte count; Monocyte count,Ulcerative colitis,Atopic asthma,Serum alanine aminotransferase measurement,Bmi-adjusted waist-hip ratio; Mhc class i polypeptide-related sequence b measurement,Angina pectoris,Clinical treatment,Beta blocking agent use measurement,Blood protein measurement; Susceptibility to mumps measurement,Anti-tetanus toxoid igg measurement; Response to vaccine; Malaria,Arterial stiffness measurement,Bmi-adjusted waist circumference; Autism spectrum disorder; Bmi-adjusted hip circumference; Bmi-adjusted waist-hip ratio,Susceptibility to plantar warts measurement,Mhc class i polypeptide-related sequence a measurement,Mhc class i polypeptide-related sequence b measurement,Susceptibility to chickenpox measurement,Susceptibility to shingles measurement,Autism spectrum disorder,Alcohol use disorder measurement,Bmi-adjusted hip circumference; Bmi-adjusted waist-hip ratio,Cytokine measurement,Testosterone measurement,Monocyte count,Platelet crit,Lobe attachment; Lymphocyte count,Bmi-adjusted waist circumference,Response to thioamide; Drug-induced agranulocytosis,Prion disease; Psychotic symptoms,Response to bezlotoxumab; Clostridium difficile infection,Colorectal cancer; Colorectal adenoma,Mosquito bite reaction size measurement; Mosquito bite reaction itch intensity measurement,Human papilloma virus infection; Oropharynx cancer,Blood protein measurement,Bmi-adjusted waist circumference; Bmi-adjusted hip circumference	ATP6V1G2-DDX39B	METTL4
ENSG00000286970	NA	-4.42488606737205	1.74445282573103e-8	LPS_vs_PBS	NA	NA	NA	NA	NA	OTULIN	IL11RA
ENSG00000286972	NA	-3.83423983083185	0.00458291778096439	LPS_vs_PBS	HSALNG0146843	integenic	Q90	NA	Abnormal paneth cell measurement,-	TOP1	ENSG00000260647
ENSG00000286977	NA	-2.7382652209728	0.00499732978006498	LPS_vs_PBS	HSALNG0138195	integenic	Not conserved	hsa-miR-4710	NA	FAAH2	MRE11
ENSG00000286989	NA	-3.16062818498954	8.08704205213278e-5	LPS_vs_PBS	HSALNG0000179	overlap_antisense	Q50	hsa-miR-338-3p,hsa-miR-4292,hsa-miR-4472,hsa-miR-1343-3p,hsa-miR-5572,hsa-miR-5587-3p,hsa-miR-6511b-3p,hsa-miR-6754-5p,hsa-miR-6803-5p,hsa-miR-6804-3p,hsa-miR-6890-3p	Serum alanine aminotransferase measurement; Sex hormone-binding globulin measurement; Low density lipoprotein triglyceride measurement; Body fat percentage; High density lipoprotein cholesterol measurement; Aspartate aminotransferase measurement,-	MIB2	PLEKHH3
ENSG00000287087	NA	-3.49786524948602	0.0405033419750407	LPS_vs_PBS	HSALNG0148606	intronic_antisense	Not conserved	hsa-miR-619-5p	Red blood cell distribution width	NDUFS4	RPL37AP8
ENSG00000287091	NA	-2.99066444948457	8.84631836916368e-8	LPS_vs_PBS	HSALNG0146641	sense	Q50	hsa-miR-1203	NA	CD302	ARL11
ENSG00000287104	NA	-3.40447668032181	7.05886573963166e-5	LPS_vs_PBS	HSALNG0032665	anti_sense	Not conserved	NA	NA	CCDC96	TUT4
ENSG00000287151	C2orf27A	1.53973332145491	0.0470203307050202	LPS_vs_PBS	HSALNG0146214	integenic	Not conserved	NA	NA	CCDC74A	TOMM40P4
ENSG00000287170	NA	-2.57555630043648	0.00561928490122815	LPS_vs_PBS	HSALNG0145803	anti_sense	Not conserved	hsa-miR-6857-5p	-	EPS8L1	KIF23-AS1
ENSG00000287188	NA	5.88597081660405	5.983740805958131e-9	LPS_vs_PBS	HSALNG0038414	anti_sense	Q50	NA	-	DDX60	NCCRP1
ENSG00000287216	NA	2.79730323704235	0.00910437668091796	LPS_vs_PBS	HSALNG0037966	anti_sense	Not conserved	hsa-miR-28-3p,hsa-miR-204-5p,hsa-miR-211-5p,hsa-miR-6784-5p	Mean reticulocyte volume; Platelet crit; Body height; Platelet count; Reticulocyte count; Mean corpuscular volume; Reticulocyte measurement,-	RNF175	ENSG00000232110
ENSG00000287263	NA	1.86063326933245	2.64895098230443e-8	LPS_vs_PBS	HSALNG0041483	integenic	Not conserved	hsa-miR-6807-3p	Intelligence,Cytokine measurement	ANXA2R	FICD
ENSG00000287265	NA	2.18695036282631	0.00528906949624925	LPS_vs_PBS	HSALNG0047279	integenic	Not conserved	NA	NA	EXOC2	LINC02102
ENSG00000287299	NA	1.73186879231095	0.00611712366658311	LPS_vs_PBS	HSALNG0021467	anti_sense	Q75	hsa-miR-7703	Reaction time measurement,Urinary albumin to creatinine ratio,Alcoholic pancreatitis; Alcoholic liver cirrhosis,-	KCTD18	TMEM54
ENSG00000287306	NA	-3.80775441283358	3.00341056922053e-5	LPS_vs_PBS	HSALNG0078581	integenic	Q50	hsa-miR-762,hsa-miR-8485	Body height,Hba1c measurement,-	TSPAN15	ENSG00000255491
ENSG00000287335	NA	3.99072601312832	0.00162261048874736	LPS_vs_PBS	HSALNG0130592	integenic	Not conserved	hsa-miR-619-5p,hsa-miR-6089	Seasonality measurement,-	NCOA3	CDKN1A
ENSG00000287367	NA	-2.18989558567207	0.0399640099179529	LPS_vs_PBS	HSALNG0041841	integenic	Q50	NA	-	SNX18	GABRA4
ENSG00000287382	NA	2.00364095339971	0.0167093221318853	LPS_vs_PBS	HSALNG0034557	anti_sense	Q50	hsa-miR-6829-3p	-	NMU	EML4-AS1
ENSG00000287431	RENO1	-2.0872817169813	0.037648214241965	LPS_vs_PBS	HSALNG0119244	integenic	Q90	NA	-	SLC38A10	ARRDC5
ENSG00000287475	NA	-3.38650092021667	0.0324668449280059	LPS_vs_PBS	HSALNG0142826	integenic	Not conserved	NA	Body mass index	GRID1	TAS2R20
ENSG00000287494	NA	-2.05838166262332	0.0136458109128336	LPS_vs_PBS	HSALNG0144545	anti_sense	Q50	hsa-miR-5787	Fev/fec ratio,Platelet component distribution width	PIF1	SRP54-AS1
ENSG00000287535	NA	6.20221789715769	6.492720487448429e-16	LPS_vs_PBS	HSALNG0064835	integenic	Not conserved	hsa-miR-744-5p,hsa-miR-6089	NA	GPAT4	OR52K1
ENSG00000287543	NA	4.21227350208311	2.10095010065918e-16	LPS_vs_PBS	HSALNG0144564	anti_sense	Q50	NA	Bmi-adjusted hip circumference,-	GOLGA6A	WDR86
ENSG00000287613	NA	-4.08785793152025	8.93997521902582e-5	LPS_vs_PBS	HSALNG0142731	anti_sense	Not conserved	NA	NA	NEBL	ZC3HAV1L
ENSG00000287623	NA	3.20419031079488	0.0168073513990032	LPS_vs_PBS	HSALNG0147456	anti_sense	Q75	NA	Self reported educational attainment	THUMPD3	RPL35AP13
ENSG00000287665	NA	1.96820990014192	0.012663342250695	LPS_vs_PBS	HSALNG0149593	sense	Not conserved	NA	NA	FOXK1	ADAMTS5
ENSG00000287691	NA	4.32029240729725	4.7561281847802495e-11	LPS_vs_PBS	HSALNG0002358	anti_sense	Q50	hsa-miR-4448	Mosaic loss of chromosome y measurement,-	HPCA	GAPDHP14
ENSG00000287733	NA	2.35407740137673	1.25543976773203e-5	LPS_vs_PBS	HSALNG0061536	integenic	Not conserved	hsa-miR-4761-3p	Monocyte count	TMEM140	OSER1
ENSG00000287778	NA	-3.41227947632903	9.83901342786359e-10	LPS_vs_PBS	HSALNG0032926	integenic	Not conserved	NA	NA	DRD5	TNFRSF11A
ENSG00000287823	NA	-3.4314395110042	7.43666360381332e-4	LPS_vs_PBS	NA	NA	NA	NA	NA	FAM120B	OLFML2B
ENSG00000287883	NA	-2.41934451645444	0.0122360579540795	LPS_vs_PBS	HSALNG0055491	anti_sense	Q50	hsa-miR-564,hsa-miR-619-5p,hsa-miR-4279,hsa-miR-4283,hsa-miR-4467,hsa-miR-4492,hsa-miR-6089,hsa-miR-7150	Heel bone mineral density,Non-word reading,Response to opioid,Glioma,-	PDGFA	ENSG00000279713
ENSG00000287892	NA	-2.4088950041885	0.00908937374507952	LPS_vs_PBS	HSALNG0108610	anti_sense	Q50	hsa-miR-619-5p,hsa-miR-6803-5p	Central corneal thickness,Body height,-	CHSY1	CFAP418-AS1
ENSG00000287932	NA	-3.38337550354918	0.0338352783876079	LPS_vs_PBS	HSALNG0059552	sense	Q75	NA	-	CDK6	MIR26B
ENSG00000287936	NA	-3.19182387467862	0.00743630233213991	LPS_vs_PBS	HSALNG0081113	integenic	Not conserved	NA	NA	WDR11	ARF4-AS1
ENSG00000288046	NA	-5.50895462036324	1.36183661729997e-8	LPS_vs_PBS	HSALNG0047831	integenic	Q75	hsa-miR-151a-5p,hsa-miR-151b,hsa-miR-4710	Serum alanine aminotransferase measurement,Reticulocyte count; Reticulocyte measurement,Bmi-adjusted hip circumference,Mean reticulocyte volume; Mean corpuscular volume; Erythrocyte count,Mean corpuscular volume,Monocyte count,Pelvic organ prolapse,Bmi-adjusted waist-hip ratio; Bmi-adjusted hip circumference; Urate measurement,-	LY86	LINC03013
ENSG00000288050	NA	4.31067004456159	0.0313255173031085	LPS_vs_PBS	HSALNG0147467	anti_sense	Not conserved	NA	NA	OXNAD1	ENSG00000232519
ENSG00000288064	NA	4.5837699574374	2.4450552391329e-4	LPS_vs_PBS	HSALNG0146290	anti_sense	Q50	hsa-miR-6085	Myositis,Celiac disease,Rheumatoid arthritis; Limited scleroderma; Systemic scleroderma,-	GLS	EREG
ENSG00000288065	NA	-3.61446826323483	2.71131702797616e-5	LPS_vs_PBS	HSALNG0146128	intronic_antisense	Not conserved	NA	NA	MPHOSPH10	LINC03013
ENSG00000288066	NA	-1.76126673306472	2.89779014805821e-4	LPS_vs_PBS	HSALNG0019641	anti_sense	Q90	NA	-	RIF1	USP4
ENSG00000288156	NA	-5.3013363140667	3.9334002462382e-19	LPS_vs_PBS	HSALNG0123151	intronic_sense	Not conserved	NA	-	NA	SOWAHD
ENSG00000288559	NA	-1.67340682907135	0.0232169172955485	LPS_vs_PBS	HSALNG0142811	integenic	Not conserved	hsa-miR-4481	NA	DNAJC9	ANKRD34A
ENSG00000288596	C8orf44	-1.12258321415528	0.0314316848639646	LPS_vs_PBS	HSALNG0065908	sense	Not conserved	NA	NA	C8orf44-SGK3	DDX20
ENSG00000288610	NA	4.10989465083923	0.00182964818564184	LPS_vs_PBS	HSALNG0103964	integenic	Q50	NA	NA	TNFAIP2	CFAP46
ENSG00000288663	NA	-1.93519965155442	0.00735124471056592	LPS_vs_PBS	NA	NA	NA	NA	NA	MYG1	ENSG00000279670
ENSG00000288736	NA	4.68888148787921	3.06906385935956e-4	LPS_vs_PBS	HSALNG0005330	integenic	Q50	hsa-miR-5703,hsa-miR-6753-5p,hsa-miR-6893-5p	NA	ABCD3	BHLHE40
ENSG00000288742	NA	-1.67528086575806	0.0353517352938105	LPS_vs_PBS	HSALNG0127521	integenic	Not conserved	NA	NA	LAIR1	IGF2R
ENSG00000288754	NA	-2.24021150823744	5.39738227366905e-6	LPS_vs_PBS	HSALNG0136023	integenic	Q50	hsa-miR-3620-5p,hsa-miR-1268b,hsa-miR-4437,hsa-miR-4505,hsa-miR-1587,hsa-miR-6131	Ocular sarcoidosis,Adolescent idiopathic scoliosis,-	GRAMD4	FOXO4
ENSG00000288755	NA	4.64644092883204	1.12766013395649e-4	LPS_vs_PBS	HSALNG0142490	integenic	Q75	NA	NA	PFKP	ACTN2
ENSG00000288767	NA	2.93849233549703	1.07973212764658e-4	LPS_vs_PBS	HSALNG0096284	integenic	Not conserved	NA	NA	RFC3	LINC02102
ENSG00000288792	NA	-2.94503191401854	1.03825433123248e-6	LPS_vs_PBS	HSALNG0055740	sense	Not conserved	hsa-miR-619-5p,hsa-miR-4701-5p	NA	TTYH3	RCCD1-AS1
ENSG00000288818	NA	2.14309677627466	0.0298313574447296	LPS_vs_PBS	HSALNG0065278	anti_sense	Q50	NA	Leptin measurement,Mitochondrial dna measurement,Bmi-adjusted waist circumference,Comparative body size at age 10, self-reported,Quality of life during menstruation measurement; Dysmenorrheic pain measurement,-	NPBWR1	ATP2B1-AS1
ENSG00000288827	NA	-1.74109344663924	0.0369094886271066	LPS_vs_PBS	NA	NA	NA	NA	NA	DHX34	EZH1
ENSG00000288833	NA	3.02170242105232	7.60797795240724e-8	LPS_vs_PBS	HSALNG0086779	integenic	Q90	NA	NA	TMEM123	PERP
ENSG00000288900	NA	3.55281776387588	5.27284597252931e-5	LPS_vs_PBS	HSALNG0021186	integenic	Q50	hsa-miR-6721-5p,hsa-miR-6808-5p	Neutrophil count	CAVIN2	RIPK2-DT
ENSG00000288908	NA	1.44755870963301	0.031889023813049	LPS_vs_PBS	HSALNG0137831	anti_sense	Q75	NA	NA	PQBP1	EPB41L4A-DT
ENSG00000288934	NA	2.44303573269478	0.0167688753831896	LPS_vs_PBS	HSALNG0009875	integenic	Q50	NA	NA	MDM4	SLC30A4-AS1
ENSG00000288971	NA	2.69284294194171	0.0442492905726288	LPS_vs_PBS	NA	NA	NA	NA	NA	BMAL2	TBPL1P1
ENSG00000288999	NA	2.53614398348319	1.66379426155704e-7	LPS_vs_PBS	HSALNG0010910	integenic	Not conserved	hsa-miR-4467	NA	CAPN2	USP38
ENSG00000289003	NA	-3.07488731439534	8.57573535476582e-4	LPS_vs_PBS	HSALNG0014372	anti_sense,sense	Q50	hsa-miR-619-5p,hsa-miR-4447,hsa-miR-6089,hsa-miR-8485	Hematocrit; Hemoglobin measurement,Hematocrit; Erythrocyte count,Hematocrit,Hemoglobin measurement,Red blood cell density measurement,Response to candesartan,-	TMEM178A	FAM13B
ENSG00000289009	NA	1.77806672629238	0.00236299283615392	LPS_vs_PBS	HSALNG0133576	anti_sense	Not conserved	NA	High density lipoprotein cholesterol measurement,Serum gamma-glutamyl transferase measurement	SLX9	GRHL1
ENSG00000289047	NA	-1.42320039729957	0.00114118389876211	LPS_vs_PBS	HSALNG0049461	integenic	Not conserved	hsa-miR-619-5p,hsa-miR-4447	Manic or hypomanic episode,Lumbar disc degeneration	PSMB9	CAB39
ENSG00000289102	NA	-1.54986737995612	1.57254036746059e-4	LPS_vs_PBS	HSALNG0145787	overlap_sense,sense	Not conserved	NA	Vitamin d measurement,Colorectal cancer; Breast carcinoma,Longitudinal alcohol consumption measurement,-	ZNF701	ELMOD2
ENSG00000289103	NA	-2.73476107399776	0.031921625812497	LPS_vs_PBS	NA	NA	NA	NA	NA	DCST2	ENSG00000273064
ENSG00000289135	NA	-2.28547955160637	0.0253172295285102	LPS_vs_PBS	HSALNG0017086	anti_sense	Q50	hsa-miR-4488,hsa-miR-9899	Parental genotype effect measurement; Birth weight,-	ANKRD23	IRS1
ENSG00000289142	NA	2.60814696088336	7.71120153859304e-5	LPS_vs_PBS	HSALNG0010765	anti_sense	Q90	hsa-miR-23a-5p,hsa-miR-6735-3p	Heart failure,Body height,Heel bone mineral density,Apolipoprotein b measurement,Urate measurement,Serum albumin measurement,Monocyte count,Neutrophil percentage of leukocytes,Leukocyte count,Granulocyte percentage of myeloid white cells; Monocyte percentage of leukocytes,Eosinophil count; Basophil count,Lymphocyte count,Neutrophil count,Fetal hemoglobin measurement,C-reactive protein measurement; Vital capacity,C-reactive protein measurement; Total cholesterol measurement,-	RAB3GAP2	CLUH
ENSG00000289161	NA	2.18135514080481	2.02041187061746e-4	LPS_vs_PBS	HSALNG0069294	anti_sense	Not conserved	hsa-miR-619-5p	-	MROH6	MOB2
ENSG00000289198	NA	2.78739158265437	9.7943665854211e-8	LPS_vs_PBS	HSALNG0052920	integenic	Q90	NA	-	MARCKS	LYRM1
ENSG00000289293	NA	1.72111170302197	3.73529024164682e-6	LPS_vs_PBS	HSALNG0117931	integenic	Q90	hsa-miR-4296,hsa-miR-4322,hsa-miR-4265,hsa-miR-3960	NA	MED13	DYNC1H1
ENSG00000289353	NA	-3.51089699629756	3.23238365243205e-6	LPS_vs_PBS	NA	NA	NA	NA	NA	CMTM1	ENSG00000230387
ENSG00000289357	NA	-3.24488092029647	0.0408023538115544	LPS_vs_PBS	NA	NA	NA	NA	NA	CDCA2	ENSG00000290548
ENSG00000289365	NA	3.39906294843002	9.03740973372656e-12	LPS_vs_PBS	HSALNG0139497	integenic	Q50	NA	NA	NXT2	COG6
ENSG00000289372	NA	3.48956840642222	0.0287758421521859	LPS_vs_PBS	HSALNG0053067	anti_sense	Q75	hsa-miR-619-5p,hsa-miR-1268b,hsa-miR-4652-5p,hsa-miR-4710,hsa-miR-6089	Pulse pressure measurement,Systolic blood pressure,-	GOPC	ROS1
ENSG00000289378	NA	-3.77590342064316	0.00294106810415989	LPS_vs_PBS	HSALNG0125414	anti_sense	Q50	hsa-miR-30b-3p,hsa-miR-1285-3p,hsa-miR-3178,hsa-miR-4508	-	SLC7A10	ENSG00000290784
ENSG00000289384	NA	3.48597295024561	0.0478620977527173	LPS_vs_PBS	HSALNG0143688	integenic	Q50	NA	-	KITLG	AMZ2P2
ENSG00000289390	NA	2.70120728368732	0.0342321477379635	LPS_vs_PBS	HSALNG0047002	integenic	Not conserved	hsa-miR-5010-5p,hsa-miR-6798-5p	NA	PHYKPL	BSPRY
ENSG00000289403	NA	5.9528869255558	1.06943336053924e-7	LPS_vs_PBS	NA	NA	NA	NA	NA	INHBA	UBE2H
ENSG00000289421	NA	-3.92916938117009	0.00735993424766255	LPS_vs_PBS	HSALNG0147211	anti_sense	Not conserved	NA	-	C21orf58	ENSG00000272692
ENSG00000289425	NA	3.18940733870413	2.04541935793173e-5	LPS_vs_PBS	NA	NA	NA	NA	NA	RABGAP1L	ENSG00000280091
ENSG00000289439	NA	-2.11274410348762	0.0476989270824802	LPS_vs_PBS	HSALNG0012076	integenic	Q90	hsa-miR-4650-5p,hsa-miR-6089	Unipolar depression,Brain volume measurement,Self reported educational attainment,Cognitive function measurement; Mathematical ability,Response to alcohol,Monocyte count,-	ADSS2	YIPF4
ENSG00000289445	NA	4.90330735894262	8.32166065822525e-8	LPS_vs_PBS	HSALNG0133098	integenic	Not conserved	hsa-miR-30b-3p,hsa-miR-6089	Heel bone mineral density,Body height,Bone fracture,Tpe interval measurement; Response to exercise,-	ETS2	LINC01961
ENSG00000289457	NA	3.84718668892973	0.00496061195432472	LPS_vs_PBS	NA	NA	NA	NA	NA	ADAMTSL4	RRAS2
ENSG00000289485	NA	3.69459359760923	0.0127586803250627	LPS_vs_PBS	HSALNG0116006	anti_sense	Not conserved	NA	C-c motif chemokine 3 measurement,Blood protein measurement,Clopidogrel metabolite measurement,Visual perception measurement,Protein measurement,Refractive error; Ccl4 measurement; Blood protein measurement; Age at onset; Myopia	TBC1D3B	ENSG00000253939
ENSG00000289504	NA	-2.31050854783887	5.6586710184953e-5	LPS_vs_PBS	NA	NA	NA	NA	NA	MAPKAPK3	GZF1
ENSG00000289507	NA	-3.09968952378076	0.00461224385247373	LPS_vs_PBS	NA	NA	NA	NA	NA	KLHL18	RAB26
ENSG00000289526	NA	3.68256962443633	6.88232249135558e-8	LPS_vs_PBS	HSALNG0083600	anti_sense	Q50	NA	Covid-19,Uterine fibroid,Heel bone mineral density,Systemic lupus erythematosus,Systemic lupus erythematosus; Heel bone mineral density,Uterine fibroid; Bone density,Hip bone mineral density,Sex hormone-binding globulin measurement,Triglyceride measurement; Response to hydrochlorothiazide,-	APIP	COMMD2
ENSG00000289530	NA	4.89409198343996	1.23713261822283e-6	LPS_vs_PBS	HSALNG0035158	integenic	Q50	NA	-	RASSF6	TENT5C
ENSG00000289574	NA	2.16480694445642	0.00856937594152737	LPS_vs_PBS	HSALNG0030964	sense	Q75	hsa-miR-363-5p,hsa-miR-1268b,hsa-miR-6089	-	MFN1	ENSG00000235419
ENSG00000289582	NA	4.25158284817613	1.11510234828191e-6	LPS_vs_PBS	NA	NA	NA	NA	NA	GBP2	HSPA1A
ENSG00000289586	NA	-2.02673522750547	0.00561524579040883	LPS_vs_PBS	HSALNG0035338	integenic	Q50	NA	NA	SOWAHB	ZBTB34
ENSG00000289589	NA	4.16908514340686	6.25408908558374e-8	LPS_vs_PBS	HSALNG0008846	integenic	Not conserved	hsa-miR-619-5p,hsa-miR-7108-5p	Eosinophil count; Eosinophil percentage of leukocytes,Eosinophil count,Neuroimaging measurement; Cortical thickness; Brain measurement,-	STX6	LINC01465
ENSG00000289614	NA	2.34144441288551	0.0198382673924004	LPS_vs_PBS	NA	NA	NA	NA	NA	NBPF9	ANKRD13C
ENSG00000289634	NA	3.38933068102612	1.32423124761481e-5	LPS_vs_PBS	NA	NA	NA	NA	NA	SLCO4A1	ENSG00000261026
ENSG00000289727	NA	-1.90685878342728	0.00375911239004483	LPS_vs_PBS	HSALNG0014065	anti_sense	Not conserved	NA	NA	SLC30A6	ENSG00000260917
ENSG00000289880	NA	3.10425344521615	2.33837171977777e-4	LPS_vs_PBS	NA	NA	NA	NA	NA	FAM177B	SMS
ENSG00000289885	NA	-2.58356986061515	0.021401793789107	LPS_vs_PBS	HSALNG0029913	sense	Q75	hsa-miR-619-5p,hsa-miR-6803-5p	Lysophosphatidylcholine 20:5 measurement,Trauma exposure measurement,Lymphocyte count,Pr interval,Platelet count,Covid-19,Lysophosphatidylcholine 22:6 measurement,Cerebral amyloid deposition measurement,Hair color; Cutaneous melanoma,Lymphocyte percentage of leukocytes,-	RAP2B	TSSK3
ENSG00000289942	NA	6.5447981373544	2.04423378987035e-10	LPS_vs_PBS	NA	NA	NA	NA	NA	TMPRSS11E	TMEM170A
ENSG00000289970	NA	3.11722253046733	3.84781298372786e-6	LPS_vs_PBS	NA	NA	NA	NA	NA	GPX3	TXN
ENSG00000289972	NA	3.3190354569680798	1.21209312650958e-4	LPS_vs_PBS	HSALNG0080384	anti_sense	Q90	hsa-miR-4327	Self reported educational attainment,White matter hyperintensity measurement,White matter microstructure measurement,-	NEURL1	INKA1
ENSG00000289977	NA	-4.88562006372519	1.00101983124812e-5	LPS_vs_PBS	HSALNG0114255	integenic	Not conserved	NA	NA	ACADVL	FGF14-AS2
ENSG00000289979	NA	2.19288983027214	0.00604158051648986	LPS_vs_PBS	HSALNG0100117	anti_sense	Q75	NA	-	GMPR2	ENSG00000289161
ENSG00000289999	NA	3.13379108005744	0.049309038309026	LPS_vs_PBS	NA	NA	NA	NA	NA	FNIP2	SPAG5
ENSG00000290013	NA	4.09177227822718	0.00322847372305657	LPS_vs_PBS	NA	NA	NA	NA	NA	JUN	FAM171B
ENSG00000290021	NA	1.76308643044377	0.00957618503101556	LPS_vs_PBS	HSALNG0148005	anti_sense,sense	Q90	hsa-miR-4467	-	BCL6	UXT
ENSG00000290034	NA	-3.69263052966593	2.34922776417607e-8	LPS_vs_PBS	HSALNG0049994	anti_sense	Q50	hsa-miR-6728-3p,hsa-miR-8485	C-reactive protein measurement,Isoleucine measurement; Leucine measurement,Supraventricular ectopy,Family history of alzheimer’s disease; Late-onset alzheimers disease,Late-onset alzheimers disease,Aortic stenosis; Aortic valve calcification,-	TREML4	KLHDC1
ENSG00000290082	NA	-2.2745757441718	0.00636800499445708	LPS_vs_PBS	HSALNG0115585	anti_sense	Not conserved	NA	NA	ABHD15	ABHD17AP5
ENSG00000290091	NA	-2.52546723352755	0.0172561157474572	LPS_vs_PBS	HSALNG0055874	anti_sense	Q50	hsa-miR-326,hsa-miR-762,hsa-miR-3195,hsa-miR-4505,hsa-miR-4632-3p,hsa-miR-5787,hsa-miR-6803-5p	Pcsk9 protein measurement,-	SLC29A4	KIF23-AS1
ENSG00000290110	NA	-3.24027797321604	0.0411834488789242	LPS_vs_PBS	NA	NA	NA	NA	NA	TCF7L1	PCP2
ENSG00000290418	TPTEP1	-2.15948118921812	0.00108503906946424	LPS_vs_PBS	HSALNG0133819	integenic	Not conserved	NA	-	IL17RA	SHROOM1
ENSG00000290427	NA	-3.74522209903628	9.16219431363163e-9	LPS_vs_PBS	HSALNG0123614	integenic	Not conserved	NA	Susceptibility to chronic sinus infection measurement	MBD3L2B	ANKRD44
ENSG00000290525	GBP1P1	8.50448623228327	7.894114660204749e-26	LPS_vs_PBS	NA	NA	NA	NA	NA	GBP6	TMEM140
ENSG00000290548	NA	-3.06047464982609	0.00550304520559919	LPS_vs_PBS	HSALNG0041076	integenic	Not conserved	NA	NA	C1QTNF3-AMACR	ENSG00000257531
ENSG00000290600	NA	-2.84114719945257	1.09324569338787e-4	LPS_vs_PBS	HSALNG0062142	sense	Not conserved	hsa-miR-331-3p,hsa-miR-4323,hsa-miR-6090	NA	ZNF783	OSBPL7
ENSG00000290720	ZNF542P	-1.32378327609459	0.00202615884560735	LPS_vs_PBS	HSALNG0127752	anti_sense	Not conserved	hsa-miR-939-3p	NA	ZNF583	PCMTD2
ENSG00000290735	NA	-3.37458667403403	0.00482663581375229	LPS_vs_PBS	HSALNG0006949	integenic	Not conserved	NA	NA	H3-7	CHIC1
ENSG00000290762	NA	-1.9821283907663	0.013306715999725	LPS_vs_PBS	HSALNG0031865	integenic	Not conserved	hsa-miR-6736-3p	-	TNK2	ENSG00000256706
ENSG00000290793	NA	-1.82960131519432	0.00213505843884437	LPS_vs_PBS	NA	NA	NA	NA	NA	AMZ2	SOX13
ENSG00000290796	NA	-1.7026186697996	0.0124690840214145	LPS_vs_PBS	HSALNG0134568	sense	Not conserved	hsa-miR-328-3p	NA	LHFPL7	ENSG00000283236
ENSG00000290838	NCF1B	3.08634867382632	3.04627495938685e-4	LPS_vs_PBS	HSALNG0058823	integenic	Not conserved	hsa-miR-619-5p	NA	FKBP6	NKX3-1
ENSG00000290854	NA	-1.49499932157057	0.0063844090308816	LPS_vs_PBS	NA	NA	NA	NA	NA	CDK11A	RTL10
ENSG00000290858	NA	-4.03136575537792	0.00542652211162445	LPS_vs_PBS	HSALNG0115677	integenic	Q90	hsa-miR-4478,hsa-miR-6089	Protein measurement,-	TEFM	SMAD9
ENSG00000290923	PGM5P2	-2.04915030745574	0.0229840460718154	LPS_vs_PBS	HSALNG0071566	integenic	Not conserved	hsa-miR-331-3p,hsa-miR-525-5p,hsa-miR-4270	NA	FOXD4L6	NUTM2A
ENSG00000290928	NA	-1.45106661250731	0.00174305649247166	LPS_vs_PBS	HSALNG0115658	integenic	Not conserved	NA	NA	ATAD5	LRRFIP2
ENSG00000290989	NA	-1.80476856453004	0.00291962611718877	LPS_vs_PBS	HSALNG0010926	integenic	Not conserved	NA	-	FBXO28	ENSG00000271327
ENSG00000290993	NA	-1.22650497543971	6.09237852114741e-4	LPS_vs_PBS	HSALNG0028889	integenic	Not conserved	hsa-miR-6871-5p	NA	EFCAB12	ZNF528
ENSG00000290994	FAM86C2P	-3.38813331054504	0.0318308666649672	LPS_vs_PBS	HSALNG0085186	integenic	Not conserved	hsa-miR-619-5p	Hair colour measurement,Bmi-adjusted waist circumference,Bmi-adjusted waist circumference; Bmi-adjusted hip circumference,Bmi-adjusted hip circumference,Body height,Interleukin 18 measurement,Qrs duration,Sex interaction measurement,-	ALDH3B2	RDH10-AS1
ENSG00000290999	NA	2.92371483652989	0.00176635997081664	LPS_vs_PBS	NA	NA	NA	NA	NA	SEC22B	ENSG00000285631
ENSG00000291003	NA	-1.3055379401625	0.00209754793582589	LPS_vs_PBS	HSALNG0104483	integenic	Not conserved	NA	NA	GOLGA6L22	SHC3
ENSG00000291015	NA	-2.54938969051367	2.62276625131447e-5	LPS_vs_PBS	HSALNG0135407	sense	Not conserved	NA	NA	TPTEP2-CSNK1E	GNA12
ENSG00000291033	TXLNGY	7.16639051107518	9.04074608417825e-4	LPS_vs_PBS	HSALNG0141378	integenic	Not conserved	hsa-miR-363-5p	NA	EIF1AY	RPS4Y1
ENSG00000291043	GLUD1P3	-1.62992820244918	1.94243756521447e-4	LPS_vs_PBS	HSALNG0078866	integenic	Not conserved	NA	-	SEC24C	ENSG00000249852
ENSG00000291055	NA	-1.7494623010228	0.0486024386835612	LPS_vs_PBS	HSALNG0039572	integenic	Not conserved	NA	Lung adenocarcinoma,-	LPCAT1	FAM228B
ENSG00000291063	NA	-2.11189427906447	2.38202051631068e-6	LPS_vs_PBS	HSALNG0145041	integenic	Not conserved	NA	NA	NF1	DRC3
ENSG00000291064	RPL23AP7	-1.24749370800823	0.0415287669717795	LPS_vs_PBS	HSALNG0136334	anti_sense	Not conserved	hsa-miR-4469	NA	ACR	ENSG00000261611
ENSG00000291066	NA	-2.12931718717491	1.17205528160563e-5	LPS_vs_PBS	HSALNG0110139	integenic	Not conserved	hsa-miR-619-5p	-	NPIPB4	UHRF2
ENSG00000291072	CROCCP2	-1.18025735047886	0.00274516893887158	LPS_vs_PBS	HSALNG0001201	integenic	Not conserved	NA	NA	NBPF1	ENSG00000279833
ENSG00000291077	NA	5.01877516843208	1.2668245742287099e-23	LPS_vs_PBS	NA	NA	NA	NA	NA	ARHGEF19	IDO1
ENSG00000291080	ZNF252P	-1.44968575469444	4.39296503320942e-4	LPS_vs_PBS	NA	NA	NA	NA	NA	ZNF16	SIRT3
ENSG00000291086	LGALS17A	5.06481238738088	8.68440786348166e-4	LPS_vs_PBS	HSALNG0126029	integenic	Not conserved	NA	NA	LGALS14	TMEM151B
ENSG00000291091	SDHAP4	-1.45546570517091	2.62628005366993e-4	LPS_vs_PBS	HSALNG0032044	integenic	Not conserved	hsa-miR-4281	NA	BDH1	UBB
ENSG00000291122	CASTOR3P	-2.40673915284612	6.97303612709969e-4	LPS_vs_PBS	HSALNG0150011	sense	Not conserved	hsa-miR-125a-3p	NA	GPC2	ENSG00000279365
ENSG00000291129	PPIEL	-1.7683522119259	0.0011818986002109	LPS_vs_PBS	HSALNG0002774	anti_sense	Q90	hsa-miR-631,hsa-miR-3135b,hsa-miR-4722-5p,hsa-miR-6089,hsa-miR-8485	Forced expiratory volume; Red blood cell distribution width; Traffic air pollution measurement; Fev/fec ratio; Peak expiratory flow; Peripheral arterial disease,Peripheral arterial disease; Alkaline phosphatase measurement; Traffic air pollution measurement,Testosterone measurement,Diastolic blood pressure,Triglyceride measurement; Mean corpuscular volume,Mean corpuscular volume; Mean corpuscular hemoglobin,Mean corpuscular hemoglobin,High density lipoprotein cholesterol measurement; Waist-hip ratio,Triglyceride measurement; C-reactive protein measurement; Waist-hip ratio,Chronic obstructive pulmonary disease; Resting heart rate,-	PABPC4	ENSG00000260005
ENSG00000291144	NA	3.28704689007892	1.11510234828191e-6	LPS_vs_PBS	HSALNG0082349	overlap_sense	Not conserved	NA	Lung carcinoma,Mean corpuscular hemoglobin concentration,Hip bone mineral density; Hip bone size,Diastolic blood pressure,-	OR52K1	ENSG00000260997
ENSG00000291147	NA	-2.31231795472316	0.0105682444112483	LPS_vs_PBS	HSALNG0146386	integenic	Not conserved	hsa-miR-4463	Vitamin b12 measurement	RTP5	ENSG00000261342
ENSG00000291149	NA	2.95693911346442	0.00410760382074811	LPS_vs_PBS	HSALNG0061972	anti_sense,sense	Not conserved	hsa-miR-6779-5p	-	CTAGE6	ENSG00000244491
ENSG00000291151	NSUN5P1	-2.45971497134879	4.74951241312361e-5	LPS_vs_PBS	HSALNG0149717	anti_sense,sense	Not conserved	hsa-miR-619-5p	Body mass index,Uric acid measurement,Energy intake,Serum alanine aminotransferase measurement; Sex hormone-binding globulin measurement; Low density lipoprotein triglyceride measurement; Body mass index; Body fat percentage; Body height; High density lipoprotein cholesterol measurement; Aspartate aminotransferase measurement,Parental longevity; Body mass index,Body weight,Serum gamma-glutamyl transferase measurement,Systemic lupus erythematosus,Visceral adipose tissue measurement,Systolic blood pressure,Systolic blood pressure; Diastolic blood pressure; Mean arterial pressure,Self reported educational attainment; Pulse pressure measurement; Diastolic blood pressure; Body mass index; Physical activity measurement; Mathematical ability; Systolic blood pressure; Body height; Smoking behavior,C-reactive protein measurement,Ankle injury,Mathematical ability; Fasting blood insulin measurement,Large artery stroke,Basophil percentage of granulocytes; Basophil count; Basophil percentage of leukocytes,Basophil count,Ccl24 measurement,Dna methylation,Cognitive behavioural therapy,Essential tremor,Colorectal cancer,Covid-19,Carotid plaque build,Eosinophil count; Eosinophil percentage of granulocytes; Basophil count; Eosinophil percentage of leukocytes,Sarcoidosis,Eosinophil count; Eosinophil percentage of leukocytes,Eosinophil count,Serum alanine aminotransferase measurement; Aspartate aminotransferase measurement,Mosquito bite reaction size measurement; Mosquito bite reaction itch intensity measurement,-,Age-related nuclear cataract,Age at first sexual intercourse measurement; Health study participation; Cognitive function measurement,Age at menarche	TRIM73	MRE11
ENSG00000291156	NA	1.38148083572146	0.00230550479741132	LPS_vs_PBS	HSALNG0000078	integenic	Not conserved	NA	-	AGRN	ARL6IP1
ENSG00000291171	NA	-1.0322931900737	0.045358631027649	LPS_vs_PBS	NA	NA	NA	NA	NA	EP400	PSMA3-AS1
ENSG00000291174	NA	4.00131050476988	9.735243577477719e-11	LPS_vs_PBS	NA	NA	NA	NA	NA	FRMD8	COL5A3
ENSG00000291186	NA	-1.74656334911697	0.00298900158549431	LPS_vs_PBS	NA	NA	NA	NA	NA	DEFB108B	ENSG00000286757
ENSG00000291188	NA	-3.20329702024534	0.00991582397232217	LPS_vs_PBS	HSALNG0110573	integenic	Not conserved	NA	NA	LAT	HEATR4
ENSG00000291203	NA	-1.48069687264446	0.00144728760501653	LPS_vs_PBS	HSALNG0148177	anti_sense	Not conserved	NA	NA	USP53	ALKBH2
ENSG00000291207	NA	-1.16059593230809	0.0135559653035916	LPS_vs_PBS	HSALNG0057744	integenic	Not conserved	NA	-	CCDC201	ENSG00000257270
ENSG00000291223	FAM86DP	-2.27213497809785	9.31358187271256e-7	LPS_vs_PBS	HSALNG0026916	integenic	Not conserved	hsa-miR-485-5p	NA	ZNF717	PSIP1
ENSG00000291224	NA	-1.75871220553278	0.045934202632296	LPS_vs_PBS	HSALNG0024079	anti_sense	Not conserved	hsa-miR-6736-3p	Blood protein measurement,Body weight,3-hydroxypropylmercapturic acid measurement,-	FANCD2	ENSG00000229425
ENSG00000291233	NA	2.33631491081802	1.7873198849685098e-11	LPS_vs_PBS	NA	NA	NA	NA	NA	NBPF9	SPSB1
ENSG00000291236	NA	1.8903120059948	0.0484103701194672	LPS_vs_PBS	NA	NA	NA	NA	NA	TNS1	LARP6
ENSG00000291263	SMG1P7	-2.10486554126163	0.0219440848773755	LPS_vs_PBS	NA	NA	NA	NA	NA	EXOSC6	ENSG00000279369
ENSG00000291286	NA	4.15472672126889	0.048603227181286	LPS_vs_PBS	HSALNG0055149	sense	Not conserved	NA	NA	CCR6	THSD1
